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ABSTRACT
This thesis examines the relationship between anatomical location and outcomes in
adult extremity soft tissue sarcoma. Four studies address differing aspects of this
question by reviewing patients treated at the Musculoskeletal Oncology Unit at the
Mount Sinai Hospital, Toronto, Canada.
The anatomical relationships of a tumour may mean that it is resected with a positive
surgical margin. The first study looks at the clinical situations in which a positive
surgical margin occurs and tests a classification of positive surgical margins. The
study shows that positive surgical margins occurring after the resection of a low-
grade liposarcoma and planned positive margins against critical anatomical structures
are associated with a low risk of local recurrence. However, positive surgical
margins occurring during reexcision of a tumour following unplanned excision and
unplanned positive margins occurring during primary resection are associated with a
significantly higher risk of local recurrence.
The second study examines differences in presentation, treatment and outcomes
between soft tissue sarcomas in the upper and lower extremities. It shows that upper
extremity tumours are smaller, are more often subjected to unplanned excision before
referral and are less often treated with radiotherapy. Upper extremity tumours are
more likely to recur locally after treatment, whereas lower extremity tumours are
more likely to metastasise.
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The third study examines the relationship between the anatomical location of lower
extremity soft tissue sarcoma and functional outcome following treatment measured by
Musculoskeletal Tumour Society (MSTS (1993)) and Toronto Extremity Salvage Score
(TESS) evaluations. It shows that treatment of superficial tumours does not lead to
significant changes in functional scores. Treatment of deep tumours, however, leads to
significant reductions in functional scores. Aggregated functional scores do not appear
to vary with anatomical location, but the items that comprise the aggregated scores do.
The final study examines whether or not the preservation of anatomical structures
leads to better functional scores by comparing scores after the planned marginal
excision or "shelling out" of a low grade liposarcoma with those seen after the wider
resection of a high grade tumour. It shows that the planned marginal excision of a
low grade liposarcoma does lead to significant changes in functional scores, although
this approach may lead to better TESS evaluations.
These novel, clinically relevant, studies confirm the importance of anatomical




The data used in these studies were collected prospectively and reviewed regularly
for the purposes of clinical audit and quality control within the Musculoskeletal
Oncology Unit at the Mount Sinai Hospital, Toronto, Canada. Functional outcome
scores were collected as part of a number of ethically approved studies for which
consent was obtained. This consent includes provision for further analysis.
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1. INTRODUCTION AND AIMS
Soft tissue sarcomas are rare malignant tumours that exhibit heterogeneity in type,
anatomical location and biological behaviour. Most are considered to be of
mesenchymal origin, meaning they originate from, and resemble, connective tissues.
By convention, this group usually also includes tumours of neural origin but not the
cutaneous Kaposi's sarcoma. Soft tissue sarcomas arise most frequently in the
extremities and trunk (55%), in the retroperitoneum or viscera (35%) or head and
QO #
neck (10%) . Lower extremity soft tissue sarcomas are more common than those in
1 8 • 79-Q8-1 77 • 1 78
the upper extremity ' ' ' ' . The disease occurs at all ages but is most frequently
seen in the middle decades of life, at a median of around 50-60 years 4'69'132.
Although local control of extremity tumours can be achieved in up to 90% of
patients, 10-year disease-specific survival is between 50 and 60% in most series
33;69;125;138 ancj jias not changed significantly in recent years 134. Treating patients with
these tumours therefore presents a number of challenges; clinical presentation is
often delayed, histological diagnosis is specialised, local control requires carefully
planned surgery and radiotherapy, there is no highly effective agent for the treatment
9
of systemic disease and the rarity and heterogeneity of the condition make research
difficult. This introduction reviews what is known about adult extremity soft tissue
sarcoma, how present treatment regimes have evolved, and describes the aims of this
thesis.
The term "sarcoma" derives from the Greek sarx, meaning flesh, as these tumours
were originally considered fleshy in appearance. Although malignant tumours were
described in the Smith Papyrus, which originated in ancient Egypt in around 1600
BC, the first recognised description of a sarcoma is attributed to Galen in the second
/TO
century AD . In the eighteenth century the development of the achromatic
microscope and thin tissue sectioning techniques lead to the recognition of different
embryonic germ layers . The French anatomist Jean Cruveilhier (1791-1874)
published illustrations of the gross anatomy of bone and soft tissue tumours, but it
was the noted pathologist Rudolf Virchow (1821-1902) who separated sarcomas
from carcinomas, defining them as arising from non-epithelial or non-
haematogenous tissues. He distinguished six major types of sarcoma: fibrosarcoma,
myxosarcoma, gliosarcoma, melanosarcoma, chondrosarcoma and osteosarcoma 94.
The contemporary understanding of the pathology of soft tissue sarcomas has
developed as a result of the efforts of, among others, Henry L Jaffe (1896-1979) and
Louis Lichtenstein (1906-1977), Dahlin from the Mayo Clinic and Stout, Enzinger
and Weiss from the Armed Forces Institute ofPathology, who have published the
clinical experience of their centres 94.
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Incidence
Although soft tissues and bone comprise around 75% of total body weight, soft tissue
sarcomas account for fewer than 1% of all cancers I10'143. The overall incidence of
soft tissue sarcoma increases with age (Figure 1.1). In England and Wales, the
Department of Health records around 1200 cases of soft tissue sarcoma in adults 30
and around 80 cases of soft tissue sarcoma per annum in children (under the age of
9Q
15) . Figures from the United States show a similar incidence, of 2.8 per 100,000
per annum 10°. Although one study suggests that the incidence of soft tissue sarcoma
may be increasing, this has not definitively been demonstrated l42.
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Figure 1.1
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Age range
Data derive from the United States' Surveillance, Epidemiology, and End Results
(SEER) Program of the National Cancer Institute (1973-2000) and include tumours
arising in the heart. These data are available at www. seer,cancer, gov
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Aetiology
In most cases of soft tissue sarcoma it is not possible to identify an aetiological
cause. However, some genetic and environmental factors have been associated with
the disease.
Genetic factors
In the Li-Fraumeni syndrome, families have a predisposition to the early
development ofmalignant tumours. In most cases there is an inherited defect in the
p53 tumour suppressor gene 143. The p53 gene product has a number of roles,
including DNA repair, and the p53 pathway is altered in most human cancers 60.
Individuals in these families are thought to have a 50% probability of developing an
1 90
invasive malignancy by the age of 30 . The spectrum of cancers in this syndrome
includes breast cancer, brain tumours, leukaemia, and adrenocortical carcinoma as
well as soft tissue sarcoma and osteosarcoma l43.
The retinoblastoma (RB) gene is a tumour suppressor gene subject to unique
inactivating mutations in retinoblastoma, osteosarcoma and other sporadic
sarcomas". Patients with the inherited form of retinoblastoma have a germline
mutation of this gene. Survivors of the inherited form of retinoblastoma have a 10-
15% lifetime risk of developing a soft tissue sarcoma .
Type 1 neurofibromatosis is an inherited autosomal dominant condition associated
with an increased risk of neurogenic sarcomas such as neurofibrosarcoma in adults,
and rhabdomyosarcoma in children. Adults with the condition have a 5-10% lifetime
risk of developing malignant change within a pre-existing neurofibroma 144. In
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Gardner's syndrome, familial polyposis of the colon is associated with fibromatosis
and rarely fibrosarcoma 107.
Environmental factors
Some medical interventions are associated with the development of soft tissue
sarcoma. Radiotherapy, especially when given in conjunction with alkylating
chemotherapeutic agents is associated with the late (median 8 years) development of
secondary sarcoma 76'97. Secondary sarcomas most often occur within or at the edge
of the previously irradiated field and the risk of secondary sarcoma is probably dose-
related 143. The absolute risk of developing a secondary sarcoma has been estimated
oi
at between 0.03 and 0.8% . A study of breast cancer survivors found the cumulative
incidence of secondary sarcoma at 15 years after diagnosis to be 3.2 per 1000 in
patients who had received radiotherapy and 2.3 per 1000 amongst those who had
not140.
Thorotrast (colloidal thorium dioxide) is an alpha-emitting radioisotope once used
for the radiographic investigation of blood vessels and has been associated with the
development of sarcoma, particularly hepatic angiosarcoma. The cumulative risk of
liver malignancy (angiosarcomas and carcinoma) has been estimated at up to 30% at
40 years 143. There are reports of sarcomas developing at the sites of injection of
• 1?•101• 113
iron-dextran compounds and chemotherapeutic agents ' ' .
Studies of Swedish forestry workers have reported a six-fold increased risk of soft
tissue sarcoma following exposure to phenoxyacetic herbicides, chlorophenols and
• • 62' 136contaminants (dioxins) within them ' .
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The chronic irritation associated with skin ulceration has been associated with the
development of soft tissue sarcoma44. Sarcomas have also been reported around
• • • •• 17*199
metal implants, in particular joint replacements ' , although large population-
based studies have failed to demonstrate an increased risk of sarcoma in patients who
have had joint replacements49'50'92'112. Theoretical evidence that metal-on-metal
bearings lead to the production ofmore carcinogenic wear debris has not yet been
translated into a higher rate ofmalignancy amongst patients 130. Smokeless tobacco,
paternal smoking habits and dietary factors have all also been related to the
development of soft tissue sarcoma l43.
Clinical Presentation
Most patients with an extremity soft tissue sarcoma present with a painless mass,
although pain may make the diagnosis ofmalignancy more likely 74. Soft tissue
sarcomas are often neglected because neither the patient nor their doctor suspects
malignancy. Presentation of an extremity soft tissue sarcoma may be delayed until
the mass interferes with normal activities, such as wearing normal clothes.
A significant proportion (approximately 40% in some series) of patients present
having had an "unplanned excision", that is removal of the tumour by a surgeon who
has not considered beforehand that it may be malignant79'88. This is more likely to
occur when tumours present in the upper extremity 18'1H. By definition, unplanned
excision is performed without regard for preoperative imaging or the necessity to
remove a margin of normal tissue covering the tumour and is therefore usually
15
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incomplete " ' . These procedures are popularly known as "whoops" operations .
• • • • 88
Afterwards, residual tumour is difficult to detect with imaging . Local recurrence is
highly likely unless residual tumour cells are removed and therefore re-excision of
88
the surgical wound is usually recommended .
Despite the strong clinical impression that unplanned excision is likely to
compromise oncological outcomes, there is controversy about this in the literature.
• 88
Some authors associate unplanned excision with higher local recurrence rates ,
some have not found a difference in local control rates 67, and others have reported
that unplanned excision followed by re-excision is associated with higher survival
rates 51;79.
Despite this controversy, in common with other rare diseases, it is generally accepted
that patients with soft tissue sarcomas should have access to an experienced
specialist multidisciplinary team. This is an expressed goal of the United Kingdom
National Plan for Cancer 31. Specialist teams allow clinicians to accumulate
experience of these rare tumours, to make collaborative decisions about appropriate
combinations of different treatment modalities and collect data. There is evidence to
suggest that patients treated in specialist centres are likely to receive higher standards
of care, undergo fewer operations and are likely to have lower local recurrence
rates15'58'88.
To avoid unplanned excision and to expedite appropriate referrals, guidelines have
been developed and circulated. The United Kingdom Department of Health
guidelines are reproduced in Figure 1.2 . Guidelines such as these balance the risk
16
Figure 1.2
Department of Health Guidelines for the referral of soft tissue masses 30
Soft Tissue Sarcoma
Can occur at any age - more common over 30 years.
Most soft tissue masses are benign (only 1 in 200 are malignant).
Features of a soft tissue mass which are suggestive ofmalignancy include:




Recurrence after previous excision
Lumps which are superficial and painless and less than 5 cms and static in size are
extremely unlikely to be malignant.
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ofmissing a rare but malignant sarcoma against the workload implications of large
numbers of referrals for benign tumours. Implementation of these guidelines in
Sweden has lead to around 10 benign tumours being referred for every proven
malignant soft tissue sarcoma55. These guidelines do not account for anatomical
location. In particular, malignant tumours in the upper extremity are smaller than
those in the lower, and a significant percentage are less than 5 centimetres in
1 8- S7* 111
maximum diameter ' ' .
Pathological characteristics
The diagnosis of soft tissue sarcoma is usually made following the histological
examination of tissue obtained at biopsy. Because definitive local treatment involves
the removal of the whole tumour and the biopsy track, biopsies must be performed
with great care. The histological classification of soft tissue sarcomas is based on the
morphological appearance under the light microscope. For example, liposarcomas
consist of cells that resemble adipocytes. However, immunohistochemical stains are
essential to further characterise tumours, and at present over 130 types are recognised
(Appendix 1).
The histological grade of a tumour is one of the best predictors of biological
behaviour. However, no consensus exists about the specific criteria that should be
used for histological grading. The two most widely used systems are the National
90
Cancer Institute System , and the French Federation of Cancer Centres Sarcoma
Group System 126. The former system is based on histological type, location,
18
necrosis, cellularity, nuclear pleomorphism and mitotic count. The latter generates a
score from considerations of tumour differentiation, mitotic rate, and degree of
tumour necrosis.
Newer techniques, in particular cytogenetic analysis, have allowed classification to
evolve further as some soft tissue sarcomas have characteristic abnormalities (Table
1.1). For example, synovial sarcoma was previously defined by morphological and
immunohistochemical features and is now defined by a characteristic X:18
translocation. Similarly, the diagnosis of gastro-intestinal stromal tumours is
strengthened if there is overexpression of the c-Kit receptor 45.
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Table 1.1






Synovial sarcoma t (X;18)(pl 1.2;ql 1.2) SSX1 or SSX2, SYT
Myxoid/round cell t (12; 16)(q13;p11) CHOP, TLS
liposarcoma t(12;22)(ql3;ql2) CHOP, EWS
Ewing's sarcoma/ t (11:22)(q24;ql2) FLU, EWS
primitive t (21:22)(q22;ql2) ERG, EWS
neuroectodermal tumour t (7;22)(p22;ql2) ETV1, EWS
t (2;22)(q33;ql2) FEV, EWS
t (12;22)(ql2;ql2) E1AF, EWS
Clear cell sarcoma t (12;22)(q 13 ;ql 2) ATF1, EWS
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Staging Systems
Although heterogeneity in anatomical location and histological type makes it
difficult to establish systems that can accurately stage all patients, a number of
staging systems are widely used. These include the American Joint Committee on
Cancer System (AJCC) , and the Musculoskeletal Tumour Society System
(MSTS)36. These systems use factors of known prognostic significance, including
histological grade, size, depth, lymph node involvement and distant metastases. The
MSTS system includes the compartmental status of the tumour, which reflects its
anatomical location. The Musculoskeletal Tumour Society system is summarised in
Table 1.2 and the fifth edition of the AJCC system, in use when these studies in this
thesis were completed, is summarised in Table 1.3. Of these two systems, the fifth
edition of the AJCC system is of greater value in predicting metastasis-free
survival138.
The sixth edition of the AJCC system has been in use since January 2003. This new
edition was developed after further analysis of data from the Memorial Sloan
Kettering Cancer Centre, which showed that large deep low grade tumours should be
classified along with large superficial low grade tumours as stage 1B rather than IIA,
reducing the number of categories in stage II to two. In addition, the new




Musculoskeletal Tumour Society staging system for primary bone and









MO No regional or distant metastases
Ml Regional or distant metastases present
Stage GTM Description


























American Joint Committee on Cancer Staging System for Soft Tissue
Sarcoma. Fifth Edition 2
Tumour grade (G)






TX: Primary tumour cannot be assessed
TO: No evidence ofprimary tumour
T1: Tumour 5 cm or less in greatest dimension
Tla: Superficial tumour
Tib: Deep tumour




Regional lymph nodes (N)
NX: Regional lymph nodes cannot be assessed
NO: No regional lymph node metastasis
N1: Regional lymph node metastasis
Distant metastasis (M)
MX: Distant metastasis cannot be assessed
MO: No distant metastasis
Ml: Distant metastasis
StageIA
Stage IA tumour is defined as low grade, small, superficial or deep.
G1 TlaNOMO / G1 Tib NO MO / G2 TlaNO MO / G2 Tib NO MO
Stage IB
Stage IB tumour is defined as low grade, large and superficial.
G1 T2a NO MO / G2 T2a NO MO
Stage IIA
Stage IIA tumour is defined as low grade, large and deep.
G1 T2b NO MO / G2 T2b NO MO
StageIIB
Stage IIB tumour is defined as high grade, small, superficial or deep.
G3 TlaNO MO / G3 Tib NO MO / G4 TlaNO MO / G4 Tib NO MO
Stage IIC
Stage IIC tumour is defined as high grade, large and superficial.
G3 T2a NO MO / G4 T2a NO MO
Stage III
Stage III tumour is defined as high grade, large and deep.
G3 T2b NO MO / G4 T2b NO MO
Stage IV
Stage IV is defined as any metastasis to lymph nodes or distant sites.
Any G, any T N1 MO / Any G, any T NO Ml
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Although useful, these staging systems can only crudely reflect the complex
interaction between tumour and host. It is likely that other indicators of tumour
behaviour, such as chromosomal abnormalities or assessments of growth rate will
become incorporated into staging systems as understanding of their prognostic value
develops 14'56'93. Likewise, larger studies may allow further refinement of these
systems, for example by including more categories for tumour size 90.
Overview of local management of extremity soft tissue sarcoma
Over the last thirty years or so, the local treatment of soft tissue sarcoma has moved
away from high rates of amputation towards limb-sparing surgery. A major factor in
this change was a study published in 1982 by Rosenberg et al under the auspices of
the National Cancer Institute106. In this study patients with extremity soft tissue
sarcoma were randomised to receive amputation or limb-sparing surgery with
radiotherapy. The study showed that although limb-sparing surgery was associated
with a higher rate of local recurrence than amputation, disease-free survival and
overall survival did not differ significantly between the groups. This has remained
the consensus view in the intervening period. Limb sparing surgery is still associated
1 "^9
with a higher rate of local recurrence than amputation , but combined surgery and
radiotherapy has been widely adopted and primary amputation rates remain around
10% 86'96'128>132_ Amputation may still be considered when it is otherwise impossible
to obtain adequate clearance, when there are contraindications to radiotherapy or the
function of the preserved limb would be poor91.
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Risk factors for local recurrence
The study of risk factors is useful for counselling patients about treatment, in
deciding about different treatment options and in enhancing understanding of a
84 •
disease . Factors shown in multivariate analyses to be associated with local
recurrence after treatment for soft tissue sarcoma are summarised in Table 1.4. In
these analyses, the effect of a particular factor is usually quoted as "relative risk",
which is defined as the incidence in patients with the risk factor, divided by the
incidence in those without the relevant risk factor. When calculated from survival
curves, the relative risk may be referred to as the "hazard ratio".
Tumour-related factors
Both histological type and grade may influence the risk of local recurrence.
Fibrosarcoma has been associated with a relative risk for local recurrence of 2.5, and
malignant peripheral nerve sheath tumour with a relative risk for local recurrence of
1.8 in one study 96. Tumours with higher histological grades are associated with
higher risks for local recurrence, with relative risks in multivariate analysis of 1.8
(histological grade 3 of 3 in the French Federation of Cancer Centres (FNCLCC)
system) 16, 1.9 (histological grade 3 of 3, system attributed to Myhre Jensen)132and
i -yn
3.0 (grade 3 or 4, Scandinavian Sarcoma Group system) . Extensive histological
necrosis, which is reflected in histological grade, has also been associated with local
recurrence (relative risk 2.1 105).
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Table 1.4




High histological grade -





Local recurrence at presentation 96'102.114




Limb sparing surgery compared with amputation 106>132
Fibrosarcoma 96
Malignant peripheral nerve sheath
tumour 96
Grade 3 of 3 16
Grade 3 of 3 132
Grade 3 or 4 vs grade 1 or 2 127
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Tumour size is not a significant predictor of local recurrence in the multivariate
analyses reviewed, although surrogates for increasing size, such as deep anatomical
location (relative risk 1.8 16) or extracompartmental location (relative risks 1.9 105,
2.6 ) are. In addition, large tumours are more likely to be resected with positive
surgical margins, which is likely to be associated with local recurrence 117. A tumour
which is locally recurrent at presentation is more likely than others to recur again
(relative risk 2.0 96, 7.4 U4).
Some studies suggest that anatomical location might be important in determining
local recurrence by showing a difference in local recurrence rates between tumours
in the extremities and those at other sites. Tumours in the extremities or torso have
better local control rates than those in the head and neck, retroperitoneum, thorax or
viscera, because in these latter sites, complete resection is difficult and the proximity
of critical anatomical structures means that local recurrence is more likely to be
167782-116 • • •fatal ' ' ' . However, there is little information about variation in local recurrence
rates within the extremities.
Host factors
Advancing age appears to have an adverse effect on the risk of local recurrence 77 96.
Treatment factors
Incomplete resection, assessed by the surgical margin, is one of the strongest
predictors of local recurrence 16'77-96>1 i4,i 17,127,132 jn muitiVariate analyses, inadequate
surgical margins have been associated with a relative risk for local recurrence of 1.8
. • Qf\ • • 197
(microscopically positive margins) , 2.2 (intralesional or marginal excisions) , 2.4
(
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(positive margin compared with a "clean" margin)114, 4.0 (microscopically positive
margins) 123, 5.3 (intraoperative tumour violation) 123 and 5.9 (marginal surgery,
histological grades 3 and 4 only)105.
Radiotherapy has been shown to reduce the risk of local recurrence (relative risk (no
1 39 1 f\
radiotherapy) 3.7 relative risk (radiotherapy) 0.4 ).
Defining the surgical margin
It is clear that to control a tumour locally, the whole of the tumour should be
removed. Achieving this requires an understanding of the local behaviour of soft
tissue sarcomas. Enneking made a major contribution to this field by developing a
model in which tumours were considered to be surrounded by a reactive zone of
compressed normal tissue, inflammatory and tumour cells (Figure 1.3) 40. He also
recognised that tissues such as bone and fascia resist invasion by tumour, and this
observation lead to the concept of anatomical "compartments". These are well-
defined anatomical spaces with osteofascial boundaries that tend to contain the local
extension of tumours (Table 1.5). Tumours within one of these spaces are said to be
"intracompartmental". Other anatomical locations, such as the popliteal fossa, which
do not have clearly defined boundaries are known as "extracompartmental" sites. It
follows that intracompartmental tumours can be completely excised by removing the
whole of the "compartment". This classification remains a useful part of the local
staging of musculoskeletal tumours.
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Figure 1.3
Diagrammatic representation of a soft tissue tumourwithin the anterior







The tumour (red) is surrounded by a reactive zone of compressed normal tissue and
inflammatory cells (pink), within an osteofascial compartment (green). Examples of
planes of resection are shown. In an intralesional excision, the plane of resection
passes through the tumour, in a marginal excision through the reactive zone, and in a
wide excision through normal tissue. In a radical excision the whole of the
compartment (green) would be excised.
29
Table 1.5
Examples of intracompartmental and extracompartmental sites for
extremity soft tissue sarcoma 113
Intracompartmental sites Extracompartmental sites
- Intra-articular
- Superficial to deep fascia
Osteofascial compartments Extrafascialplanes or spaces
- Ray of hand or foot - Mid- and hindfoot
- Posterior calf - Popliteal space
- Anterolateral leg - Groin/femoral triangle
- Anterior thigh - Intrapelvic
- Medial thigh - Mid hand
- Posterior thigh - Antecubital fossa
- Buttocks - Axilla
- Volar forearm - Periclavicular
- Dorsal forearm - Paraspinal




Examination of the surgical margin is important to assess whether or not a tumour
has been completely excised. In Enneking's system the margins of resection of a
tumour were defined in terms of the relationship between the plane of resection, the
tumour and its reactive zone, and the anatomical compartment. Resections were
defined as intralesional when resection was carried out within the reactive zone and
through tumour, as marginal when resection was carried out through the reactive
zone, as wide when resection was performed outside the reactive zone through
normal tissue and as radical when the whole compartment was excised. Although
these concepts have their limitations (e.g. compartments such as the posterior thigh
do not have clear boundaries at the superior and inferior extent), they are useful in
planning the local treatment of soft tissue sarcoma. In Enneking's paper, the rate of
local recurrence following surgical treatment alone was 50% after marginal, 25%
after wide and 4% after radical excision40.
These concepts of surgical margins have been developed further by others. Rydholm
and Rooser considered an intact muscle to be a distinct anatomical compartment and
subclassified wide margins as wide-S (subcutaneous) when a subcutaneous tumour
was excised with a cuff of subcutaneous tissue and deep fascia, wide-F (fascia) when
a deep tumour was excised with an intact envelope of uninvolved fascia and wide-
AM (areolar tissue and muscle) when a deep tumour was excised with a wide
margin, some or all of which comprised muscle or areolar tissue. The five-year local
recurrence rate was 10% with wide-S and wide-F margins and 30% with a wide-AM
10R
margin when patients were treated with surgery alone
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Kawaguchi et al. suggested a classification that abandoned the use of compartmental
anatomy to describe the resection71. Wide margins were classified as curative,
adequate or inadequate depending on the width and quality of tissue comprising the
margin. Inadequate wide margins did not ensure local control even with adjuvant
radiotherapy in high-grade sarcoma, but were sufficient for low-grade tumours 70.
However, this is a complex system which, although used by the Japanese
Orthopaedic Association, has not been adopted elsewhere.
As combined management with limb-sparing surgery and adjuvant treatments has
developed, the description of surgical margins as simply positive or negative has
become more common 6'6l'64'78>96-109'n4>123 However, it is likely that all "positive
margin" resections do not have the same risk of local recurrence, and this has not
been explored in the literature.
The likelihood that a tumour is going to be resected with positive margins depends
on a number of factors, such as size and local anatomy 6. Stojadinovic et al reported
that factors associated with a positive surgical margin included anatomical location
(retroperitoneum or head and neck), size >10cm, fibrosarcoma histology, and stage
T2b (>5cm, deep) 117. Heslin et al found that resections leading to positive surgical
margins were associated with more blood loss and longer operating times than
others64. Trovik et al reported that adequate resections were associated with patients
under 50 years of age, high grade, smaller (<7 cm) tumours, or those in superficial
locations or the extremities 127. After excision of trunk and extremity soft tissue
sarcomas, reported positive margin rates vary from 1% 47to 26% 123. In a review of
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patients treated entirely by an experienced multidisciplinary sarcoma group in
Toronto, Wilson reported 9 positive margins in 62 patients, a rate of 14.5% 135.
Adjuvant radiotherapy
Adjuvant radiotherapy is frequently used with surgery to improve local control. In
the only randomised controlled trial to address this issue, Yang et al reported local
control rates of 80% with surgery alone and 99% when surgery is used with
1 TQ
radiotherapy . Although some tumours (particularly those that are small or
superficial) can be adequately treated with surgery alone, radiotherapy may be given
after consideration of a number of factors, such as histological grade, surgical margin
and the anatomical location of the tumour 91.
In the treatment of soft tissue sarcoma, radiotherapy is usually given as external
beam therapy or with radioactive wires (brachytherapy). Radiotherapy may be given
either preoperatively, rarely intraoperatively, or postoperatively 124. Postoperative
external beam radiotherapy is the most common modality in the United Kingdom.
However, there are potential benefits of preoperative radiotherapy. In particular, the
extent of the tumour is easier to define, the treatment volume is lower, tissues are
87103better oxygenated and a lower dose of radiotherapy can be given ' .
Unfortunately, preoperative radiotherapy leads to a higher rate of wound
complications. The largest study to compare pre and postoperative radiotherapy
randomised 190 patients across Canada to 50 Gray preoperatively with a 16 Gray
postoperative boost to areas where the excision margins were considered inadequate
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or 66 Gray postoperatively. The study showed significantly more wound
complications amongst patients receiving preoperative radiotherapy (35% vs 17%).
OQ
The local recurrence rates in both arms of the study were similar . Functional
outcome, using a number ofmeasures, appeared to be similar at a year after
surgery24.
Brachytherapy is a technique in which radioactive wires are placed into fine catheters
implanted into the wound and has the advantage of delivering radiation to a small
volume of tissue. This is most useful in areas where there is a concentration of
radiosensitive structures, such as the head and neck, or in the treatment of local
recurrence in a previously irradiated area. Local control rates are thought to be
equivalent to those achieved with external beam radiotherapy, with a dose of
between 42 and 45 Gray 95. Treatment is given over a shorter period (4 to 6 days) but
is more labour intensive.
Endpoints for assessment of systemic disease
Studies that address prognostic factors for systemic disease in soft tissue sarcoma
may use the diagnosis of metastasis (metastasis-free survival), death from the disease
(disease-specific survival), or survival after the diagnosis of metastasis as
endpoints16'96. Disease-free survival, in which the diagnosis of local recurrence or
metastasis is taken as the event of interest, may be used to reflect systemic metastatic
disease in the clinical situation in which local recurrence is unlikely. The time to
diagnosis ofmetastases is likely to be heavily influenced by follow-up protocols.
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Patients who are regularly screened, for example with a chest x-ray, are likely to
have pulmonary metastases diagnosed earlier than others. Soft tissue sarcomas
arising in the extremities usually cause death by pulmonary metastases, and therefore
factors associated with the development of these metastases are also those which are
likely to be associated with disease-specific survival. This is not the case with
retroperitoneal or head and neck sarcomas, which are more likely to cause death by
77
local recurrence, rather than systemic disease . Survival after the diagnosis of
metastases is likely to relate to whether or not effective treatment for the metastasis
can be administered, which may also relate to how early metastases have been
diagnosed. The choice of endpoint depends upon the purpose of the analysis. For the
purposes of this introduction, risk factors for disease-specific survival in the
literature have been addressed, and then differences between risk factors for
metastasis-free survival and disease-specific survival are compared.
Disease specific survival
A number of studies have investigated risk factors for disease specific survival.
These are summarised in Table 1.6.
Tumour-related factors
The three most consistent predictors of disease-specific survival are tumour size,
histological grade and anatomical depth. In published studies of soft tissue sarcoma,
tumour size is usually represented by the maximum single dimension, rather than by
estimating tumour volume. Large tumours are associated with an increased risk of
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death from disease (>5cm relative risk 1.8 132; >10 cm relative risk 2.1 96; >7.0 cm
relative risk 2.3 127; tumour size >=5cm, relative risk not specified 16). Large tumours
tend to be deep, therefore these variables are not independent. Nevertheless, some
studies appear to show independent prognostic importance for tumour size and depth
16;96
The relationship between histological grade and metastatic potential has been
1 T9
confirmed by many studies (grade 3 of 3 (relative risk 2.6 ); grade 3 of 3 (relative
risk 2.8 16); grades 3 or 4 versus grades 1 or 2 (relative risk 3.3, 127); high grade
versus low grade (relative risk 4.0 %); high grade versus low grade 77). Histological
type may also influence disease-specific survival. Leiomyosarcoma (relative risk 1.9)
and malignant peripheral nerve sheath tumour (relative risk 1.9) have been associated
with lower disease-specific survival and liposarcoma associated with a better
prognosis in one large study 96. However, another study did not find an adverse
relationship for malignant peripheral nerve sheath tumour, but found adverse effects
for Ewings sarcoma, angiosarcoma and synovial sarcoma "4.
Tumours referred to a specialist centre after local recurrence are also associated with
poorer disease-specific survival (relative risk 1.5 96).
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Table 1.6
Factors predicting disease-specific survival after treatment of soft
tissue sarcoma
Adverse Prognostic Factor
Large size ^;96;i02;i ,4
High histological grade 16-96-102'114;131
Histological type - Leiomyosarcoma, malignant
peripheral nerve sheath tumour 96
- Ewings sarcoma, synovial sarcoma,
angiosarcoma 114
Deep anatomical location l6'96
Lower extremity location 96
• • 109
Proximal extremity site
Local recurrence at presentation 96'102
Older age114;131;I32
Male gender 16'105
Positive surgical margin 96>116'117
Local recurrence after treatment105
No chemotherapy 16
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A relationship between anatomical location and disease-specific survival has been
suggested by a number of studies, although none address this issue directly. Tumours
in the proximal extremities or lower extremity (proximal lower extremity, relative
risk 1.6 96); proximal extremity, hazard ratio 0.8134) and those in extracompartmental
1T9 •
locations (relative risk 2.1 ) have been associated with poorer disease specific
survival. Highest disease-specific survival has been reported in upper extremity, then
1 "2
trunk, then lower extremity tumours . Another study found improved survival for
• • f\8
extremity tumours when compared to trunk or intraabdominal tumours . The
question of how upper and lower extremity tumours differ in terms of their risk of
metastasis and survival has not been directly addressed in the literature.
Host factors
Other adverse prognostic factors for disease-specific survival include advancing age
(relative risk 1.03 114; relative risk 2.3 132), and male gender (relative risk 1.9 16).
Underlying medical conditions may also influence outcomes. For example, type 1
neurofibromatosis appears to be associated with unusually aggressive behaviour of
malignant peripheral nerve sheath tumours ' .
Treatment factors
Factors related to treatment that may have an effect on disease-specific survival
include a positive surgical margin 96'"6,117, local recurrence after treatment105 and
the use of chemotherapy 16. These issues are discussed below.
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Differences between risk factors for metastasis and disease-specific
survival
In the treatment of adult extremity soft tissue sarcoma, factors predicting metastasis
and those that predict death from the disease are similar. Analysis ofmetastasis-free
survival has the benefit of including patients who are alive with systemic disease,
thereby increasing the number of events and therefore the power of the survival
analysis. However, the literature highlights some interesting differences in studies
that have looked at both the metastasis-free rate and disease-specific survival. In the
study by Coindre et al that included patients with tumours in all anatomical locations,
male gender was associated with an increase in tumour-specific death, but not with
the development of distant metastases 1 . Pisters et al reported that microscopically
positive surgical margins, lower extremity site and malignant peripheral nerve sheath
tumour type were associated with disease-specific survival, but not distant recurrence
in extremity soft tissue sarcoma 96. In a study of small, high grade extremity soft
tissue sarcomas, Fleming et al also demonstrated that male gender was associated
with lower disease-specific survival, but not metastasis-free survival 43.
Unfortunately, the clinical significance of these differences is not clear.
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The relationship between local recurrence and metastasis
Given that limb conservation is associated with a higher rate of local recurrence than
amputation 10 , the relationship between local recurrence and metastasis is of great
interest, but has proved both "controversial" and "enigmatic" 41. Studies can be
quoted selectively to provide arguments for or against a causative relationship
between local recurrence and metastasis. In two prospective randomised studies
examining the effect of radiotherapy on local control, an increase in local recurrence
rates was not associated with an increase in the rate ofmetastasis10'106. Some take
the view that local recurrence is an expression of biological activity and therefore
metastatic potential, but that local recurrence itself does not increase the risk of
metastasis 59. Others support the view that local recurrence is likely to lead to
metastasis, particularly when local recurrence is analysed as a time-dependent
variable35;77;80;119;127.
Clearly, what the surgeon wants to know is whether or not the positive surgical
margin that is accepted to preserve function will shorten the life of the patient. The
relationship between a positive surgical margin and local recurrence has been well
described. However, the relationship between a positive surgical margin, local
recurrence and metastasis is less well understood, with opinions varying from no
1 9T ■ 197
relationship ' , to a stronger relationship (Positive surgical margin leads to
systemic disease (relative risk 1.7 96)) or a relationship that is not strong, but
increases with time 116
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To summarise, in the management of extremity soft tissue sarcoma, limb sparing
surgery appears to be safe and does not have a major adverse impact on survival,
although complete resection is the goal of local treatment. Local recurrence indicates
that the tumour is biologically aggressive, and may therefore metastasise. Patients
who have a local recurrence are at risk of further local or systemic relapse and may
benefit from aggressive local or systemic therapy .
Systemic therapy
Perhaps the best guide to the effectiveness of chemotherapy comes from the Sarcoma
• 19 S • • ...
Meta-Analysis Collaboration . This meta-analysis used individual patient data
from 1568 patients enrolled in 14 randomised controlled studies of doxorubicin-
based chemotherapy. Data were used from patients with tumours at all anatomical
sites, including the head and neck, retroperitoneum and uterus. The results suggested
chemotherapy lead to statistically significant improvements in local relapse-free
survival (hazard ratio 0.73, 95% CI, 0.56 to 0.94 P=0.016), distant metastasis-free
survival (hazard ratio 0.70, 95% CI 0.57 to 0.85, P=0.0003) and overall disease-free
survival (hazard ratio 0.75, 95% CI 0.64 to 0.87, P=0.0001). Chemotherapy lead to
reductions in the absolute risk of local recurrence of 6% at 10 years, in the absolute
risk of distant metastases of 10% at 10 years, and in the absolute risk of death of 4%
at 10 years. However, the reduction in overall survival did not reach statistical
significance. Criticisms of this meta-analysis are that incorporating tumours at all
sites might mask a benefit of chemotherapy for particular sites, that tumours of low
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or indeterminate grade were included, and that only one of the studies used
ifosfamide, which along with the anthracyclines doxorubicin/epirubicin and
dacarbazine is one of the three drugs with activity in this disease 9. For 886 patients
with soft tissue sarcoma of the extremities in this study, the hazard ratio for overall
survival was 0.80 (P=0.029), equivalent to a 7% absolute benefit at 10 years 9.
These results raise the question of whether individual patients likely to benefit from
chemotherapy can be identified. One study randomised patients with high-risk soft
tissue sarcoma of the extremities and limb girdles to chemotherapy (ifosfamide and
doxorubicin with hydration, mesna and granulocyte colony-stimulating factor) or
control (no chemotherapy) groups. High risk tumours were defined as histological
grade 3 or 4, and greater than 5cm diameter or any size of recurrent tumour. Median
disease-free survival was 48 months in the treatment group and 16 months in the
control group (p=0.04). Median overall survival was 75 months for treated and 46
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months for untreated patients (p=0.03) . Another study which targeted patients at
high risk of systemic relapse with doxorubicin and ifosfamide found no statistically
significant difference in disease-free and overall survival between the treated and
control groups 53.
A number of approaches have been taken to improving the effectiveness of
chemotherapy including the use of docetaxel 129, liposomal doxorubicin 13, high-dose
chemotherapy with autologous hematopoetic stem-cell transplantation 7 and
cytokines in conjunction with chemotherapy 54.
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Evidence that different histological types of soft tissue sarcoma respond differently
to chemotherapy is accumulating, and it has been suggested that synovial sarcoma
and liposarcoma are more sensitive to chemotherapy than other histological types115.
New therapeutic agents are showing great promise in the treatment of soft tissue
sarcoma. The best known is STI-571 (Imatinib [Gleevec]; Novartis, Basel,
Switzerland), an agent that selectively inhibits the c-kit receptor pathway, which is
subject to a gain-of-function mutation in gastro-intestinal stromal tumours 45. Before
STI-571, even complete surgical resection of the tumour was associated with a 5-
year disease-specific survival rate of 54% . The use of STI-571 has been associated
with partial response or stable disease in 88% of patients, and is associated with a
rapid biological response, manifest by changes in FDG-positron emission
tomography (PET) scanning 11. Unfortunately, other soft tissue sarcomas do not
appear to express c-kit to the same extent and are therefore unlikely to be as
responsive 65.
ET-743 is a novel antineoplastic DNA binding agent derived from a marine organism
which has shown activity against sarcoma cell lines in vitro and in phase II studies,
with clinical response rates of around 8% 21. However, this agent has recently failed
to win marketing approval within the European Union.
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Functional outcomes
As limb-sparing treatments have evolved, interest in the "functional outcome" of the
patient has increased. Definitions of function have included a variety ofmeasures,
including clinical measures of range ofmotion or muscle strength 75>104j activities of
daily living 75, the Musculoskeletal Tumour Society Scale (MSTS 1987) which
• • • T7
includes site-specific details of symptoms and clinical measures , the revised
MSTS, which includes symptoms, mobility and the use of walking aids, generic
measures of health status such as the Short-Form 36 (SF 36) questionnaire and the
Toronto Extremity Salvage Score (TESS)26
The World Health Organisation (WHO) International Classification of Impairments,
•••• • 137 ( # • #Disabilities and Handicaps (ICIDH) clarifies what is meant by "function" . In this
classification, impairments are "any loss or abnormality of psychological,
physiological, or anatomical structure or function". Disability is "any restriction or
lack of ability to perform an activity in the manner or within the range considered
normal for a human being".
MSTS scores most closely follow the definition of impairment in this classification.
The MSTS (1993) is completed by the clinician and consists of 6 items; pain, overall
function, emotional acceptance, walking ability, walking aids and gait handicap or
• 78 i • ••
limp (Appendix 3). Each item is rated on a scale of 1 to 5. The total score is
calculated from a sum of the individual items and expressed as a percentage.
* The ICIDH classification was revised in 2001 to the "International Classification of Function"
(World Health Organisation, Geneva, 2001) which emphasises function rather than disabilities.
However, for the purposes of the studies in this thesis, the original definitions have been used.
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The Toronto Extremity Salvage Score (TESS) is based on the WHO definition of
disability and has shown reliability, validity and responsiveness in the extremity
sarcoma population (Appendix 4)22'26. The TESS questionnaire is completed by the
patient and comprises 30 items in which the patient indicates the difficulty
experienced in performing a range of everyday activities, such as dressing,
96 • r»
grooming, mobility, work, sports and leisure . Each item is rated on a scale of 1 to 5
and the total expressed as a percentage.
Factors predictive of functional scores have been investigated by Davis et al in a
study looking at MSTS 1987, MSTS 1993, TESS and SF36 scores in patients treated
for lower extremity soft tissue sarcoma25. Using multivariate analysis, it was found
that different measures had different predictors. Large tumour size, bone resection,
motor nerve resection and complications were predictive of lower MSTS 1987 and
1993 scores. Patients with large, high grade tumours requiring motor nerve resection
were more disabled, reflected in lower TESS scores. Age and prior surgery were the
sole predictors of lower SF-36 scores . Although anatomical site, as defined by the
nearest major joint (hip, knee or ankle) was not predictive of functional scores in this
analysis, it is likely that anatomical location has a role in determining functional
outcome. For example, function after treatment of a buttock tumour is likely to differ
from function after treatment of a tumour in the foot or ankle by virtue of anatomical
location alone. Knowledge of the likely impact upon function of treating a tumour in
any particular anatomical location may be helpful during treatment. This question
has not been explored in the literature.
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Another question that has not been addressed in the literature is the whether or not
the planned marginal excision of low grade liposarcomas leads to better functional
outcomes than the wider "negative margin" surgery used for other high grade
tumours. Although the preservation of "normal" tissues might be expected to lead to
better functional outcomes, the differences between these two approaches have not
been investigated.
Aims of this thesis
Review of the literature points to a close relationship between anatomical location
and outcome in the treatment of soft tissue sarcoma. There is variation in
presentation, with upper extremity tumours being smaller than those in the lower
extremity 57. There is variation in local treatment, with upper extremity soft tissue
sarcomas being more often treated by unplanned excision than those in the lower
extremity 18'1H. Positive margin rates also vary by anatomical location U7. The risk
of local recurrence and systemic disease differs between tumours in the extremities
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and those at other sites ' ' ' . Deep or extracompartmental location is associated
with local recurrence 16'132 and systemic disease 16'96. Lower or proximal extremity
location is also associated with systemic disease 96-102.
The studies in this thesis examine novel aspects of this relationship. The anatomical
relationships of a tumour are major factors in determining the surgical margins, and
are major considerations in determining the most appropriate local therapy. Although
most studies treat all positive surgical margins as equal, this may not be appropriate,
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as the volume of residual disease is likely to relate to the clinical situation in which
the positive margin occurs. This has not been addressed in the literature, and the first
study in this thesis examines this issue.
The literature suggests that there are differences between the upper and lower
extremities in the manner in which soft tissue sarcomas present, are managed and in
their oncological outcomes, but this has not been directly addressed in the literature.
The second study examines differences in presentation, the characteristics of the
tumour, treatment and outcome between the extremities.
The role of anatomical location in determining functional outcome has not been
addressed in the literature. The third study in this thesis examines this question in an
analysis of tumours in the lower extremity. Preservation of muscle and other non-
critical anatomical structures around a tumour may have an influence on functional
outcomes. The final study looks at differences in functional outcomes following the
planned marginal fashion or "shelling out" of low grade liposarcomas, compared
with those following the wider resection of other tumours.
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The specific objectives of the studies in this thesis were therefore
1. To classify and determine the risk of local recurrence of a positive surgical
margin after the resection of an extremity soft tissue sarcoma.
2. To examine differences in presentation, treatment and oncological outcomes
between upper and lower extremity soft tissue sarcomas.
3. To examine the influence of the anatomical location of lower extremity soft
tissue sarcomas on functional outcome.
4. To determine the effect of planned marginal surgery on functional outcome.
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2. GENERAL METHODS
A clinical database held in the Musculoskeletal Oncology Unit at the Mount Sinai
Hospital, Toronto, Canada was used to identify appropriate patients for the studies in
this thesis. Data for the studies were extracted from this database and supplemented
with additional data from clinical records as required. The studies were therefore
secondary analyses of existing data, rather than analyses based on the prospective
collection of new data. Preexisting data definitions were therefore accepted.
All of the patients in these studies were adults with extremity soft tissue sarcoma
treated at the Musculoskeletal Oncology Unit of the Mount Sinai Hospital in
Toronto, Canada between 1986 and 1997. Subjects were selected for each study on
the basis of appropriate inclusion and exclusion criteria as stated in the appropriate
chapters.
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Data collection, validation and storage
The clinical database at the Musculoskeletal Oncology Unit at the Mount Sinai
Hospital is password-protected and held on an Apple Macintosh Computer running a
Filemaker Pro database. Data have been collected prospectively since 1986 as
patients attend clinics and are reviewed at weekly Multi-Disciplinary Team
Meetings. This database has been the basis of a large number of publications and the
data have been regularly validated as a result. Functional outcome data are
prospectively collected in clinics routinely as part of the standard care of patients in
the Musculoskeletal Oncology Unit or as part of a number of other studies.
Clinical records relating to patients under the care of the Musculoskeletal Oncology
Unit are held within the orthopaedic offices at the Mount Sinai Hospital. This means
that records were available for all patients. The recording of surgical procedures is
standardised and comprehensive. MRI and CT scans were available as hard copies
from other centres or electronically when performed within the Toronto Teaching
Hospitals network.
Data in this thesis were initially extracted from the Filemaker Pro database and
imported in anonymised form into an Excel spreadsheet on a password-protected
Dell computer (Microsoft Excel 97, Microsoft Corporation, Redmond) to which
other appropriate data items were added. Data were verified by looking for out-of-
range values, for missing values and for logical consistency. For example, if there
had been no local recurrence, there should not have been a date for local recurrence
in the spreadsheet. When clinical records were reviewed, data already extracted from
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the clinical database were verified from the clinical records. When data relating to
anatomical location were generated, data items were checked for consistency with
the preexisting anatomical coding. Errors detected in this fashion were corrected on
the clinical database where appropriate. Statistical analysis was performed using
Statistical Package for the Social Sciences (SPSS) for Windows Software Release
10.1.0 Chicago: SPSS inc.
Functional outcome data are stored on a separate Excel spreadsheet within the
Musculoskeletal Oncology Unit at the Mount Sinai Flospital. In the studies dealing
with functional outcomes, MSTS (93) and TESS item and total scores were extracted
from this spreadsheet, linked with other anonymised clinical data and then imported
into SPSS for analysis.
Data fields and definition of terms
The data fields extracted from the database are listed in Appendix 2.
Standard definitions were used throughout.
- The upper extremity was defined as commencing at the medial border of the
scapula, including pectoral, periscapular and latissimus dorsi muscles. The lower
extremity was defined as commencing at the iliac crest.
- Tumours above and not involving the investing fascia of the extremity were
considered superficial, while others were considered deep.
- Tumours with a predominant mass above the knee or elbow were considered
proximal and those below as distal.
- Compartmental status was defined as described by Enneking .
- An unplanned excision was defined as an excisional biopsy or unplanned
resection performed without adequate preoperative staging or consideration of
the need to remove normal tissue around the tumour 51. After unplanned excision,
tumour size was determined from pathology reports of the first resection, the
operative note or preoperative imaging if available.
- A pathologist with an expertise in sarcoma determined the histological type and
graded tumours as 1, 2 or 3 66.
- A positive margin was defined as the presence of viable or non-viable tumour at
the inked resection margin or intraoperative exposure of tumour at any stage.
Margins were defined as grossly positive when the surgeon or the pathologist
could see tumour at the margin of resection with the naked eye, following
intralesional surgery or en face exposure of the tumour surface. A margin was
said to be microscopically positive when tumour could not be seen on visual
inspection of the inked surface, but was evident on microscopic examination.
- Surgical margins were assessed in the operating suite by the surgeon and
pathologist during the procedure, using frozen sections where appropriate.
Positive surgical margins identified in this fashion were revised if appropriate.
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- Complications of surgery were defined as major wound dehiscence requiring
surgical intervention, infection or fracture.
- Local recurrence was defined as the reappearance of tumour, proven by biopsy,
adjacent to or within the previously treated field at any time after initial
treatment. The date of biopsy was used as the date of local recurrence.
- Metastatic disease was defined as tumour identified on chest X-ray or CT scan
during follow up, or the development of lymphadenopathy containing tumour.
The date of metastasis was taken as the date of the chest X-ray or CT scan, or the
date on which lymphadenopathy was detected clinically or radiologically.
Principles of local treatment
During the period in which patients in these studies were treated at the
Musculoskeletal Oncology Unit of the Mount Sinai Hospital, they were offered limb-
sparing surgery whenever possible following multidisciplinary discussion.
Amputation was performed where limb-sparing surgery would not have adequately
resected the tumour or would have resulted in a limb without useful function.
Adjuvant radiotherapy was given for high grade tumours resected with less than a
wide surgical margin, or low grade tumours with a deliberately marginal surgical
excision.
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Following unplanned excision at another centre, an assessment of the extent and
adequacy of the initial unplanned excision was made in discussion with the original
surgeon and by review of the initial pathology report, the initial operative note, and
imaging studies. Re-excision was performed if there was gross residual tumour on
clinical examination or imaging or if the resection had been assessed as inadequate.
Follow up protocols
During this period the standard follow up protocol for patients with extremity soft
tissue sarcoma included clinical examination and chest x-ray every three months for
two years, every four months in the third year, six monthly in years four and five and
annually thereafter. Most patients were followed up at the Musculoskeletal Oncology
Unit at the Mount Sinai Hospital, or in a peripheral clinic in London, Ontario. A
minority, usually for geographical reasons, was followed up closer to home by local
clinicians according to the same protocol.
Statistical tests
For each study, descriptive data were calculated using means, medians, standard
deviations and ranges for continuous variables and proportions for categorical data.
Significance was taken at the 0.05 level throughout. The Student t-test was used to
compare means of continuous variables between 2 groups. The paired t-test was
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used to compare data before and after an intervention. Differences in mean values
between more than two groups were compared using one way analysis of variance
(ANOVA) and the Tukey post-hoc test. The Pearson Chi-squared test was used to
compare differences in proportions between groups.
Kaplan-Meier survival curves, rather than life tables, were used to compare the local
recurrence-free rate, metastasis-free rate and disease specific survival amongst
groups. These curves represent events over time graphically. Subjects entered the
studies at different time points and length of follow up varied for each patient
depending on when a defined event (local recurrence or metastasis) had occurred, the
patient had died, or the last attendance at a clinic was recorded. Data were censored
at the time of last follow up or death. Censored data points are represented on graphs
with a cross and 95% confidence intervals are shown where appropriate. The date of
surgery was taken as the origin for survival analyses. The Log Rank test was used to
compare Kaplan-Meier curves.
The Cox Proportional Hazards Model was used to investigate whether there were
differences in survival in two or more groups having adjusted for other variables.
The Cox Proportional Hazards Model assumes that the hazard ratio for each co-
variable is proportional over time. These graphs were plotted in order to ensure this
was the case. The rule of thumb attributed to Harrell, that there should be more than
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10 events for each variable entered into the analysis , was applied. A stepwise entry
method in which all variables were entered into the model at the start of the
calculation was used with multiple iterations. Tables of results are presented which
show the P value for selection into the model (which tests the null hypothesis that the
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relative risk for that variable is 1), the relative risk and the 95% confidence intervals
of the relative risk.
Non-parametric data (i.e. TESS and MSTS scores) were analysed using the Mann-
Whitney test, or the Wilcoxon test for paired data. The Kruskal-Wallis Test was used
to compare scores for non-normally distributed data across more than two groups.
Multiple linear regression was used to determine the contribution of anatomical
location to functional outcomes whilst compensating for factors already shown to
have an influence on functional outcome. Once more, Harrell's guide, that there
should be more than 10 patients for each variable entered in multiple regression
analysis was applied . In these analyses, comparisons were only performed when
there was a complete set of relevant data items for each patient. Postoperative
functional scores were taken at one year or at two years if the one year value was
missing. An entry method in which all variables were entered at the start of the
analysis was used. In this analysis, "dummy" variables were assigned to each of the
nine anatomical locations, in which the value 0 or 1 was assigned as appropriate.
Tables of results are presented which show the standardised P coefficient, the t
statistic and significance values for each variable in the analysis. The standardised P
coefficient allows the variables to be compared with each other for their effect on the
outcome variable. The t statistics and the significance values reflect the relative
importance of each variable in the model.
Each study was designed to incorporate as many of the patients in the database as
possible. Therefore formal apriori power calculations were not performed.
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3. ANALYSIS OF POSITIVE
SURGICAL MARGINS
Introduction
The purpose of this study was to evaluate the clinical significance of a positive
surgical margin by considering the clinical situations in which a positive surgical
margin occurs and the risk of local recurrence associated with each situation. In
particular, it was hypothesised that when a positive surgical margin is accepted by an
experienced surgeon against a critical anatomical structure the risk of local
recurrence is likely to be relatively low.
Patients and methods
Four mutually exclusive clinical groups representing situations in which a positive
surgical margin occurs after limb-sparing surgery for extremity soft tissue sarcoma
were defined (Figure 3.1).
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Figure 3.1
Clinical situations in which positive surgical margins occur and
hypothesised risk of local recurrence
Group 1. Low grade liposarcomas (Low Risk)
The positive margin followed an intentionally marginal excision of a low-grade
liposarcoma.
Group 2. Plannedpositive margins against critical structures (Low Risk)
In order to preserve a functional extremity, a positive margin was accepted against
one or more critical structures (i.e. major nerve, vessel or bone).
Group 3. Positive margins during re-excision afterprior unplanned excision
(High Risk)
An intralesional or marginal unplanned excision was performed prior to referral. A
positive margin followed re-excision.
Group 4. Unplannedpositive margins (High Risk)
A positive margin was unexpectedly found during primary resection of the tumour,
usually following a surgical error.
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Clinical groups
Group 1. Low-grade liposarcomas
The first group included all patients with a diagnosis of low-grade, well-
differentiated liposarcoma. When these tumours originate in the extremity they
seldom recur locally after treatment and rarely metastasise 55' 41. Therefore they can
be treated safely by planned marginal excision or "shelling out", unlike other
tumours which require wider, negative margin excision. Low-grade liposarcomas are
often large and may involve critical structures such as nerves, vessels or bones. In
this situation positive margins may be accepted in order to preserve normal anatomy
(Figure 3.2).
Group 2. Planned positive margins against critical structures
This group included patients who had positive surgical margins against one or more
critically important anatomical structures (nerve, vessel or bone) that were planned
preoperatively as part of a primary resection. The decision to accept a positive
margin was made in advance by the multidisciplinary team as an acceptable
compromise between tumour clearance and surgical morbidity and was confirmed
after resection by the surgeon and pathologist (Figure 3.3).
Group 3. Positive margin during re-excision after prior unplanned
excision
Patients in this group underwent unplanned excision of a sarcoma at another
institution before referral, and a positive surgical margin occurred during re-excision
at the Musculoskeletal Oncology Unit of the Mount Sinai Hospital.
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Figure 3.2
Axial CT scan showing a homogenous fat lesion in the proximal thigh (indicated by




T2 weighted axial MRI scan demonstrating a myxoid liposarcoma in the proximal
thigh, excised with a planned positive margin along the femoral artery (indicated by
arrow).
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Group 4. Unplanned positive margins
In this group, during primary resection at the Musculoskeletal Oncology Unit of the
Mount Sinai Hospital, a positive margin occurred that had not been planned (Figure
3.4). This rare and unexpected event usually followed an error in assessing the extent
of the primary lesion despite review of local site imaging (usually MRI).
The presence of a positive surgical margin was recognised at one of three times: (1)
intraoperatively during dissection of the tumour, (2) in the pathology suite
immediately after removal and gross and microscopic inspection of the resected
tumour or (3) after final histological examination of the inked margins.
If the positive margin was recognised during or immediately after surgery, further
tissue at the site of the positive margin was re-excised if this did not compromise
critical structures. If the positive margin was recognised following definitive
histological evaluation, a further wide excision was always considered. No patients
had grossly evident tumour left in the wound at the completion of surgery.
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Figure 3.4
T2 weighted axial MRI scan demonstrating a myxoid liposarcoma in the lateral ankle
with considerable subcutaneous oedema. The anterior resection margin was positive
in the subcutaneous tissues (indicated by arrow).
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The hypothesis was that Groups 1 and 2 would be at low risk of local recurrence and
that Groups 3 and 4 would be at higher risk. The database was used to identify
patients meeting the following inclusion criteria: (1) a diagnosis of soft tissue
sarcoma, other than dermatofibrosarcoma protuberans, (2) location in an extremity,
(3) limb-sparing surgery with curative intent, (4) a positive surgical margin, (5)
(neo)adjuvant radiotherapy. All patients underwent surgery between January 1986
and April 1997 so that there was potential for a minimum of three years of follow up.
Patients who received chemotherapy because of histological type or metastatic
disease were excluded, as this might have an impact on local control. Patients who
had not received "standard" adjuvant external beam radiotherapy (either 50 Gy
preoperatively with a postoperative boost of 16 Gy if there was a positive margin, or
66 Gy postoperatively by a reducing field technique, in 2 Gy daily fractions) because
of previous radiotherapy, comorbidity or contraindications were also excluded for
this reason. Because this study was designed to assess local control rates, patients
with metastases at presentation were included.
The following items were extracted from the database and verified against clinical
records: age at surgery, gender, status at presentation, unplanned excision, extremity,
histological type and grade, maximum diameter, depth, and whether the margin(s)
were grossly or microscopically positive. Data relating to oncological outcomes were
specifically excluded from this part of the analysis. Data about tumour biopsy and
compartmental status were retrieved from clinical records.
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That part of the clinical record that would have been available at the time of the
multidisciplinary conference was reviewed. Information relating to outcome was,
once more, excluded. These data were used to assign each patient to one of the four
groups whilst being blinded to outcome. All low-grade liposarcomas were assigned
to Group 1 and all patients who had an unplanned excision prior to referral were
assigned to Group 3 regardless of further management. Following this initial
classification, the operating surgeons (RSB and JW) reviewed the classification of
each tumour to ensure consensus. Two patients were reclassified in this fashion. Both
were thought to have had low grade liposarcomas and had been placed in Group 1.
However, the resected tumours were higher grade and both patients were therefore
placed into Group 2. Once all patients had been assigned to groups, the number,
timing and further management of local recurrences were reviewed using database
fields and clinical records.
Analysis
Given that low-grade liposarcomas (Group 1) differ in their biological behaviour and
management from tumours of other histological types they were analysed separately.
The remainder (Groups 2 to 4) were compared for differences in age, gender, local
recurrence at presentation, histological grade, length of follow up, histological type,
depth, compartmental status, upper or lower extremity location, and the local
recurrence-free rate. To assess differences in systemic disease between these groups,
disease-specific survival was used rather than metastasis-free survival because
patients presenting with metastases had not been excluded from the analysis.
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Results
There were a total of 566 patients entered in the database between January 1986 and
April 1997. 112 had positive surgical margins of whom 25 patients were excluded;
12 who did not receive standard radiotherapy, seven who received chemotherapy,
four with advanced metastatic disease who had palliative procedures, one with a
positive margin following primary amputation and one who underwent exploration
of an extensive sarcoma in the foot secondarily treated by amputation. Of the 12
patients who did not receive standard radiotherapy, seven had received external beam
radiotherapy before referral and could not be irradiated further, and in the remaining
five cases radiotherapy was not used because of patient preference, or wound healing
complications. Chemotherapy was given for a diagnosis of Ewing's sarcoma/
primitive neuroectodermal tumour (PNET) or alveolar soft part sarcoma in four
patients, and advanced metastatic disease in three.
Eighty-seven patients remained, 42 men and 45 women, with a mean age of 60 years
(21 to 95). Clinical records relating to all patients were available. The mean follow
up of 55 surviving patients was 5.4 years (3.0 to 9.5). Twenty-four patients died of
metastatic disease at a mean of 1.8 years (0.3 to 6.6), and eight died of unrelated
causes at a mean of 2.1 years (0.2 to 7.7 years).
24 patients with low-grade liposarcomas were placed in Group 1. None had grossly
positive margins. There was one local recurrence (4.2%, 95% confidence interval 0
to 12.2) at four months, which was re-excised at the time of relapse. All patients
were alive and free of disease at a mean follow-up of 5.1 years (3.2 to 9.3).
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Of the remaining patients, 28 were allocated to Group 2 (planned positive margins
against critical structures), nineteen to Group 3 (positive margins after previous
unplanned excision) and sixteen to Group 4 (unplanned positive margins)(Table 3.1).
When Groups 2, 3 and 4 were compared, Group 3 tumours were significantly smaller
than Group 4 (mean diameter 4.8 cm vs 9.6cm p=0.04), and Group 4 tumours were
smaller than Group 2 (mean diameter 9.6cm vs 14.7cm, p=0.02). There were more
proximal limb tumours in Group 2 than Group 3 (22 of 28 (79%) vs 8 of 19 (42%),
p=0.01) and Group 4 (7 of 16 (44%), p=0.02). However, groups 2, 3 and 4 did not
differ significantly for age, gender, local recurrence at presentation, grade and length
of follow-up. No difference in the distribution of histological types across the groups
could be detected. In particular, the number of leiomyosarcoma, angiosarcoma,
fibrosarcoma and malignant peripheral nerve sheath tumours, which may predispose
to local failure l8;80; 6 did not differ significantly between the three groups. There was
no significant difference between the groups when deep and superficial,




Summary of characteristics of patients and tumours at presentation
1.Lowgrade liposarcomas 2.Plannedpositive marginag inst criticalst ucture 3.Positivemargin duringre-excisionafter priorunplanned excision 4.Unplannedpositive margin
Number of cases 24 28 19 16
Mean age 54.8 62.5 66.7 57.5
Proportion male 54% 54% 37% 44%
Presentation with local recurrence 4 3 2 1
Presentation with metastases 1 - 1
Open biopsy 5 11 19 9
Grade of tumour 1 24 1 - 2
2 8 9 6
3 19 10 8
Mean max diameter (cm) 14.4 14.7 4.8 9.6
Histological type MFH* 13 8 6
Liposarcoma 24 8 6 3
Other 7 5 7
Location Upper extremity 6 6 5 6
Lower extremity 18 22 14 10
Proximal extremity 19 22 87
Distal extremity 5 6 11 9
Superficial 2
Deep 24 28 17 16
Intracompartmental 10 6 13
Extracompartmental 14 22 18 13
* MFH= Malignant fibrous histiocytoma.
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In Group 2 (planned positive margins against critical structures), one of 28 cases
developed a local recurrence (3.6%, 95% confidence interval 0 to 10.4) at two
months. This case was one of 25 with microscopically positive margins. There were
no local recurrences in three patients with grossly positive margins. Twelve patients
in the group were alive at a mean of 5.2 years (3.0 to 7.4), eleven died of metastatic
disease at a mean of 1.6 years (0.3 to 2.8) and five died of other causes at a mean of
1.6 years (0.2 to 4.7) (Table 3.2).
In Group 3 (positive margin after prior unplanned excision), there were six local
recurrences in 19 cases (31.6%, 95% confidence intervals 10.7 to 52.5). The mean
time to local recurrence was 34.5 months (2.7 to 82.0)(Table 3.2). Eleven patients in
this group had a residual tumour mass identified on clinical examination or imaging
before re-excision. In five of these eleven cases, the positive margins were planned
against critical structures adjacent to the residual tumour mass and one of these had a
local recurrence. In comparison, an unplanned positive margin occurred during
resection of the other six of eleven cases with a residual tumour mass, and three of
these had local recurrences. In eight patients without a residual tumour mass there
were two local recurrences (Figure 3.5).
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Table 3.2
Summary of surgical margins, local recurrence and systemic disease
1.Lowgrade liposarcomas 2.Plannedpositive marginagainst criticalst ucture 3.Positivemargin duringre-excisionafter priorunplanned excision 4.Unplannedpositive margin
Number of cases 24 28 19 16
Type of positive Microscopically
margin positive 24 25 17 12
Grossly positive 0 3 2 4
Number of local recurrences 1(4.2%) 1(3.6%) 6(31.6%) 6(37.5%)
Mean time to local recurrence (months) 4 2 35 25
Mean follow up of surviving patients
(years) 5.1 5.2 6.3 5.6
Final status Alive, without disease 24 10 9 8
Alive with disease 2 1 1
Died of disease 11 6 7
Died of other causes 5 3
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Of all nineteen patients in Group 3, two had grossly positive margins and both had
local recurrences, compared with four local recurrences in seventeen patients with
microscopically positive margins. In four cases, the positive margin was recognised
intraoperatively, and the margin was revised during the same procedure. Two of
these four patients had a local recurrence. In two cases, the positive margin was
recognised intraoperatively but the margin could not be revised with acceptable
morbidity. Neither of these patients had a local recurrence. In thirteen cases, the
positive margin was recognised after definitive histological examination of the
specimen. None of these margins were revised surgically. Four of these thirteen
patients had a local recurrence (Figure 3.6). Of all nineteen patients, ten were alive
at a mean of 6.3 years (3.5 to 9.4), six died of metastatic disease at a mean of 1.7
years (0.7 to 3.2) and three died of other causes at a mean of 3.1 years (0.7 to 7.7)
(Table 3.2).
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In Group 4 (unplanned positive margins), there were six local recurrences in sixteen
cases (37.5%, 95% confidence interval 13.8 to 61.2). The mean time to local
recurrence was 24.9 months (5.9 to 68.1)(Table 3.2). One of four patients with
grossly positive margins and five of twelve patients with microscopically positive
margins had a local recurrence. In nine cases, the positive margin was recognised
intraoperatively, and the margin was revised during the same procedure. Four of
these nine patients had a local recurrence. In three cases, the positive margin was
recognised intraoperatively but the margin could not be revised with acceptable
morbidity. None of these three patients had a local recurrence. In four cases, the
positive margin was recognised after definitive histological examination of the
specimen. Three of these had no further surgery, and two of these three had a local
recurrence. In the fourth case, a second wide excision was performed to revise the
margin and there has not been a local recurrence (Figure 3.7). Of sixteen cases in
Group 4, nine were alive at a mean of 5.6 years (3.0 to 8.9) and seven died of
metastatic disease at a mean of 2.0 years (0.3 to 6.6).
The crude local recurrence rate in Group 2 was significantly lower than in Group 3
(p=0.03) and Group 4 (p=0.01). The crude local recurrence rates in Group 3 and
Group 4 were not significantly different. The local recurrence-free rate was
significantly different between groups 2 and 3 (p=0.01) and groups 2 and 4 (p=0.02),
but not between groups 3 and 4 (p=0.64) (Figure 3.8). Disease-specific survival in
groups 2, 3 and 4 did not differ significantly (p=0.74) (Figure 3.9).
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Discussion
This analysis has shown that the significance of a positive surgical margin after
resection of extremity soft tissue sarcoma depends on the clinical situation, and that
patients can be classified into groups that reflect the risk of local recurrence. Low-
grade liposarcomas are recognised as biologically different, requiring a different
treatment approach from other soft tissue sarcomas and have a low risk of local
recurrence despite marginal excision. Planned positive margins against critical
structures during primary resection, in association with adjuvant radiotherapy, are
associated with a low risk of local recurrence. Positive margins following re-excision
of a sarcoma treated by unplanned excision before referral, as well as unplanned
positive margins during primary resection are associated with a higher risk of local
tumour relapse.
The overall positive margin rate (112 of 566 patients, 19.8%) is within published
rates which vary from 1% 47to 26% 123. The higher rate of positive margins after
resection of low-grade liposarcomas in this study (27 of 49 patients, 55%) reflects a
philosophy of deliberate marginal excision and confirms that this approach, with
adjuvant radiotherapy, is associated with a low rate of local recurrence at this length
of follow-up. The only recurrence occurred after resection of an extensive tumour in
the axilla. There were no local recurrences in 22 low-grade liposarcomas treated by
excision with a negative surgical margin. The positive margin rate for other
histological types (85 of 518 cases, 16%) is within the accepted range.
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The fact that a planned positive margin against a critical anatomical structure is
associated with a low risk of local recurrence shows that this is a safe approach for
many tumours. However, the experience of the multidisciplinary team is important
in making the decision to approach a tumour in this fashion and may contribute to
better outcomes in specialised centres.
All patients who had undergone an unplanned excision were offered re-excision
oo
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unless the margins could be reliably assessed as adequate . If there was a residual
mass after unplanned excision it acted as a visual and palpable guide to re-excision
and if the mass was adjacent to a critical anatomical structure, a positive margin was
planned. There was one local recurrence in five such cases in this study. If there is a
residual mass and the positive margin was not planned, the local recurrence rate may
be even higher (three of six cases). If there was no residual mass, the extent of
contamination is difficult to determine and re-excision was planned based on an
estimate of the area at risk and the morbidity of the excision. A positive margin not
only means there is residual tumour, which is itself a risk factor for local recurrence,
• • 9-2
but that the area involved with tumour has been underestimated .
Exposure of tumour during primary resection because of an error in surgical
• • TQ
judgement is associated with a high risk of local recurrence in this and other series .
Of sixteen cases in which an unplanned positive margin occurred, four had grossly
positive margins, one of whom went on to local recurrence. The remaining twelve
had microscopically positive margins and five of these went on to local recurrence,
suggesting that microscopically positive margins are also associated with a high risk
of local failure in this situation.
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The distinction between microscopically positive and grossly positive margins is one
of degree. In this study, grossly positive margins have been defined as recognisable
with the naked eye, which is not the same as leaving gross residual disease in the
wound. However, the potential for wound contamination is greater when margins are
grossly rather than microscopically positive. In Group 3, both patients with an
identifiable mass and grossly positive margins had a local recurrence, compared with
4 of 17 patients with microscopically positive margins. The distinction between
grossly and microscopically positive margins was less clear in Group 4, where 1 of 4
patients with grossly positive margins had a local recurrence compared with 5 of 12
with microscopically positive margins, not significantly different.
It is recognised that the assessment of a surgical margin as "positive" or "negative"
depends upon careful examination of the specimen. The reliability and validity of
this process in the treatment of extremity soft tissue sarcomas has not been formally
assessed. Sampling errors, particularly with very large tumours, may lead to an error
in assessment of the true margin. However, the approach described here, in which the
surgeon can orientate the specimen and indicate areas of concern to the pathologist
whilst the patieht is still on the table, leads to a consensus, which is likely to be a
more accurate assessment than when the pathologist works in isolation. It is
interesting that despite this assessment at the time of surgery, a significant number of
positive margins (13 of 19 patients in Group 3 and 4 of 16 in Group 4) were not
recognised until after definitive examination of the specimen.
This study was not designed to assess the effect of revision of a positive margin.
However, it is of interest that amongst patients who could not have revision of the
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positive margin because of local anatomical constraints there were no local
recurrences. It may be that a positive margin against a structure such as muscle that
is readily revised is associated with more residual disease than a positive margin
against a critical structure such as bone, nerve or vessel, which is not easily resected
and which may be more resistant to tumour invasion. When margins were revised
intraoperatively, the data in Figures 3.6 and 3.7 appear to show that there is still a
significant risk of local recurrence (two local recurrences in four revisions in Group
3, four local recurrences in nine revisions in Group 4).
One of the most significant differences between groups 2, 3, and 4 was tumour size.
The smallest tumours were those treated by initial unplanned excision, which has
also been the experience of other authors 47. However, given that the largest tumours
in this study were in the group with the lowest local recurrence rate (Group 2), size is
unlikely to have adversely influenced the results.
Patients who received chemotherapy were excluded because it may have an effect on
o.,?c
local recurrence ' . As the number of patients who received chemotherapy is small,
this is unlikely to have influenced the results of this study. The decision to exclude
patients who did not receive "standard" radiotherapy was made on the basis that
radiotherapy is an effective adjuvant and without it the surgeon may attempt to
achieve wider margins ' ' . This excluded patients presenting with a local
recurrence after prior treatment that included radiotherapy. Although presentation
with locally recurrent disease is associated with lower local control rates, after
excluding the group of patients who had "non-standard" radiotherapy, the number of
patients presenting with a local recurrence was similar in groups 2, 3 and 4.
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No difference in disease-specific survival between the groups was demonstrated in
this series at a mean follow-up of 5.3 years, confirming that the association between
local recurrence and metastatic disease is weak. However, it is possible that a
difference may become apparent with longer follow-up.
To summarise, this study has shown that the clinical significance of a positive
surgical margin depends upon the clinical situation in which it occurs, and it is
possible to classify positive surgical margins in this fashion. This is a novel finding.
Differences in positive margins of this kind have not been demonstrated previously.
This is highly relevant in the clinical situation in which the approach to an extremity
soft tissue sarcoma is being planned. In particular it shows that a planned positive
margin to preserve a critical anatomical structure is safe and associated with a low
risk of local recurrence, and that a positive surgical margin after reexcision of a soft
tissue sarcoma previously treated by unplanned excision is associated with a high
risk of local recurrence. This may influence the choice of local treatments and allow
a more aggressive approach to the management of positive surgical margins in high-
risk groups.
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4. COMPARISON OF THE UPPER
AND LOWER EXTREMITIES
Introduction
The purpose of this study was to examine differences in presentation, treatment and
outcomes between upper and lower extremity soft tissue sarcomas.
Patients and Methods
The database was used to identify and retrieve information about patients who had an
extremity soft tissue sarcoma treated by limb-sparing surgery between January 1986
and April 1997 and therefore had the potential for a minimum of 3 years follow-up.
Patients with metastatic disease at presentation or with the histological types
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dermatofibrosarcoma protuberans, Ewing's sarcoma/ primitive neuroectodermal
tumour or rhabdomyosarcoma were excluded.
The following fields were extracted from the database: age at surgery, gender,
unplanned excision before referral, status at presentation, maximum tumour
diameter, histological type and grade, surgical margin status, radiotherapy given or
chemotherapy given. Fields relating to local recurrence and metastasis were used to
derive data for whether or not local relapse or metastasis had occurred and the time
to that event. Length of follow up was derived from the database and checked against
clinical records.
The following data relating to anatomical location were retrieved: extremity,
anatomical site (nearest joint) and depth. Location within the extremity was recorded
in the database as proximity to the closest major joint (shoulder, elbow, wrist/hand,
hip, knee and foot/ankle).
Data were first used to define the characteristics of the whole group and the
anatomical distribution of tumours. Next, differences in presenting features, tumour
characteristics and treatment between the extremities were determined. The local
recurrence-free rate in the extremities was compared using the methods of Kaplan
and Meier and the log-rank statistic. The Cox proportional hazards model was then
used to investigate first whether maximum tumour diameter and then whether
surgical margin status, extremity and unplanned excision before referral were
predictive of time to local recurrence. Thereafter exploratory analyses examined the
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influence of unplanned excision before referral, surgical margin status and
radiotherapy on local recurrence.
To assess the rate of systemic disease, metastasis-free rate was used in preference to
disease-specific survival in order to maximise the number of events in the survival
analysis, and was compared using the methods of Kaplan and Meier and the log-rank
statistic. The Cox proportional hazards model was used to investigate whether
histological grade, maximum tumour diameter, depth and extremity were predictive
of time to metastasis.
Results
566 patients were entered into the database between January 1986 and April 1997.
There were six primary amputations in 168 upper extremity tumours (3.6%) and 22
primary amputations in 398 lower extremity tumours (5.5%). A further 58 patients
were excluded; 34 presenting with metastatic disease, 12 with a diagnosis of
dermatofibrosarcoma protuberans, seven with primitive neuroectodermal tumour and
five with rhabdomyosarcoma. 480 patients remained in the study.
There were 261 men (54.4%) and 219 women ofmedian age 56 years (15 to 96).
Malignant fibrous histiocytoma (MFH) (163 cases, 34.0%) and liposarcoma (107
cases, 22.3%) were the most common histological types. Tumours were grade one in
83 (17.3%) cases, grade two in 172 (35.8%) and grade three in 225 (46.9%).
85
Forty-eight patients (10.0%) had a local recurrence at a median of 1.4 years (0.1 to
9.2). No patients died of local recurrence. 131 patients (27.3%) developed
metastases at a median of 1.0 years (0.1 to 12.8), 86 of whom died ofmetastatic
disease at a median of 1.5 years (0.1 to 6.8). Nineteen patients died from causes other
than metastatic disease at a median of 1.0 years (0.0 to 7.7). Three of these nineteen
patients died in the immediate postoperative period following a pulmonary embolus.
Median follow-up for the 375 surviving patients was 4.8 years (0.1 to 12.9).
Anatomical distribution
There were 139 (29.0%) tumours in the upper extremity and 341 (71.0%) in the
lower (Table 4.1). Seventy-four (15.4%) were around the shoulder, 41 (8.5%) the
elbow, 24 (5.0%) the hand or wrist, 154 (32.1%) the hip, 148 (30.8%) the knee and
39 (8.1%) the ankle or foot (Table 4.2). Three hundred and seventy seven (78.5%)
were deep to or involving the investing fascia of the extremity.
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Table 4.1
Summary of presenting features and treatment by extremity
Upper extremity Lower extremity
Number of cases 139 341
Median age at surgery (range) 54 (17 to 86) 56 (15 to 96)
Proportion of males 84 (60.4%) 177 (51.9%)
Mean maximum tumour diameter (cm) 6.0 (1 to 26) 9.3 (1 to 40)
Deep to or involving investing fascia 97 (69.8%) 280 (82.1%)
Histological grade 1 30(21.6%) 53 (15.5%)
2 44 (31.7%) 128 (37.5%)
3 65 (46.8%) 160 (46.9%)
Unplanned excision before referral 89 (64.0%) 160 (46.9%)
Presentation with a local recurrence 18 (12.9%) 38 (11.1%)
Positive surgical margins 28 (20.1%) 71 (20.8%)
Adjuvant radiotherapy 98 (70.5%) 289 (84.8%)
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Table 4.2
Summary of local recurrence and systemic disease by extremity
Upper extremity Lower extremity
Median follow-up of survivors in years 4.9(0.1 to 11.1) 4.7(0.2 to 12.9)
Number of patients with local recurrence 23 25
Median time to local recurrence (years) 1.3 (0.2 to 9.2) 1.6(0.1 to 6.6)
Local recurrence-free rate at 5 years 82% 93%
Number of patients developing metastases 26 105
Median time to metastasis (years) 1.0(0.1 to 6.7) 1.0(0.1 to 12.8)
Metastasis-free rate at 5 years 82% 69%
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Differences between the extremities
Upper extremity tumours were more often treated by unplanned excision before
referral than lower extremity tumours (89 (64.0%) vs. 160 (46.9%), p<0.001). The
proportion of patients presenting with a local recurrence was similar in each
extremity (18 (12.9%) vs. 38 (11.1%), p=0.576). Upper extremity tumours were
significantly smaller than lower extremity tumours (6.0 cm vs. 9.3cm, p<0.001) and
were less often deep to or involving the investing fascia (97 (69.8%) vs. 280
(82.1%), p=0.003) (Table 4.1). Mean tumour diameter decreased from proximal to
distal in both extremities (Table 4.3). There was a relative excess of synovial
sarcoma, epithelioid sarcoma and fibrosarcoma in upper extremity sites and of
liposarcoma and myxoid liposarcoma in the lower extremity (Table 4.4). Histological
grade did not differ significantly between the upper and lower extremities (p=0.219)
(Table 4.1).
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The proportion of patients with a positive surgical margin did not differ significantly
between the upper and lower extremities (28 (20.1%) vs. 71 (20.8%), p=0.868)(Table
4.1). However, within the upper extremity positive surgical margins were more
frequent around the elbow (16 of 41 (39.0%)), than the wrist and hand (5 of 24
(20.8%)) or shoulder (7 of 74 (9.5%), p<0.001)(Table 4.3).
Overall, radiotherapy was given less often for upper than lower extremity tumours
(98 (70.5%) vs. 289 (84.8%) p<0.001)(Table 4.1). This was because tumours around
the shoulder were not treated with adjuvant radiotherapy (45 of 74 (60.8%)) as often
as tumours around the elbow (34 of 41 (82.9%)) or wrist (19 of 24 (79.2%), p=0.048)
(Table 4.3). The proportion of patients given adjuvant chemotherapy did not differ
significantly between the upper and lower extremities (2 of 139 (1.4%) vs. 8 of 341
(2.3%), p=0.528)
Median follow-up for survivors was 4.9 (0.1 to 11.1) years in the upper and 4.7 (0.2
to 12.9) years in the lower extremity.
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Local recurrence
There were 23 local recurrences in the upper extremity and 25 in the lower. The
median time to local recurrence was 1.3 (0.2 to 9.2) years in the upper extremity and
1.6 (0.1 to 6.6) years in the lower. The local recurrence-free rate at five years was
82% in the upper and 93% in the lower extremity (log-rank test, p=0.002) (Figure
4.1).
The difference in the local recurrence-free rate between the extremities was
investigated with a Cox proportional hazards regression model. First, recognising the
difference in tumour size between the extremities, regression was performed using
tumour diameter as a single continuous variable. This did not reach significance
(p=0.074), confirming that tumour size is not a significant determinant of local
recurrence. A second model was constructed using, in this order, categorical
variables for surgical margin status (negative or positive), extremity (lower or upper),
unplanned excision before referral (no or yes) and an interaction variable of
extremity and unplanned excision before referral. Plots for each variable confirmed
proportionality of the hazard ratio over time. Surgical margin status reached
significance in the model (p<0.001) with a hazard ratio of 3.16 (95% confidence
interval 1.76 to 5.69) associated with a positive margin. Extremity, unplanned
excision before referral and the interaction variable of extremity and unplanned


















1l I 11 I III II -h
i i i i i i i i iii II
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Table 4.5




























An exploratory analysis of the relationship between an unplanned excision before
referral, surgical margin status and local recurrence compared crude local recurrence
rates in four groups (Table 4.6). Amongst patients who had primary excision of a
tumour with a positive surgical margin, those with upper extremity tumours were
more likely to have local recurrence than those with lower extremity tumours (3/13
(23.1%) vs. 2/46 (4.3%), p=0.032).
A further exploratory analysis examined the effect of radiotherapy on local
recurrence by calculating how many patients with local recurrences in these four
groups had received radiotherapy (Table 4.6). Six of 11 patients with upper extremity
tumours treated by unplanned excision before referral and re-excision with negative
margins who had a local recurrence had not received radiotherapy. In three cases, all
located around the shoulder, this was because radiotherapy had been given on a
previous occasion, precluding further radiotherapy. In two of the remaining patients
radiotherapy was not given because no tumour was identified in the re-excision
specimen. The sixth patient had a low-grade fibrosarcoma around the shoulder,
thought to have been completely excised.
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Twenty-six of 139 patients with upper extremity tumours developed a metastasis
compared with 105 of 341 with a lower extremity tumour. The median time to
metastasis was 1.0 (0.1 to 6.7) years after surgery in the upper and 1.0 (0.1 to 12.8)
years after surgery in the lower extremity. The metastasis-free rate at five years was
82% in the upper extremity and 69% in the lower (log-rank test, p=0.013)(Figure
4.2). There was a trend towards fewer metastases in the distal extremities (Table 4.2).
To investigate the difference in metastasis-free rates between the extremities a Cox
proportional hazards model was constructed using, in this order, histological grade
(low (grade 1) or high (grade 2 or 3)), maximum tumour diameter in centimeters,
depth (superficial or deep), and extremity (upper or lower). The hazard ratio for each
variable was plotted to confirm proportionality over time. There was an increased
risk of metastasis with high histological grade (hazard ratio 17.28 (95% confidence
interval 4.26 to 70.10), p<0.001), maximum tumour diameter (increased hazard ratio
of 1.05 (95% confidence interval 1.02 to 1.08) per centimeter increase, p<0.001) and
deep location (hazard ratio 1.93 (95% confidence interval 1.07 to 3.48), p=0.028).
The variable for extremity did not reach significance (p=0.21 l)(Table 4.7).
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Figure 4.2
Kaplan-Meier estimate for the metastasis-free rate
Time in years
Tick marks represent censored cases.
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Table 4.7























This study has compared the presentation, treatment, local recurrence-free and
metastasis-free rates of upper and lower extremity soft tissue sarcomas in this group
of patients. The study shows that upper extremity tumours are smaller, more often
treated by unplanned excision before referral, are of different histological types, and
less often meet the criteria for adjuvant radiotherapy. The study also shows that after
treatment of extremity soft tissue sarcoma, the local recurrence-free rate and
metastasis-free rate vary with anatomical location. In particular, local recurrence is
more frequent after treatment of an upper extremity sarcoma. Conversely, lower
extremity sarcomas are associated with an increased metastatic rate.
A number of factors may contribute to the higher local recurrence rate in the upper
extremity. These include differences in tumour characteristics, such as histological
type, and differences in treatment, such as the effect of unplanned excision before
referral and the use of radiotherapy. The strongest predictor of local recurrence in
many studies is a positive surgical margin, which implies the presence of residual
f\ • 1 HQ • 1 0 ^ • 1 "7 7
disease ' ' ' . The Cox model confirms this relationship in this series, and shows
that after incorporating the effect of a positive surgical margin, the effect of an
unplanned excision before referral, or the upper rather than lower extremity location
of a soft tissue sarcoma do not reach significance. Sadoski et al suggested that the
relationship between a positive surgical margin and local recurrence is stronger in the
upper than the lower extremity 109. However, in our series there was a higher local
recurrence rate in the upper extremity in both positive and negative margin cases
(Table 4.4).
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The proportion of patients with a positive surgical margin was particularly high (16
of 41 cases) for tumours around the elbow, which may reflect local anatomy. Despite
this the local recurrence rate in this group was not as high as in other upper extremity
sites (Table 4.2). The reason for this may be that four patients in this group had low
grade liposarcomas, and were therefore at low risk of local recurrence.
Although it is a subgroup analysis and should therefore be treated with caution, it is
interesting that there was a significant difference in local recurrence rates between
the extremities amongst patients treated by primary excision with positive margins.
There are a number of possible explanations. The previous study shows that an
unexpected positive margin following a surgical error is associated with a higher risk
of local recurrence than a planned positive margin against a critical structure (such as
nerve, vessel or bone) or a planned marginal resection of a low grade liposarcoma. In
five of 16 (31.3%) patients undergoing primary resection of an upper extremity
sarcoma with a positive surgical margin, the positive margin was unexpected
compared with eight of 48 (16.7%) in the lower extremity. This suggests that primary
resection of a soft tissue sarcoma in the upper extremity is technically more
demanding, or that in order to preserve function, the surgeon is prepared to operate
closer to the tumour in the upper extremity. Another explanation for the difference in
local recurrence rates is that there were more low grade liposarcomas in the lower
extremity, which are at low risk of local recurrence (17 of 48 (35.4%) in the lower
extremity vs. four of 16 (25%) in the upper)141.
The distribution of histological types may have contributed to the difference in local
recurrence rates between the extremities in another way. The histological types
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angiosarcoma and malignant peripheral nerve sheath tumour have been associated
with an increased risk of local recurrence 18'19. Both of these types were relatively
more frequent amongst upper compared to lower extremity tumours. Within the
upper extremity, these histologic types were associated with four of 23 (17.4%) local
recurrences, compared with two of 25 (8.0%) lower extremity tumours (Table 4.3).
Variation in the use of radiotherapy may also have influenced the local recurrence
rate. In particular, tumours around the shoulder did not meet the criteria for
radiotherapy as often as those in other upper extremity sites. This is likely to be
because a proportion of soft tissue sarcomas around the shoulder occur in muscle
(such as deltoid) where they can be excised with an adequate margin more readily
than in other upper extremity sites. Therefore an unplanned excision is more likely to
have been successful in removing all identifiable tumour and adjuvant radiotherapy
is not indicated after re-excision. It was also more common for the shoulder to have
been treated with radiotherapy previously, both for the presenting tumour and for
unrelated conditions, such as Hodgkin disease.
Upper extremity tumours more frequently undergo unplanned excision before
referral, possibly because they are smaller and more often superficial. However, this
study does not conclusively prove an adverse influence of unplanned excision on
local recurrence in the Cox model.
The finding that lower extremity tumours are associated with a higher rate of
metastasis confirms that of other authors57'68'96. The Cox model suggests that that
most of this difference is accounted for by recognised risk factors for metastasis,
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namely grade, size and depth l6' 8'96'127'138, rather than another hitherto unrecognised
feature of lower extremity sarcomas. The analysis makes the assumption that after
the treatment of an extremity soft tissue sarcoma, local recurrence and metastasis are
independent and not competing events. Length of follow-up of survivors was similar
in the upper and lower extremities, and therefore it is unlikely that the higher local
recurrence rate of upper extremity tumours was caused by an increased death rate
and shorter follow up of lower extremity tumours.
There were more lower than upper extremity tumours in this series, an experience
1 8'79'QR" 197" 198
shared by other authors ' ' ' ' . This probably reflects the greater volume of
mesenchymal tissue in the lower extremity.
Tumours in the upper extremity are smaller probably either because the smaller
volume of the extremity allows tumours to be detected earlier or because the upper
extremities are exposed and abnormal swellings are identified readily. However, this
study, like others, suggests that tumour size is not a strong predictor of local
recurrence l6'96'127. This study was not designed to assess delays in referral, and it is
therefore not possible to conclude if upper extremity tumours present earlier than
those in the lower extremity. The smaller size of upper extremity tumours supports
the suggestion that the threshold above which a mass should be treated as potentially
malignant should be lower in the upper extremity 57. The larger size of lower
extremity tumours probably explains why they more often involve the investing
fascia of the limb and are therefore classified as deep.
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This study is novel in directly comparing upper and lower extremity soft tissue
sarcomas treated in one centre. It highlights differences in treatment and outcomes
despite the fact that the treating clinicians felt that they were applying similar
principles in both locations. It shows that in this group of patients, upper extremity
sarcomas are associated with a higher local recurrence rate than those in the lower
extremity probably because of differences in histological type, the use of
radiotherapy and local anatomy. Although upper extremity sarcomas are more often
treated by unplanned excision before referral, the study does not conclusively prove
that this has an adverse effect on local tumour control. In contrast, lower extremity
sarcomas tend to be larger, and more often deep than upper extremity sarcomas, and
therefore have an increased risk of metastasis. This study also shows that in this
patient population, the higher rate of local recurrence in the upper extremity was not
matched by a higher rate of metastatic disease. This supports the philosophy of
preserving function in the upper extremity where possible. These results are directly
relevant to the management of patients with extremity soft tissue sarcoma.
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5. ANATOMICAL LOCATION AND
FUNCTIONAL OUTCOME
Introduction
The purpose of this study was to explore the relationship between anatomical
location and functional outcome scores in lower extremity soft tissue sarcoma.
Patients and Methods
It was decided at the outset to exclude patients with upper extremity tumours from
this study because they were too few in number to allow meaningful analysis.
Functional outcome was assessed using MSTS (1993) and TESS evaluations. The
MSTS (1987) evaluation is site-specific (i.e. pelvis/hip/proximal thigh, distal
thigh/knee/proximal leg and distal leg/ankle/foot) and was therefore not suitable for
this study. The generic general health status measure Short-Form 36 (SF-36) was not
9 S
used because it is not sensitive to local treatment factors .
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The TESS was first used in April 1994 and therefore patients treated before this date
were excluded. A minimum of 1 year follow up for functional evaluation was
required, at which point functional scores plateau5'24. Patients were also excluded if
they had metastases at presentation, had a local or systemic relapse before functional
assessment at 1 year or received chemotherapy, as all of these factors are likely to
have an adverse effect on functional scores.
The database was used to identify suitable patients and the following data were
extracted from it; age, gender, status at presentation, unplanned excision, histological
type and grade, maximum tumour diameter, depth, type of procedure, and
complications of surgery. Resection of bone, resection of major motor nerve, MSTS
and TESS item and aggregated scores were extracted from the function database.
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Anatomical definitions
Tumours were first categorised as superficial or deep, as defined previously. Next,
deep tumours were assigned to one of nine anatomical regions in the lower
extremity. These regions were based upon the concept of anatomical compartments
developed by Enneking as these have both oncological and functional significance 40
The thigh compartments as described by Enneking were used and the following
anatomical regions were defined; the groin/femoral triangle, the buttock, the
popliteal fossa, anterolateral leg, posterior calf, and foot and ankle. The boundaries
and contents of these anatomical regions are described in Table 5.1. The anatomical
location of the tumour was determined by review of the operating note and imaging.
A tumour involving more than one region was assigned to the region containing the
greatest part of the tumour.
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Table 5.1 Anatomical regions within the lower extremity
Region Anatomical boundaries and contents
Groin/femoral
triangle
Proximally the inguinal ligament, posteriorly iliopsoas and
anterior hip capsule, laterally the tendon of rectus femoris.
Contains proximal extent of femoral artery, vein, nerve and
inguinal nodes.
Buttock
Proximally the posterior brim of pelvis, medially the sacrum,
anteriorly the posterior border of tensor fascia lata, anterior
border of gluteus medius, and as the deep boundary, the
outer table of pelvis. Contains gluteus maximus, minimus,
medius, quadratus femoris, and the proximal extent of the
sciatic nerve.
Anterior thigh
Proximally the brim of pelvis, distally the patella, and
laterally the intermuscular septum. Contains quadriceps
including patella and patellar tendon, sartorius, tensor fascia
lata, femoral artery, vein, and nerve.
Medial thigh
Proximally the pubic rami and ischial tuberosity,
anterolaterally the adductor canal and medial intermuscular
septum, posteriorly the posterior surface of adductor magnus,
distally the pes anserinus. Contains gracilis, adductors
brevis, longus, magnus, pectineus, and profunda femoris
vessels.
Posterior thigh
Laterally the intermuscular septum, medially the adductor
magnus fascia, proximally the ischial tuberosity, distally the
musculotendinous junctions of the hamstring muscles,
anteriorly the linea aspera and posterior face of femur.




Region Anatomical boundaries and contents
Popliteal fossa
Superficially the deep fascia, anteriorly the posterior
capsule of knee joint and the heads of gastrocnemius,
distally the confluence of gastrocnemius and proximally
the musculotendinous junctions of hamstrings. Contains
sciatic nerve, popliteal vessels and lymph nodes.
Posterior calf
Anteriorly, the posterior surface of the tibia, interosseous
membrane, posterior aspect of fibula and posterior
intermuscular septum. Posteriorly, the deep fascia of the
calf. Superiorly the confluence of gastrocnemius, distally
the commencement of the tendo Achilles. Contains
gastrocnemius, plantaris, soleus, popliteus, flexor
digitorum longus, flexor hallucis longus, tibialis posterior,
and the posterior tibial vessels and nerve.
Anterolateral
leg
Anteriorly, the deep fascia of the leg, posteriorly the lateral
surface of the tibia, the interosseous membrane, the fibula
and the posterior intermuscular septum. Proximally the
proximal extent of the insertion of tibialis anterior into the
tibia, distally the superior extensor retinaculum of the
ankle. Contains peroneus longus and brevis, peroneus
tertius, extensor digitorum longus, extensor hallucis
longus, tibialis anterior, the anterior tibial vessels and deep
peroneal nerve.
Foot and ankle
Proximally this space in bounded by the superior extensor




To minimise transcription errors, data relating to anatomical location were entered
twice into a spreadsheet and checked for compatibility with the pre-existing
anatomical classification in the database in which tumours were grouped by their
proximity to the nearest major joint.
Analysis
Initially, descriptive variables were calculated for the whole group of eligible
patients. Next the characteristics, MSTS (1993) and TESS evaluations of superficial
and deep tumours were compared. Factors influencing MSTS (1993) and TESS
scores for deep tumours alone were then investigated using linear regression. Models
were constructed using variables previously shown to be predictive of functional
9S • • •
outcome and adding further variables for anatomical location. Therefore, to
investigate the effect of anatomical location on postoperative MSTS (1993) scores,
the linear regression model used variables for tumour diameter, high histological
grade (N/Y), resection of bone (N/Y), resection ofmotor nerve (N/Y), complications
of surgery (N/Y) and dummy variables for each of the nine anatomical locations. The
regression model for postoperative TESS used variables for tumour diameter, high
histological grade (N/Y), motor nerve resection (N/Y) and dummy variables for each
of the nine anatomical locations.
To investigate variation in pre- and postoperative MSTS (1993) and TESS score
items for deep tumours by anatomical location an exploratory analysis compared the
mean scores for each item across the anatomical locations.
Ill
To assess the effect ofmissing MSTS and TESS results, patients with and without
postoperative MSTS and TESS results were compared for characteristics which
might have an effect on these scores, namely tumour diameter, bone resection, motor
nerve resection, complications of surgery and anatomical location.
Results
Between April 1994 and March 1999, data relating to 397 patients were entered in
the database. Ninety-seven of these had upper extremity tumours, and 17 had an
amputation and were therefore excluded. The following patients were also excluded;
22 with metastases at presentation, 32 who developed metastases before functional
evaluation, two who died of other causes, three with a local recurrence in the first
year, and ten patients who received chemotherapy. Seven patients had no function
data available. Therefore 207 patients were included in this study.
Characteristics of the whole group
There were 106 (51.2%) females and 101 males of median age 54 (15 to 89) years.
Twelve patients (5.8%) presented with a local recurrence after treatment elsewhere.
Seventy-six patients (36.7%) had been treated by unplanned excision before referral.
The distribution of histological types was similar to that in other series, with
malignant fibrous histiocytoma in 48 (23.2%), liposarcoma otherwise undesignated
in 49 (23.7%) and myxoid liposarcoma in 28 (13.5%). Tumours were grade one in
40 (19.3%) cases, grade two in 76 (36.7%) and grade three in 91 (44.0%). The
median maximum tumour diameter was 8.0 cm (0.3 to 36.0).
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A tissue transfer or split-skin graft was used for wound closure in 40 (19.3%) cases,
and 170 (82.1%) patients received adjuvant radiotherapy. Resection of bone was
required in twelve (5.8%) cases and resection of a major motor nerve in twelve
(5.8%) cases. Forty-eight (23.2%) patients had a wound complication and three
(1.4%) had a fracture.
After anatomical classification there were 58 (28.0%) superficial and 149 (72.0%)
deep tumours. Superficial tumours were significantly smaller than deep tumours (4.6
vs 11.2 cm, p<0.001)(Table 5.2). Of the deep tumours, six were located in the
groin/femoral triangle, eight in the buttock, 52 in the anterior thigh, 22 in the medial
thigh, 20 in the posterior thigh, ten in the popliteal fossa, thirteen in the posterior
calf, eleven in the anterolateral leg and seven in the foot and ankle (Table 5.3). Of the
deep tumours, 119 (79.9%) involved one site only, 28 (18.8%) involved 2 sites and 2
(1.3%) involved three sites.
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Differences between deep and superficial tumours
Functional scores grouped according to whether the tumour was superficial or deep
are shown in Table 5.2. There was no significant difference in MSTS (1993) or
TESS at presentation when superficial and deep tumours were compared (mean
MSTS (1993) 90.6% for superficial tumours vs. 86.9% for deep tumours, p=0.271;
mean TESS 86.4% for superficial tumours vs. 81.8% for deep tumours, p=0.081).
Treatment of superficial tumours was not associated with a significant change in
MSTS (1993) (mean MSTS (1993) 90.6% preoperatively vs 93.0% postoperatively,
p=0.566) and TESS (mean TESS 86.4% preoperatively vs 90.9% postoperatively,
p=0.059). However, treatment of deep tumours was associated with a significant
reduction in MSTS (1993) and TESS (mean MSTS (1993) 86.9% preoperatively vs.
83.0% postoperatively, p<0.001; mean TESS 81.8% preoperatively vs. 79.5%
postoperatively, p=0.015). MSTS (1993) and TESS differed significantly between
superficial and deep tumours after treatment (mean MSTS (1993) 93.0% for
superficial tumours vs 83.0% for deep tumours, p<0.001; mean TESS 90.9% for
superficial tumours vs 79.4% for deep tumours, p<0.001).
Variation in characteristics of deep tumours by anatomical location
Variation in tumour size, type, treatment and functional scores amongst deep
tumours by anatomical location is summarised in Table 5.3. Comparison of MSTS
(1993) and TESS scores by anatomical location revealed no significant differences in
preoperative MSTS (1993) (p=0.120) or TESS (p=0.282). Significance values from
the regression model for postoperative MSTS (1993) are shown in Table 5.4. The
only factor to reach significance was resection ofmotor nerve (pO.OOl). The
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variables for anatomical location did not reach significance. Significance values
from the linear regression analysis for postoperative TESS are shown in Table 5.5.
Once more, the only variable to reach significance was resection ofmotor nerve
(p=0.002). The variables for anatomical location did not reach significance.
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Table 5.4





High or low histological grade -0.037 -0.417 0.678
Resection ofmotor nerve -0.349 -4.169 <0.001
Groin/femoral triangle -0.064 -0.738 0.462
Buttock 0.068 0.817 0.416
Medial thigh 0.146 1.633 0.105
Posterior thigh 0.044 0.495 0.622
Popliteal fossa 0.134 1.591 0.114
Posterior calf 0.103 1.197 0.233
Anterolateral leg 0.124 1.256 0.212
Foot and ankle 0.040 0.457 0.649
Maximum tumour diameter -0.161 -1.764 0.080
Any complication of surgery -0.106 -1.234 0.220










High or low histological grade 0.012 0.123 0.902
Resection ofmotor nerve -0.306 -3.242 0.002
Groin/femoral triangle -0.130 -1.354 0.179
Buttock -0.045 -0.467 0.641
Medial thigh 0.075 0.729 0.468
Posterior thigh 0.002 0.016 0.987
Popliteal fossa 0.041 0.429 0.669
Posterior calf 0.139 1.373 0.173
Anterolateral leg 0.026 0.265 0.791
Foot and ankle 0.069 0.712 0.478




Comparison of MSTS (1993) and TESS items by anatomical location
Exploratory analysis of score items showed significant variation by anatomical
location for the pain and gait items of the preoperative MSTS (1993) (Figure 5.1).
Tumours in the groin/femoral triangle were associated with more pain than those in
other locations. All patients with tumours in the groin/femoral triangle required
analgesia, with most requiring narcotic analgesia. The lowest mean score for gait was
for tumours in the groin/femoral triangle, followed by the posterior calf, the foot and
ankle and the anterolateral leg (Figure 5.1).
In the postoperative MSTS (1993), significant variation was also seen in item scores
for gait. Once more, the lowest scores were seen in tumours in the groin/femoral
triangle. Patients with tumours in the medial thigh, popliteal fossa, posterior calf and
foot and ankle all walked normally (Figure 5.2). In the preoperative TESS,
exploratory analysis did not identify items with significant variation by anatomical
location although the item score for sitting approached significance. Patients with
tumours in the groin/femoral triangle, buttock and posterior thigh had the greatest
difficulty with sitting (Figure 5.3).
In the postoperative TESS significant variation was seen in the items for putting on
pants (trousers), putting on socks or stockings, getting in and out of the bath, or
bending to pick something up off the floor. Once more, patients with tumours in the
groin/femoral triangle had the greatest difficulty with these activities. Putting on
socks and stockings also appeared to be difficult for those with posterior thigh or
buttock tumours (Figure 5.4). Getting in and out of the bath was also difficult for
those with posterior thigh or anterolateral leg tumours. Bending to pick something up
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off the floor was most difficult for patients with tumours in the groin/femoral
triangle, buttock and the posterior thigh (Figure 5.5).
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Figure 5.1
Mean preoperative MSTS (1993) "pain" and
"gait handicap or limp" items by anatomical location





























Gait 4.0 5.0 4.8 5.0 5.0 4.9 4.2 4.7 4.3
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Figure 5.2
Mean postoperative MSTS (1993) "pain"
"gait handicap or limp" items by anatomical
and
location




























Pain 2.7 3.8 4.0 4.4 3.9 4.4 4.2 4.2 4.0
Gait 3.8 4.7 4.6 5.0 4.8 5.0 5.0 4.6 5.0
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Figure 5.3

















































































3.8 3.9 4.7 4.4 4.2 4.9 4.6 4.9 5.0
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Figure 5.4
Mean postoperative TESS "pants" and "socks"





























Pants 3.5 4.2 4.6 4.4 4.1 4.6 4.9 4.9 5.0
Socks 3.0 3.8 4.1 3.9 3.1 4.4 4.8 4.3 5.0
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Figure 5.5
Mean postoperative TESS "bath" and "bending"
items by anatomical location





























Bath 3.2 4.0 4.1 4.2 3.5 4.6 4.6 3.9 4.8
Ben¬
ding
3.2 3.4 3.9 4.0 3.8 4.0 4.7 4.0 4.8
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Completeness of function data
Preoperative MSTS (1993) results were available for 203, and 1 or 2 year MSTS
(1993) results were available for 189 patients. Preoperative TESS results were
available for 172 and 1 or 2 year TESS results were available for 155 patients. Of the
patients for whom 1 or 2 year TESS results were not available, twenty did not speak
English, eleven were lost to follow up, seven were infirm and unable to complete the
questionnaire and fourteen had no data for other reasons.
Differences in the characteristics of patients with postoperative MSTS (1993)
evaluations and those without are summarised in Table 5.6. There were no
significant differences in factors thought to have an influence in determining MSTS
(1993) scores when patients with and without postoperative MSTS (1993)
evaluations were compared.
Differences between patients with and without postoperative TESS evaluations are
summarised in Table 5.7. The analysis shows that patients with incomplete
postoperative TESS data had larger tumours than others, but fewer major motor
nerve resections.
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Table 5.6 Comparison of patients with and without postoperative
MSTS(1993) scores
Postoperative Postoperative
MSTS (1993) MSTS (1993) P
not available available
Number of patients 25 189










































Groin/femoral triangle 0 6
Buttock 2 6
Anterior thigh 5 49
Medial thigh 1 21
Posterior thigh 4 18 0.582
Popliteal fossa 1 9
Posterior calf 2 12
Anterolateral leg 1 10
Foot and ankle 2 5
P-value for difference between patients with and without postoperative MSTS scores
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Table 5.7







Number of patients 59 155






















Groin/femoral triangle 0 6
Buttock 3 5
Anterior thigh 16 38
Medial thigh 5 17
Posterior thigh 9 13 0.551
Popliteal fossa 3 7
Posterior calf 4 10
Anterolateral leg 1 10
Foot and ankle 2 5
P-value is for difference between patients with and withoutpreoperative TESS scores
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Discussion
The purpose of this study was to examine the influence of anatomical location on
function as measured by MSTS (1993) and TESS evaluations. The study shows
differences between MSTS (1993) and TESS evaluations for superficial and deep
tumours, that anatomical location does not appear to be predictive of aggregated
MSTS (1993) and TESS, but that MSTS (1993) and TESS items do vary with
anatomical location.
Although a proportion ofMSTS (1993) and TESS evaluations were not available, the
analysis suggests that patients with missing postoperative MSTS (1993) data did not
differ significantly from those with data available for factors likely to have an impact
on MSTS (1993) evaluations. However, patients without postoperative TESS
evaluations appeared to have larger tumours, but fewer motor nerve resections when
compared to those with postoperative TESS evaluations. Large size has an adverse
effect on function whereas preservation of major motor nerves is associated with
better functional scores. It has been assumed that these missing data items would not
have changed the conclusions of this study.
Higher MSTS (1993) and TESS evaluations for superficial tumours likely reflects
their smaller size and the fact that treatment does not involve major muscle, motor
nerve or bone resection. In fact, the treatment of superficial tumours was associated
with an increase in MSTS (1993) and TESS although this did not reach statistical
significance. Treatment of deep tumours when considered as a group was, as
expected, associated with a significant decrease in MSTS (1993) and TESS.
However, it is of note that the change in total scores varied with anatomical location.
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In some locations, such as the groin/femoral triangle, the medial thigh, and the
posterior calf, treatment of deep tumours was associated with an increase in
functional scores, but treatment of tumours in the anterior thigh, the posterior thigh,
the popliteal fossa and the anterolateral leg all lead to a decrease in functional scores.
This may in part reflect the relative importance of these anatomical compartments in
determining functional scores.
In the regression model, variables for anatomical location were not predictive of
aggregated postoperative MSTS (1993) or TESS scores for deep tumours in this
group of patients using these anatomical definitions. The exploratory analysis,
however, indicates that individual score items do show variability with anatomical
location. Tumours in the groin/femoral triangle were associated with more
preoperative pain, as measured by the MSTS (1993) item for pain than those in other
locations. This may be related to the relatively high rate ofmajor nerve involvement
in this location (2 of 6 patients requiring major motor nerve resection). Other than
those in the groin, tumours located below the knee appeared to be associated with the
lowest preoperative gait handicap or limp scores, reflecting the contribution of these
compartments to normal gait. The lowest mean postoperative MSTS (1993) gait
handicap or limp scores were seen in tumours in the groin/femoral triangle, although
the group included one patient who had undergone a major femoral nerve resection
and scored zero for gait postoperatively.
The TESS evaluation contains a greater number of items than the MSTS (1993) and
some items, such as the ability to sit, have an intuitive relationship with anatomical
location. Tumours in the buttock and posterior thigh were associated with greater
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difficulty in sitting than those in other locations, likely reflecting the discomfort
experienced when sitting directly on a tumour. Patients with tumours in the
groin/femoral triangle also had difficulty sitting normally, perhaps because of
restriction of normal hip flexion. The postoperative TESS evaluation confirms that
after treatment, patients with tumours in the groin/femoral triangle continue to score
lower for the items putting on socks, getting out of the bath and bending to pick up,
all of which involve hip flexion.
The anatomical definitions in this study are based on Enneking's compartments as
these have both oncological and functional significance. The muscles in any one
compartment tend to have similar functions. This classification lead to the use of
nine anatomical regions, which in turn meant the numbers of patients with tumours
in any one compartment was small. Additionally, tumours were assigned to one
compartment for this analysis, although they may have involved more than one. The
validity of this classification has not been tested. Other anatomical classifications
may have lead to different conclusions, although it is of note that in another study, in
which the anatomical location was defined by the proximity of the tumour to the
nearest major joint, anatomical location was not a significant predictor of functional
scores 25.
This study therefore shows that the anatomical location of a lower extremity soft
tissue sarcoma has a role in determining the function of the patient after treatment.
This question has not been directly addressed in the literature before. The treatment
of superficial tumours is associated with little change in functional scores, a fact that
is likely to be helpful when counselling patients about treatment. Treatment of deep
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* tumours leads to a decrease in functional scores. Anatomical location does not appear








The purpose of this study was to investigate whether the preservation of "normal"
non-critical anatomical structures around a tumour associated with the "shelling out"
or planned marginal excision of low-grade liposarcomas leads to better functional
outcomes than the wider, negative margin surgery performed for higher grade
malignant tumours.
Patients and Methods
The same criteria were used to select patients for this analysis as in the previous
study of functional outcome and anatomical location. Patients with upper extremity
tumours were excluded as were those treated before the TESS was first used in April
1994, and those without a minimum of 1 year of follow up. Patients were also
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excluded if they had metastases at presentation, had a local or systemic relapse
before functional assessment at 1 year or received chemotherapy. Superficial
tumours were excluded as treatment does not lead to significant changes in MSTS
and TESS evaluations. The following data were derived from the database; age,
gender, status at presentation, unplanned excision, histological type and grade,
maximum tumour diameter, depth, type of procedure, and complications of surgery.
Resection of bone, resection ofmajor motor nerve, MSTS and TESS item and
aggregated scores were extracted from the function database.
Patients were assigned to two groups; those with a diagnosis of low-grade
liposarcoma and others. The diagnosis of low-grade liposarcoma was suspected
preoperatively on the basis ofCT and/or MRI scanning. These tumours are
characterised by their homogenous fat content, and biopsy was not usually
performed, the diagnosis being confirmed after definitive resection. The surgical
management of these tumours usually involves approaching the surface of the lesion
and resecting the tumour covered with a thin film of normal tissue. The surgical
margin is usually positive in parts, but an attempt is always made to obtain complete
resection whilst preserving normal tissues. Occasionally, neurovascular structures are
involved in these tumours, and may be resected with the tumour to obtain clearance.
This differs from the treatment of higher grade tumours, when an attempt is usually
made to resect the tumour with a mobile covering of normal tissue such as muscle or
fascia outside the reactive zone. Radiotherapy was given based on the perceived risk
of local recurrence, following multidisciplinary assessment of the predicted or actual
surgical margins and the histological appearance of the tumour.
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Initially the characteristics of the two groups and pre-and postoperative aggregated
MSTS (1993) and TESS values were compared. Next, regression models were
constructed with postoperative MSTS (1993) and TESS values as dependent
variables using factors previously shown to be predictive of them with the addition of
a variable for low grade liposarcoma. Given that there was a difference in the use of
radiotherapy between the groups, a variable for the use of radiotherapy was also
added. Therefore the model for postoperative MSTS (1993) contained variables for
tumour diameter, high histological grade (N/Y), resection of bone (N/Y), resection of
motor nerve (N/Y), complications of surgery (N/Y), low grade liposarcoma (N/Y)
and radiotherapy (N/Y). The model for postoperative TESS included variables for
tumour diameter, high histological grade (N/Y), motor nerve resection (N/Y), low
grade liposarcoma (N/Y) and radiotherapy (N/Y).
Results
As stated in the previous study, data relating to 397 patients were entered in the
database between April 1994 and March 1999. The following patients were
excluded; 97 with upper extremity tumours, 17 who had an amputation, 22 with
metastases at presentation, 32 who developed metastases before functional
evaluation, two who died of other causes, three who had a local recurrence in the first
year, and ten patients who received chemotherapy. 60 patients with superficial
tumours were also excluded. Of the 154 patients remaining, five had no function data
available, leaving 149 patients in this analysis.
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Of the 149 patients in this study, 27 had low-grade liposarcomas (Table 6.1). The
mean age of the 149 patients was 52 years (15 to 89). 71 were male. Mean age and
gender did not differ significantly between patients with low-grade liposarcomas and
the rest (58.0 vs 51.2 years, p=0.082; 45.9% vs 55.6% male, p=0.363). Low grade
liposarcomas were significantly larger than other tumour types (mean maximum
diameter 16.5 vs 10.0 cm, p<0.001). However, the two groups of patients did not
differ significantly in the number requiring resection of major motor nerves or bone
(Table 6.1). Four of 27 patients with low-grade liposarcomas had complications of
surgery (one fracture and 3 wound complications). 37 of 122 patients in the other
group had complications of surgery (2 fractures, 35 wound complications), also not
significantly different (p=0.102). However, radiotherapy was used significantly less
often in the treatment of low-grade liposarcomas than other tumours (21 of 27 vs 114
of 122, p=0.012).
There were no significant differences in aggregated preoperative MSTS (1993),
preoperative TESS, postoperative MSTS (1993) and postoperative TESS evaluations
when low-grade liposarcomas and other tumour types were compared. Treatment of
low-grade liposarcomas was associated with a significant decrease in MSTS (1993)
and TESS (93.7 vs. 84.9, p=0.010; 86.8 vs. 80.7, p=0.044). Treatment of other
tumours was associated with a significant decrease in MSTS (1993) (85.4 vs. 82.6;
p=0.016) and a decrease in TESS which did not reach statistical significance (80.9
vs. 79.3, p=0.068)(Table 6.2).
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In the regression model for postoperative MSTS (1993), the variable for resection of
motor nerve was the only one to reach significance (Table 6.3). In the model for
postoperative TESS, the variables for histological grade, resection ofmotor nerve
and low-grade liposarcoma all reached significance (Table 6.4).
Completeness of function data
Of the 154 patients eligible for this study, postoperative MSTS (1993) evaluations
were not available for 18. Differences in the characteristics of patients with
postoperative MSTS (1993) evaluations and those without are summarised in Table
6.5. There were no significant differences in factors thought to have an influence in
determining MSTS (1993) scores when patients with and without postoperative
MSTS (1993) evaluations were compared.
Postoperative TESS evaluations were not available for 43 patients in this analysis.
Differences between patients with and without postoperative TESS evaluations are
summarised in Table 6.6. As in the previous study, patients with incomplete









High or low histological grade 0.090 0.553 0.581
Resection ofmotor nerve -0.388 -4.868 <0.001
Maximum tumour diameter -0.162 -1.908 0.059
Low grade liposarcoma 0.077 0.468 0.640
Resection of bone -0.070 -0.865 0.389
Any complication of surgery -0.077 -0.945 0.347
Radiotherapy -0.127 -1.559 0.121
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Table 6.4





High or low histological grade 0.422 2.299 0.024
Resection ofmotor nerve -0.346 -3.934 <0.001
Maximum tumour diameter -0.147 -1.618 0.109
Low grade liposarcoma 0.414 2.259 0.026
Radiotherapy -0.121 -1.345 0.181
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Table 6.5









Number of patients 18 136
Mean tumour diameter (cm) 12.1 (2.0-26.0) 11.0 (2.0-36.0) 0.498
High histological No 4 30
0.987
grade Yes 14 106
Resection of bone No 18 124
0.189
Yes 0 12
Resection ofmajor No 17 127
0.864
motor nerve Yes 1 9
Complications of No 15 98
0.309
surgery Yes 3 38
Low grade No 14 112
0.636
liposarcoma Yes 4 24
P-value for difference between patients with and without postoperative MSTS scores
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Table 6.6







Number of patients 43 111
Mean tumour diameter (cm) 13.2 (2.0-28.0) 10.4 (2.0-36.0) 0.016
High histological No 14 20
0.051
grade Yes 29 91
Resection ofmajor No 43 101
0.042
motor nerve Yes 0 10
Low grade No 31 95
0.051
liposarcoma Yes 12 16
P-value is for difference between patients with and without preoperative TESS scores
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Discussion
The aim of this analysis was to assess whether the "shelling out" of low-grade
liposarcomas in which almost all normal tissue is preserved is associated with better
functional outcomes that the more extensive, "negative margin", surgery used for
other tumours in the lower extremity. This question has not been addressed
elsewhere in the literature. This study shows that the planned marginal excision of
low-grade liposarcomas still leads to a decrease in MSTS (1993) and TESS
evaluations, despite a more conservative surgical approach. Although aggregated
functional scores do not differ significantly between patients with low-grade
liposarcomas and other tumours, the regression analysis suggests that the planned
marginal excision of low-grade liposarcomas may be associated with higher TESS
evaluations.
This analysis uses multiple regression to compensate for the effect of variables
previously shown to have an effect on functional scores. Elowever, it is clear that the
oncological significance of a diagnosis of low-grade liposarcoma is very different to
the diagnosis ofmalignant soft tissue sarcoma. It is not clear what effect this may
have had on patient responses to function questionnaires. This difference might have
had an effect on functional scores. The regression analysis suggests that other
differences between these groups, particularly tumour diameter and the use of
radiotherapy do not have a significant effect on functional scores.
The regression analysis also suggests that the treatment of low-grade liposarcomas
does not lead to better postoperative MSTS (1993) evaluations, but may be
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associated with improved postoperative TESS evaluations. This may reflect
differences in what the scores measure (MSTS(1993) is a measure of impairment,
TESS of handicap), or in their ability to discriminate between patients.
It is interesting to note that the surgery of low-grade liposarcomas has a complication
rate similar to the surgery of other soft tissue sarcomas. One patient had a large
(26cm in maximum diameter) low-grade liposarcoma in the proximal thigh treated
with preoperative radiotherapy and partial resection of the femoral nerve. This was
followed by a femoral fracture treated with internal fixation. Despite this, the TESS
score of this patient increased from 82.4 preoperatively to 87.0 after treatment. All
three patients with low-grade liposarcomas who had wound complications received
radiotherapy, two preoperatively and one postoperatively.
The effect ofmissing functional data is difficult to evaluate. Comparison of the
characteristics of patients with missing data with others suggests that missing MSTS
(1993) evaluations are unlikely to have adversely influenced the results. The
proportion of patients with missing TESS evaluations was higher however, and
patients for whom these were missing appeared to have had larger tumours and fewer
motor nerve resections than the rest, which may have influenced the results.
In summary, this study shows that the planned marginal excision of low-grade
liposarcomas is associated with significant changes in functional scores and
complication rates, similar to those seen after the resection of other tumours. This has
not been shown previously in the literature. This information is helpful in counselling
patients about the likely effects of treatment, and confirms that removing the tumour
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alone, without other tissues, has a significant impact on patient function. The
treatment of low-grade liposarcomas is not associated with better MSTS scores.
However, this approach is associated with improved TESS scores, supporting the
proposition that the preservation of normal non-critical anatomical structures leads to
better function for patients.
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7. CONCLUSIONS AND FUTURE
DIRECTIONS
This thesis confirms that anatomical location is an important determinant of the
presentation, treatment and outcome of adult extremity soft tissue sarcoma, and a
number of novel aspects of this relationship have been demonstrated. It has been
shown that the significance of positive surgical margins depends on the clinical
context in which they occur, and in particular, that important anatomical structures
adjacent to soft tissue sarcomas can be safely preserved. It has been shown that soft
tissue sarcomas of the upper and lower extremities differ in presentation, treatment
and outcome. Tumours in the upper extremities have a higher local recurrence rate,
but a lower rate ofmetastasis than tumours in the lower extremities, and there are
differences in surgical margins and the use of radiotherapy. Furthermore it has been
shown that functional outcome scores are influenced by anatomical location, and in
particular, that the treatment of superficial tumours does not lead to significant
changes in functional scores, unlike the treatment of deep tumours. Finally, it has
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been shown that the preservation of non-critical anatomical structures during the
planned marginal excision of a low-grade liposarcomas may have a beneficial effect
on TESS evaluations.
Are these findings justified?
The studies in this thesis rely on the retrospective analysis of clinical data from a
single centre. There are a number ofweaknesses inherent in this kind of analysis. For
example, the data were not collected with these specific research questions in mind,
and a prospective study specifically designed to answer each of the questions in turn
would strengthen the conclusions. In addition, the experience of a single centre may
not be applicable to others. There is likely to be significant variation between centres
in surgical technique, the assessment of surgical margins, the histological
classification of tumours (particularly low-grade fatty tumours) and the use of
radiotherapy. In particular, the decision making process by which a positive surgical
margin is deemed acceptable or not is highly dependent on the experience of the
local team, and it is difficult to standardise this kind of assessment across patients
and between centres. To confirm whether these conclusions are applicable to other
centres and other groups of patients would require prospective, possibly multicentre
studies and standardisation of the major variables. Furthermore, where they have
been performed, the statistical analysis of subgroups should be treated with caution,
particularly in the functional score studies, in which the analysis of large numbers of
item scores increases the chance of a false positive result.
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In order to accumulate sufficient numbers of these rare tumours for meaningful
analyses, the combination of a large number of different histological types of soft
tissue sarcoma into studies is common throughout the literature. However, this is a
potential flaw in these and other studies. It is becoming clear that not all histological
types of tumour behave in the same fashion. For example, the histological types
fibrosarcoma and malignant peripheral nerve sheath tumour are locally infiltrative
and perhaps require wider margins than other histological types. The effect of this
variation on these studies may only become clear in the future, when larger studies of
single histological types are performed.
The length of follow-up of patients is similar in the studies and has been determined
by the length of time over which the Musculoskeletal Oncology Unit at the Mount
Sinai Hospital has been in existence. It has been suggested that the effect of local
treatment variables, such as a positive surgical margin, may become more significant
over time "6. It is therefore possible that, in the longer term, further differences may
become apparent in local and systemic relapse between patients with different classes
of positive surgical margin, between the upper and lower extremities, and in
functional outcomes. Patients treated at the Mount Sinai Hospital are often involved
in clinical trials. A study comparing preoperative and postoperative radiotherapy was
in progress at the time that these patients were treated. Although the results of this
study appear to show little difference in tumour control and 1 -2 year functional
scores between groups, it is possible that a difference will become apparent at longer
term follow up.
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To be scientifically rigorous, questionnaires or other scoring systems used in clinical
practice should be reliable, valid and responsive. These attributes have been tested
• 9 f\
for the TESS evaluation . However, less is known about these factors in the MSTS
evaluation, which was developed without patient input. The fact that clinicians rather
than patients complete the MSTS introduces another potential source of bias.
Implications for practice
These studies have a number of clinical implications. Consideration of the
anatomical location may allow patients to be better counselled about what to expect,
in terms of tumour control and functional outcomes. The understanding that not all
positive surgical margins have the same risk of local recurrence may allow
appropriate patients to be treated more aggressively, in the hope that a local
recurrence might be avoided.
It has been suggested by Pisters (plenary session, Connective Tissue Oncology
Society, Barcelona 2003) that the classification of positive surgical margins
developed in this thesis could be useful in developing or refining staging systems for
local recurrence. Whether or not anatomical location might be a useful part of
staging systems for systemic disease is not clear.
Knowledge that superficial tumours can be treated without a major impact on
functional scores is useful for patients. When discussing the functional outcome
expected after treatment of a deep tumour, patients may find a discussion of how
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their ability to perform particular activities will be changed (in other words, changes
in score items), rather than changes in aggregated scores. When considering low
grade fatty tumours, the surgeon also needs to emphasise that there will be adverse
changes in function after treatment, despite the preservation of non-critical
anatomical structures.
In conclusion, just as extremity and retroperitoneal soft tissue sarcomas differ in
terms of their anatomical location and therefore their clinical behaviour, the
anatomical location of an extremity soft tissue sarcoma appears to have an influence
on its presentation, management and outcomes. Anatomical location is therefore an
important consideration in the management of extremity soft tissue sarcomas.
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Future directions
This thesis suggests a number of avenues for further research, both clinical and
biological. Clinical studies might be usefully divided into those concerned with local
control and others concerned with systemic disease. It is clear that there is a need for
an effective systemic agent for the treatment of soft tissue sarcoma, and it is to be
hoped that the future will bring developments in this regard. However, given that the
studies in this thesis were more concerned with local anatomy, this will not be
discussed further here.
Considering how local treatment may develop in future, it is likely that clinical
studies will continue to support the trend towards more "conservative" surgery and
closer surgical margins. However, this will require a deeper understanding of what
represents an adequate margin, and the refinement of the present systems for
describing surgical margins into systems that are reproducible and better reflect the
volume of residual disease. The direct assessment of residual disease may become
feasible, perhaps by using targeted antibodies in the operating theatre, or
postoperatively with more sensitive scanning techniques than those presently
available. Further clinical research is likely to demonstrate that the adequacy of a
surgical margin is dependent on the histological type of tumour.
The future is likely to bring developments in local imaging techniques, which may
allow the tumour to be better defined and allow surgery to be better planned. As
clinical experience of presently available techniques, such as MRI grows,
radiologists may be better able to define the extent of the tumour34. The ability to
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deliver radiotherapy to the tumour and not normal surrounding tissues is likely to
improve with the development of new technologies, for which knowledge of the
anatomical extent of the tumour is also critical.
The major aim of pursuing closer surgical margins is to achieve better functional
outcomes for patients. This requires objective measures of function that can
discriminate between patients. It is likely that the assessment of function will develop
further towards measures known to be valid and reproducible, such as TESS. The
MSTS system, with the inherent disadvantages of being completed by clinicians, and
summating item scores for fundamentally different variables, such as "gait handicap
or limp" and "emotional acceptance" is likely to fall into disuse without a major
revision. The reporting of patient outcomes is likely to broaden, to include measures
of how patients adapt and function in society, rather than measures of physical
function alone. However, explaining these scores to patients in a meaningful way
remains a major challenge.
Further evolution in the staging systems used to classify patients for their risk of
oncological endpoints, such as local recurrence and metastasis is likely. Although
disease-specific survival is the endpoint ofmost current staging systems, the
development of a staging system to predict local recurrence, perhaps using variables
for histological type, classification of positive surgical margins and anatomical
location may be a useful development in the local management of these patients.
This thesis suggests a number of directions for biological research in soft tissue
sarcoma. One potential avenue of research is would be to investigate why particular
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types of soft tissue sarcoma are more likely to arise in one anatomical location than
another, suggested in the study comparing upper and lower extremity tumours. There
is likely to be variation in tissue types or exposure to environmental carcinogens
between the extremities. Further research in this field may shed light on the
pathogenesis of soft tissue sarcomas. The study of positive surgical margins suggests,
as did Enneking, that tissues vary in their resistance to tumour invasion. It is not clear
why this should be at a cellular level. Further research into tumour/host interactions
may encourage different approaches to the surgery of soft tissue sarcomas. Tumours
that express biological markers of locally aggressive behaviour may, for example,
spread easily along tissue planes and may require wider surgical margins than others.
An understanding of this interaction may enhance surgical practice.
All of these developments will benefit greatly from the combination of experience
from more than one centre. Agreement about standard definitions, such as the
assessment of histological grade and surgical margins is a key component of this.
Biological studies require access to tumour tissue, and it is to be hoped that
specimens will be banked routinely in all centres for this purpose in future. However,
there is no doubt that these developments will be built on a foundation of closer co¬
operation between clinicians and scientists in different centres and different
countries. We must work together to improve the lot of our patients.
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Fibro-osseous pseudotumour of digits
Ischaemic fasciitis
Elastofibroma







BLASTS Inclusion body fibromatosis



































Low grade fibromyxoid sarcoma,







Giant cell tumour of tendon sheath
Diffuse-type giant cell tumour








Giant cell 'MFH' / Undifferentiated
pleomorphic sarcoma with giant cells
Inflammatory 'MFH7 Undifferentiated

































































Intramuscular myxoma (incl. cellular variant)
Juxta-articular myxoma
Deep ('aggressive') angiomyxoma













Alveolar soft part sarcoma
Clear cell sarcoma of soft tissue
Extraskeletal myxoid chondrosarcoma
("chordoid" type)
PNET/ Extraskeletal Ewing tumour
Desmoplasitc small round cell tumour
Extra-renal rhabdoid tumour
Malignant mesenchymoma
Neoplasms with perivascular epithelioid cell
differentiation (PEComa)








Age at surgery (years) Continuous variable
Status at presentation Primary tumour present, no metastases
Local recurrence, no metastases


































Histological grade 1 (1 of 3 or 1 of 4)
2 (2 of 3 or 2 of 4)
3(3 of 3, 3 and 4 of 4)
Maximum diameter Value in centimetres
Depth Superficial
Deep
Age at surgery Continuous variable
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Type of procedure Excision/ re-excision





















Treatment of complications Not applicable
Debridement
Dressings













Radiotherapy for first relapse Not applicable
None
Radiotherapy given
















Chemotherapy for second relapse Not applicable
None
Chemotherapy given
Final status Alive, no evidence of disease
Alive with evidence of disease
Died of disease
Died of other causes
Disease free survival after surgery
(months)
Continuous variable, to time of relapse if
applicable
Overall survival after surgery (months) Continuous variable
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Please answer the following questions.
1A) Please state your current work status:
1 Employed full-time 4 Retired
2 Employed part-time 5 Student
3 Unemployed 6 Disabled
IB) If you are employed, please describe your current job activities (examples: desk job; truck
driver):
1C) If you are retired, unemployed, or disabled, please describe your former job activities:
1D) If you are a student, please describe your area of study:
IE) If you are not working do you receive financial assistance such as insurance, sick benefits or
a pension?
1 Yes 2 No
2) Briefly describe your leisure or recreational activities (examples: sports, gardening, reading):
3A) Pain medication 1 none
2 NSAIDS e.g. anti-inflammatory drugs
3 non-narcotics e.g. paracetamol
4 narcotics e.g. morphine, dihydrocodeine, DF118
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3B) Frequency of pain medication: 1 not applicable i.e. no medication
2 intermittent
3 once a day
4 twice a day
5 3 times a day
6 4 times a day
7 more than 4 times a day
4) Describe the mobility or walking aid you use:
1 No aid





7 Motorised wheelchair or scooter









The following questions are about activities commonly performed in daily life. Mark each item (as in
the example below) opposite the description that best describes your ability to perform each task
during the past week. Some activities will be extremely easy for you to do, others will be extremely
difficult or impossible.
EXAMPLE







___ This task is not applicable for me.
You should choose the response "impossible to do ...." If the activity is something that you normally
do in your daily activities but are now unable to do because of physical limitations such as weakness,
stiffness or pain.
If you do not perform an activity as part of your normal lifestyle you would choose the response "99"
to indicate that the item is not applicable.





a little bit difficult,
not at all difficult.
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The following questions ask about your ability to perform activities that are common to every day life.
Considering the amount of difficulty you have performing the activity due to the current problem you
are having with your leg, answer the questions by choosing the answer that best describes your ability
to do the activity over the past week.










a little bit difficult.
not at all difficult.
This task is not applicable for me.









a little bit difficult.
not at all difficult.
This task is not applicable for me.
3) Putting on socks or stockings is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
4) Showering is: 1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
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5) Light household jobs such as tidying and dusting are:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
6) Gardening and yard work are:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
7) Preparing meals is: 1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
8) Going shopping is: 1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
9) Heavy household jobs such as vacuuming and moving furniture is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
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Getting in and out of the bath tub is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
Getting out of bed is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
Rising from a chair is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
Kneeling is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
Bending to pick something up off the floor is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
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Walking upstairs is: 1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
Walking downstairs is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
Driving is: 1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
Walking in the house is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
Walking outdoors is: 1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
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20A) Sitting is: 1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
21) Walking up or down hills or a ramp is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
1 4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
22) Standing is: 1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.







24) Getting in and out of a car is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.




a little bit difficult.
not at all difficult.
This task is not applicable for me.
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25) Participating in sexual activities is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
26) Completing my usual duties at work is: (Work includes both a job outside the home and as
a homemaker.)
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
27) Working my usual number of hours is: (Working includes both a job outside the home and
as a homemaker,)
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
28) Participating in my usual leisure activities is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
193
29) Socialising with friends and family is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
30) Participating in my usual sporting activities is:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.
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1) Considering all the activities in which I participate in daily life, I would rate the ability to
perform these activities during the past week as:
1 impossible to do.
2 extremely difficult.
3 moderately difficult.
4 a little bit difficult.
5 not at all difficult.
99 This task is not applicable for me.





5 Not at all disabled.
99 This task is not applicable for me.
Please make any additional comments about difficulties you experience below.
Please check to make sure that you have answered all the questions.
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We considered whether a positive marginoccurring after resection f a soft-tissue sarcoma
of a limb would affect the incidence of local
recurrence. Patients with low-grade liposarcomas were
expected to be a low-risk group as were those who
had positive margins planned before surgery to
preserve critical structures. Two groups, however,
were expected to be at a higher risk, namely, patients
who had undergone unplanned excision elsewhere with
a positive margin on re-excision and those with
unplanned positive margins occurring during primary
resection.
Of 566 patients in a prospective database, 87 with
positive margins after limb-sparing surgery and
adjuvant radiotherapy were grouped according to the
clinical scenario by an observer blinded to the
outcome. The rate of local recurrence differed
significantly between the two low- (4.2% and 3.6%)
and the two high-risk groups (31.6% and 37.5%). This
classification therefore provides useful information
about the incidence of local recurrence after
positive-margin resection.
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After resection of a soft-tissue sarcoma the status of the
surgical margin predicts the risk of local recurrence.'
Enneking et al described the margin as intralesional
when resection was carried out within the (pseudo) cap¬
sule of the tumour, marginal when the tumour was shelled
out within the surrounding reactive zone, wide when the
resection passed through normal tissue outside the reac¬
tive zone but within the anatomical compartment which
was involved, and radical when the entire compartment
was resected. The rate of local recurrence was 50% after
marginal, 25% after wide and 4% after radical excision.
Rydholm and Rooser7 considered an intact muscle to
be a distinct anatomical compartment and subclassified
wide margins as wide-S (subcutaneous) when a subcuta¬
neous tumour was excised with a cuff of subcutaneous
tissue and deep fascia, wide-F (fascia) when a deep
tumour was excised with an intact envelope of unin-
volved fascia and wide-AM (areolar tissue and muscle)
when a deep tumour was excised with a wide margin,
some or all of which comprised muscle or areolar tissue.
The five-year rate of local recurrence was 10% with
wide-S and wide-F margins and 30% with a wide-AM
margin.
Kawaguchi, Matumoto and Manabe suggested a clas¬
sification which abandoned the use of compartmental
anatomy to describe the resection. Margins were classi¬
fied as curative, adequate or inadequate depending on the
width and quality of the tissue comprising the margin.
Inadequate wide margins did not ensure local control
even with adjuvant radiotherapy in high-grade sarcomas,
but were sufficient for low-grade tumours.
Since the development of management which com¬
bines limb-sparing surgery and adjuvant treatment, the
description of surgical margins as sim^l^ positive or
negative has become more common. A positive
surgical margin in which there is tumour at the resection
margin, implies that there is residual disease and is
associated with an increased risk of local recurrence.
In this situation, the volume and biological activity of
residual disease are presumably critical to the risk of
recurrence. While recognising that a positive surgical
margin may occur under different circumstances, we have
examined how these may influence the risk of
recurrence.
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Axial CT scan showing a homogeneous tat lesion in the proximal thigh which was treated by
excision with positive margins. 'Hie final histological findings confirmed it to be low-grade
liposarcoma.
Fig. 2
T2-weighted axial MR image showing a myxoid liposarcoma in the proximal thigh which
was excised with a planned positive margin along the femoral artery.
Patients and Methods
We agreed a classification of four mutually exclusive clin¬
ical groups representing the clinical scenario in which a
positive surgical margin may occur after limb-sparing sur¬
gery for sarcoma of a limb. A positive margin was defined
as the presence of tumour at the margin of resection or
intraoperative exposure of the tumour, even if the margin
was subsequently revised to 'negative'. We defined margins
as grossly positive when the surgeon or the pathologist
could identify tumour at the margin of resection. A micro¬
scopic positive margin occurred when inspection of the
margin did not reveal tumour, which was identified at
histological examination.
Low-grade liposarcomas (group 1). The first group
included all patients with a low-grade, well-differentiated
liposarcoma. In our experience, and that of others, low-
grade liposarcoma arising in the limb seldom recurs locally
after treatment and rarely metastasises.'"'3 These lesions
are often extensive at the time of presentation and adjacent
to critical structures such as nerves, vessels or bones. In this
situation we frequently accept microscopically positive
margins after resection to preserve critical structures. A
positive margin in this situation reflects this treatment
philosophy of deliberate marginal excision (Fig. 1).
Planned positive margins against critical structures
(group 2). This group included patients who had positive
surgical margins against one or more critical structures
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(nerve, vessel or bone) which had been planned prcopcr-
atively as part of a primary resection. The decision to
accept a positive margin was made in advance at a multi-
disciplinary team conference and confirmed at the time of
resection by the surgeon and pathologist (Fig. 2).
Positive margin during re-excision after prior unplan¬
ned excision (group 3). Patients in this group had under¬
gone unplanned excision of a sarcoma at another institution
before referral, and subsequent re-excision at our centre
with a positive surgical margin. An unplanned excision was
defined as an excisional biopsy or resection carried out
without adequate preoperative staging or consideration of
the need to remove normal tissue around the tumour.'4 The
extent and adequacy of the unplanned excision were
assessed in discussion with the original surgeon and by
review of the initial pathology report, the initial operative
note, and imaging studies undertaken before re-excision in
our centre. Further excision was done if there was gross
residual tumour on clinical examination or imaging, or if
the resection had been inadequate.
Unplanned positive margins (group 4). In this group,
during primary resection in our centre, a positive margin
occurred which had not been planned (Fig. 3). This usually
followed an error in assessing the extent of the primary
lesion despite review of the imaging of the local site. If the
positive margin was recognised during or immediately after
surgery, further tissue was excised if this did not com¬
promise critical structures. If the positive margin was re¬
cognised after definitive histological evaluation, a further
Fig. 3
T2-»eighted axial MR image showing a myxoid liposarcoma in
relation to the lateral aspect of the ankle, with considerable sub¬
cutaneous oedema. The anterior resection margin was positive in
Ihe subcutaneous tissues.
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wide excision was always considered. No patients had
grossly evident tumour left in the wound at the completion
of surgery.
It was considered that groups 1 and 2 would he at low risk
of local recurrence and that groups 3 and 4 would be at
higher risk. To test this hypothesis, a prospectively collected
database containing all patients undergoing surgery for soft-
tissue sarcoma in our centre was used to identify suitable
patients. The inclusion criteria were: 1) a diagnosis of sarco¬
ma other than dermatofibrosarcoma protruberans; 2) location
in a limb; 3) the undertaking of limb-sparing surgery with
curative intent; 4) a positive surgical margin; and 5) the
administration of neoadjuvant radiotherapy. All patients
underwent surgery between January 1986 and April 1997 to
allow a minimum follow-up period of three years.
Patients who received chemotherapy because of histo¬
logical type or metastatic disease were excluded. Our
standard protocol of adjuvant external-beam radiotherapy
comprises either 50 Gy preoperatively, with a postoperative
boost of 16 Gy if there is a positive margin, or 66 Gy
postoperatively by a reducing-field technique.
The following data were extracted from the prospective
database and verified against the clinical records: age at
surgery, gender, presentation with a primary tumour or
local recurrence, open or needle biopsy, histological type,
grade, anatomical location (deep or superficial, extra- or
intracoinpartmental), maximum diameter of the tumour, the
presence of lung metastases at presentation (all patients
were staged by chest CT) and grossly or microscopically
positive margins. The further management of positive mar¬
gins was assessed from the clinical records. A pathologist
with expertise in sarcoma determined the histological type
and graded the tumours as 1, 2 or 3.15
A reviewer (CHG), blinded to the clinical outcome,
assigned each case to one of the four groups. All low-grade
liposarcomas were assigned to group 1 and all patients who
had had an unplanned excision before referral were
assigned to group 3, regardless of further management.
After the initial classification, the surgeons who undertook
the operations reviewed the classification of each tumour to
ensure a consensus. The number and timing of local recur¬
rences were reviewed. Local recurrence was defined as the
reappearance of the tumour, proven by biopsy, adjacent to
or within the previously treated field at any time after
treatment in our centre.
Statistical analysis. We consider that low-grade liposarco¬
mas (group 1) differ in their biological behaviour and
management from tumours of other histological types and
therefore they were analysed separately. The remainder
(groups 2 to 4) were compared for differences in the local
recurrence-free rate and the disease-specific survival as
well as variables which may account for differences in
these outcomes.
Continuous variables were compared using one-way
analysis of variance (ANOVA) and the Tukey post-hoc test.
Differences in proportions were compared using the chi-
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squared test. Curves for the local recurrence-free rate and
disease-specific survival were constructed using the method
of Kaplan and Meier and compared using the log-rank
statistic. A p value of 0.05 or below was considered to be
significant. Data were analysed using the SPSS version
10.0.5 (SPSS Inc, Chicago, Illinois).
Results
Between January 1986 and April 1997, 566 patients had
been entered on the database, 112 of whom had positive
surgical margins. We excluded 25 patients as follows: 12
who did not receive standard radiotherapy, seven who
received chemotherapy, four with advanced metastatic dis¬
ease who underwent palliative procedures, one with a
positive margin after primary amputation and one who had
exploration of an extensive sarcoma in the foot and was
secondarily treated by amputation.
The remaining 87 patients, 42 men and 45 women, had a
mean age of 60 years (21 to 95). A total of 24 patients died
from metastatic disease at a mean of 1.8 years (0.3 to 6.6),
and eight from unrelated causes at a mean of 2.1 years (0.2
to 7.7). The mean follow-up of the 55 surviving patients
was 5.4 years (3.0 to 9.5).
The 24 patients with low-grade liposarcomas were
placed in group 1. None had grossly positive margins.
There was one local recurrence (4.2%, 95% CI 0 to 12.2) at
four months, which was re-excised. All patients were alive
and free from disease at a mean follow-up of 5.1 years (3.2
to 9.3).
Of the remaining patients, 28 were placed in group 2, 19
in group 3 and 16 in group 4 (Table I). When these groups
were compared, group-3 tumours were significantly smaller
than group-4 (p = 0.04), and group-4 tumours were smaller
than group-2 (p = 0.02). There were more tumours in the
proximal limb in group 2 than in group 3 (79% v 42%,
Table I. Details of the 87 patients who had resection of soft-tissue sarcoma of a limb
Group*
1 2 3 4
Number of patients 24 28 19 16
Number of local recurrences (%) 1 (4.2) 1 (3.6) 6 01.6) 6 (j
Mean time to local recurrence (months) 4 2 35 25
Mean age (years) 54.8 62.5 66.7 57.5
Proportion male (%) 54 54 37 44
Presentation with local recurrence 4 3 2 1
Open biopsy 5 11 19 9
Grade of tumour
1 24 1 - 2
2 - 8 9 6
3 - 19 10 8
Type of positive margin
Microscopically positive 24 25 17 12
Grossly positive 0 3 4
Mean maximum diameter (cm) 14.4 14.7 4.8 9.6
Histological type
MFH+ - 13 8 6
Uposarcoma 24 8 6 3
Other - 7 5 7
Location
Upper limb 6 6 5 6
Lower limb 18 22 14 10
Proximal limb 19 22 8 7
Distal limb 5 6 11 9
Superficial - - 2 -
Deep 24 28 17 16
Intracompartmental 10 6 1 3
F.xtracompartmen tal 14 22 18 13
Mean follow-up of surviving patients (years) 5.1 5.2 6.3 5.6
Presentation with metastases - I - 1
Final status
Alive, without disease 24 10 9 8
Alive with disease - 2 1 I
Died from disease - 11 6 7
Died from other causes - 5 3 -
* see text
f malignant fibrous histiocytoma
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p = 0.01) and group 4 (44%, p = 0.02). Groups 2, 3 and 4
did not differ significantly in regard to age, gender, local
recurrence at presentation, grade and length of follow-up.
There was no difference in the distribution of histological
types across those groups, and no significant difference
between the groups when deep and superficial, intra- and
extracompartmental, and upper- and lower-limb tumours
were compared.
In group 2, one of 28 patients developed a local recur¬
rence (3.6%. 95% CI 0 to 10.4) at two months. This case
was one of the 25 with microscopically positive margins.
There were no local recurrences in the three patients with
grossly positive margins. Twelve patients were alive at a
mean of 5.2 years (3.0 to 7.4), 11 died from metastatic
disease at a mean of 1.6 years (0.3 to 2.8) and five from
other causes at a mean of 1.6 years (0.2 to 4.7).
In group 3, there were six local recurrences (31.6%, 95%
CI 10.7 to 52.5). The mean time to local recurrence was
34.5 months (2.7 to 82.0). Clinical examination or imaging
before re-excision identified 11 patients with a residual
tumour mass. In five of these the positive margins were
planned against critical structures adjacent to the residual
mass and one had a further local recurrence. In comparison,
an unplanned positive margin occurred during resection of
the other six of the 11 patients with a residual tumour mass,
and three of these had a local recurrence. In the eight
patients without a residual tumour there were two local
recurrences. Of all 19 patients, two had grossly positive
margins and both had local recurrences, compared with
four local recurrences in 17 patients with microscopically
positive margins. In four patients, the positive margin was
recognised intraoperatively, and the margin revised; two of
these had a local recurrence. In two patients, the positive
margin was recognised intraoperatively, but the margin
could not be revised with acceptable morbidity. Neither of
these developed a local recurrence. In 13 patients, the
positive margin was recognised after histological examina¬
tion; four of these developed a local recurrence. Of all 19
patients, ten were alive at a mean of 6.3 years (3.5 to 9.4),
six died from metastatic disease at a mean of 1.7 years (0.7
to 3.2) and three died from other causes at a mean of 3.1
years (0.7 to 7.7).
In group 4, there were six local recurrences in 16 patients
(37.5%, 95% CI 13.8 to 61.2). The mean time to the
development of local recurrence was 24.9 months (5.9 to
68.1). One of four patients with grossly positive margins
and five of 12 with microscopically positive margins de¬
veloped a local recurrence. In nine patients, the positive
margin was recognised intraoperatively, and the margin
revised. Four of these developed a local recurrence. In three
patients the positive margin was recognised intraopera¬
tively, but the margin could not be revised with acceptable
morbidity and none developed a local recurrence. In four
patients, the positive margin was recognised after histo¬
logical examination; three of these had no further surgery
but two developed a local recurrence. In the fourth case, a
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second wide excision was carried out and there has not
been local recurrence. Of the 16 patients in group 4, nine
were alive at a mean of 5.6 years (3.0 to 8.9) and seven
died from metastatic disease at a mean of 2.0 years (0.3 to
6.6).
The crude local recurrence rate in group 2 was sig¬
nificantly lower than that in group 3 (p = 0.03) and group 4
(p — 0.01), but that of group 3 and group 4 was not
significantly different. The local recurrence-free survival
was significantly different between groups 2 and 3
(p = 0.01) and groups 2 and 4 (p = 0.02), but not between
groups 3 and 4 (p = 0.64; Fig. 4). The disease-specific
survival in groups 2, 3 and 4 did not differ significantly
(p = 0.74; Fig. 5).
Discussion
Our study shows that the significance of a positive surgical
margin after resection of a soft-tissue sarcoma in a limb is
determined by the clinical scenario, and that classifying
patients into groups may predict the risk of the develop¬
ment of local recurrence. Low-grade liposarcomas are bio¬
logically different, with a low risk of local recurrence
despite marginal excision. Planned positive margins during
primary resection (with adjuvant radiotherapy) are asso¬
ciated with a low risk of local recurrence. Positive margins
following unplanned excision before referral as well as
unplanned positive margins are associated with a higher
risk of local recurrence.
Positive margins are more likely after limb-sparing pro¬
cedures, although amputation does not guarantee negative
margins.1' Trovik et al'6 reported that positive margins
were more common in patients over 50 years of age, with
either low-grade tumours, tumours the diameter of which
was more than 7 cm, deep tumours or tumours involving
the trunk. After excision of soft-tissue sarcomas of the
trunk or limb the reported rates of positive margins vary
from 1% 'to 26%. In a review of patients treated by an
experienced multidisciplinary sarcoma group in Toronto.
Wilson et al reported nine positive margins in 62 patients,
a rate of 14.5%. The higher rate of positive margins after
resection of low-grade liposarcomas in our database (27 of
49 patients, 55%) reflects a management philosophy which
accepts deliberate marginal excision in many patients. Our
study confirms that this approach, when combined with
adjuvant radiotherapy, is associated with a low rate of local
recurrence at the medium-term follow-up. Our rate of
positive margins for other histological types (85 of 518
patients, 16%) is within the range which has previously
been described.
When a soft-tissue sarcoma is adjacent to critical struc¬
tures, the multidisciplinary team has to weigh the benefits
of wider excision against the morbidity. The low rate of
local recurrence after a planned positive margin in this
situation demonstrates that this is a safe approach for many
tumours. The experience of the multidisciplinary team is
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.







Kaplan-Meier survival analysis for the rate of









Kaplan-Meier survival analysis for disease-
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critical in making the decision to approach treatment in this
way and may contribute to better outcomes in specialised
centres.
It is our practice to offer re-excision to all patients who
have undergone an unplanned excision unless the margins
can be reliably assessed as adequate. If after unplanned
excision there is a residual mass which lies adjacent to
critical anatomical structures, a positive margin may be
planned. If there is no residual mass, the extent of con¬
tamination by tumour cannot be accurately defined and re-
excision has to be planned based on an estimate of the area
at risk and the associated morbidity. A positive margin
under these circumstances not only means that there is
residual tumour, which may lead to local recurrence, but
that the area involved with tumour has been
14
underestimated.
The exposure of tumour during primary resection
because of surgical error is associated with a high risk of
->o
local recurrence." There was one local recurrence in four
such cases in group 4. Of 16 patients in whom an unplan¬
ned positive margin occurred, 12 had microscopically pos¬
itive margins and five developed local recurrence,
suggesting that microscopically positive margins are also
associated with a high risk of local failure.
Our study was not designed to assess the effect of
revision of a positive margin. In patients who were not able
to undergo revision of the positive margin because of local
anatomical constraints, there were no local recurrences. It
may be that a positive margin against a structure such as
muscle, which is readily revised, is associated with more
residual disease than a positive margin against a critical
structure such as bone, nerve or vessel, which may not
readily be resected and which may be more resistant to
invasion by tumour.
The experience which we have gained while treating this
group of patients was used to generate hypotheses tested on
the same group and this study thus remains exploratory. A
prospective study on a different group of patients is
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required to confirm the value of this classification. Classify¬
ing patients who have a positive resection margin in this
way may provide useful information with regard to the
development of local recurrence.
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BACKGROUND. The anatomic location of an extremity soft tissue sarcoma may
influence the patient's presentation, management, and local and systemic recur¬
rence rates. The objective of this study was to compare the presentation, manage¬
ment, and outcome of patients with soft tissue sarcomas of the upper extremity
and the lower extremity.
METHODS. Prospectively collected data from patients who underwent limb-sparing
surgery for extremity soft tissue sarcoma between January, 1986 and April, 1997
were analyzed. Local recurrence free rates and metastasis free rates were calculated
using the method of Kaplan and Meier. Univariate and multivariate analyses of
potential predictive factors were evaluated with the log-rank test and the Cox
proportioned hazards model.
RESULTS. Of 480 eligible patients, 48 patients (10.0%) had a local recurrence, and
131 patients (27.3%) developed distant metastasis. The median follow-up of sur¬
vivors was 4.8 years (range, 0.1-12.9 years). Patients with upper extremity tumors
had smaller lesions (6.0 cm vs. 9.3 cm; P < 0.001), more often underwent un¬
planned excision before referral (89 patients (64.0%1 vs. 160 patients [46.9%]; P
< 0.001), and less often received radiotherapy (98 patients [70.5%] vs. 289 patients
[84.8%]; P < 0.001). The 5-year local recurrence free rate was 82% for patients with
sarcomas of the upper extremity and 93% for patients with sarcomas of the lower
extremity (P = 0.002). The 5-year metastasis free rate was 82% for patients with
sarcomas of the upper extremity and 69% for patients with sarcomas of the lower
extremity (P = 0.013).
CONCLUSIONS. Local recurrence was more frequent in patients who had sarcomas
of the upper extremity compared with patients who had sarcomas of the lower
extremity. Factors that contributed to this difference included histologic type, the
use of radiotherapy, and local anatomy. Metastasis was more frequent among
patients with sarcomas of the lower extremity, because those tumors tended to be
large and deeper compared with upper extremity tumors. Cancer 2003;97:485-92.
© 2003 American Cancer Society.
D0I 10.1002/cncr.11076
KEYWORDS; sarcoma, neoplasm, local recurrence, metastasis, surgical procedures,
operative.
Factors known to influence local recurrence after treatment of anextremity soft tissue sarcoma include a positive surgical margin,
presentation with a local recurrence, and age > 50 years.1-3 The
development of metastasis is associated with large, high-grade, deep
tumors.4-8 However, because tumor size, the width and quality of the
surgical margin, and the use of adjuvant radiotherapy all may vary
with anatomic location,9 the site of a tumor may be an important
determinant of oncologic outcome. A comparison of extremity and
retroperitoneal soft tissue sarcomas illustrates this point. Compared
© 2003 American Cancer Society
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with extremity tumors, retroperitoneal soft tissue sar¬
comas tend to be large at presentation, difficult to
excise with a wide margin, and difficult to irradiate
because of adjacent vital structures. Proximity to vital
structures also means that retroperitoneal sarcomas
more often cause death by local recurrence, whereas
extremity sarcomas are fatal through the development
of pulmonary metastases.10
Clearly, there is wide variation in both the ana¬
tomic location of a soft tissue sarcoma and in the
anatomy of the upper and lower extremities. The
question of how this anatomic variation influences
patient presentation, treatment, and outcome has not
been addressed directly in the literature. However,
some differences have been reported. Lower extremity
tumors are more common,11-15 larger,9 and more
likely to lead to metastasis4,9,16 compared with tumors
of the upper extremity. Conversely, patients with up¬
per extremity tumors are more likely to have under¬
gone unplanned excision before referral.12,17 The pur¬
pose of this study was to determine whether there
were differences in the presentation and management
of patients upper extremity soft tissue sarcomas and
lower extremity soft tissue sarcomas among our pa¬
tient population and, subsequently, whether there
were differences in the local recurrence free rate and
the metastasis free rate.
MATERIALS AND METHODS
Since January, 1986, a record of all patients who un¬
derwent surgery in our center for an extremity soft
tissue sarcoma has been kept in a password-pro¬
tected, computerized data base. Data are collected
prospectively in outpatient clinics and at a weekly
multidisciplinary meeting. This data base was used to
identify and retrieve information about patients who
had an extremity soft tissue sarcoma and underwent
limb-sparing surgery between January 1986 and April
1997 and, thus, had the potential for a minimum fol¬
low-up of 3 years. The upper extremity was defined as
commencing at the medial border of the scapula, in¬
cluding the pectoral, periscapular, and latissimus
dorsi muscles. The lower extremity was defined as
commencing at the iliac crest. Patients with metastatic
disease at the time of presentation or with the histo¬
logic types dermatofibrosarcoma protruberans, prim¬
itive neuroectodermal tumor, or rhabdomyosarcoma
were excluded.
The following information was extracted from the
data base: age at surgery, gender, unplanned excision
before referral, presentation with a local recurrence,
greatest tumor dimension (in centimeters), histologic
type and grade, surgical margin status, adjuvant ra¬
diotherapy or chemotherapy, local recurrence, time to
local recurrence after surgery, systemic recurrence,
and time to systemic recurrence after surgery. An un¬
planned excision was defined as an excisional biopsy
or unplanned resection that was performed without
adequate preoperative staging or consideration of the
need to remove normal tissue around the tumor.18 A
pathologist with an expertise in sarcoma determined
the histologic type and graded tumors as 1, 2 or 3.19
The status of the surgical margin was recorded as
positive if the pathologist had identified tumor, viable
or not, at the inked resection margin or if there had
been intraoperative exposure of tumor. A local recur¬
rence was defined as tumor within or at the edge of
the previously treated field at any time after treatment.
Metastatic disease was defined as tumor identified on
chest X-ray or computed tomography scan during fol¬
low-up or the development of lymphadenopathy con¬
taining tumor. Wherever possible, after multidisci¬
plinary discussion, patients were offered limb-sparing
surgery. Amputation was performed when limb-spar¬
ing surgery would not have adequately resected the
tumor or would have resulted in a limb without useful
function. Adjuvant radiotherapy was given to patients
with high-grade tumors who underwent resection
with less than wide surgical margins or patients with
low-grade tumors who underwent deliberately mar¬
ginal surgical excision.
The following data relating to anatomic location
were retrieved: extremity, location within the extrem¬
ity, and depth. Location within the extremity was re¬
corded in relation to the closest major joint as the
shoulder, elbow, wrist/hand, hip, knee, and foot/an¬
kle. Tumors above and that did not involve the invest¬
ing fascia of the limb were considered superficial, and
other tumors were considered deep.
Data were used first to define the characteristics
of the whole group and the anatomic distribution of
tumors. Next, differences in presenting features, tu¬
mor characteristics, and treatment between the ex¬
tremities were determined. The local recurrence free
rate in the extremities was compared using the meth¬
ods of Kaplan and Meier and the log-rank statistic.
Then, the Cox proportional hazards model was used to
investigate first whether greatest tumor dimension
was predictive of time to local recurrence and then
whether surgical margin status, extremity, and un¬
planned excision before referral were predictive of
time to local recurrence. Thereafter, exploratory anal¬
yses examined the influence of unplanned excision
before referral, surgical margin status, and radiother¬
apy on the rate of local recurrence. The metastasis free
rate was compared using the methods of Kaplan and
Meier and the log-rank statistic. The Cox proportional
hazards model was used to investigate whether histo-
logic grade, greatest tumor dimension, depth, and ex¬
tremity were predictive of time to metastasis.
Differences in the mean values between groups
were compared using one-way analyses of variance
and the Tukey post-hoc test. Differences in propor¬
tions were compared using the Pearson chi-square
test. When constructing Kaplan-Meier curves and in
the Cox proportional hazards model, patients were
censored at the time of last follow-up or death. In the
Cox proportional hazards model, the hazard ratio for
each covariate was plotted to ensure proportionality
over time. Throughout, results with a P value < 0.05
were considered significant. Analyses were performed
using SPSS software for Windows (release 10.0.5; SPSS
Inc., Chicago, IL).
RESULTS
Five hundred sixty-six patients were entered into the
data base between January 1986 and April 1997. There
were 6 primary amputations in 168 patients with up¬
per extremity tumors (3.6%) and 22 primary amputa¬
tions in 398 patients with lower extremity tumors
(5.5%). Another 58 patients were excluded: 34 patients
who presented with metastatic disease, 12 patients
who presented with a diagnosis of dermatofibrosar-
coma protruberans, 7 patients who presented with
primitive neuroectodermal tumors, and 5 patients
who presented with rhabdomyosarcoma. Four hun¬
dred eighty patients remained in the study.
Characteristics of the Whole Group
There were 261 men (54.4%) and 219 women (45.6%)
with a median age of 56 years (range, 15-96 years).
Malignant fibrous histiocytoma (163 patients; 34.0%)
and liposarcoma (107 patients; 22.3%) were the most
common histologic types. Tumors were Grade 1 in 83
patients (17.3%), Grade 2 in 172 patients (35.8%), and
Grade 3 in 225 patients (46.9%).
Forty-eight patients (10.0%) developed a local re¬
currence at a median of 1.4 years (range, 0.1-9.2
years). No patients died of local recurrence. One hun¬
dred thirty-one patients (27.3%) developed metastases
at a median of 1.0 years (range, 0.1-12.8 years), and 86
of those 131 patients died of metastatic disease at a
median of 1.5 years (range, 0.1-6.8 years). Nineteen
patients died from causes other than metastatic dis¬
ease at a median of 1.0 years (range, 0.0-7.7 years).
Three of those 19 patients died in the immediate post¬
operative period after developing a pulmonary embo¬
lus. The median follow-up for the 375 surviving pa¬
tients was 4.8 years (range, 0.1-12.9 years).
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TABLE 1
Summary of Results by Extremity
Upper Lower
Characteristic extremity extremity
No. of patients 139 341
Age at Surgery (yrs)
Median 54 56
Range 17-86 15-96
Proportion of males (%) 84 (60.4) 177 (51.9%)
Greatest tumor dimension (cm)
Mean 6.0 9.3
Range 1.0-26.0 1.0-40.0
Deep to or involving investing fascia 97 (69.8) 280 (82.1)
Histologic grade (%)
1 30 (21.6) 53 (15.5)
2 44 (31.7) 128 (37.5)
3 65 (46.8) 160 (46.9)
Unplanned excision before referral (%) 89 (64.0) 160(46.9)
Presentation with a local recurrence (%) 18 (12.9) 38 (11.1)
Positive surgical margins (%) 28 (20.1) 71 (20.8)
Adjuvant radiotherapy (%) 98 (70.5) 289 (84.8)
Follow-up of survivors (yrs)
Median 4.9 4.7
Range 0.1-11.1 0.2-12.9
No. of patients with local recurrence 23 25
Time to local recurrence (yrs)
Median 1.3 1.6
Range 0.2-9.2 0.1-6.6
Local recurrence free rate at 5 years (%) 82 93
No. of patients developing metastases 26 105
Time to metastasis (yrs)
Median 1.0 1.0
Range 0.1-6.7 0.1-12.8
Metastasis free rate at 5 yrs (%) 82 69
Anatomic Distribution
There were 139 tumors (29.0%) of the upper extremity
and 341 tumors (71.0%) of the lower extremity (Table 1).
Seventy-four tumors (15.4%) were located around the
shoulder, 41 tumors (8.5%) were located in the elbow, 24
tumors (5.0%) were located in the hand or wrist, 154
tumors (32.1%) were located in the hip, 148 tumors
(30.8%) were located in the knee, and 39 tumors (8.1%)
were located in the ankle or foot (Table 2). Three hun¬
dred seventy-seven tumors (78.5%) were deep to or in¬
volved the investing fascia of the extremity.
Differences between the Extremities
Presenting features
Patients with tumors of the upper extremity more
often underwent unplanned excision before referral
compared with patients who had tumors of the lower
extremity (89 patients [64.0%] vs. 160 patients [46.9%];
P < 0.001). The proportion of patients presenting with
a local recurrence was similar in each extremity (18
patients in the upper extremity [12.9%] vs. 38 patients
in the lower extremity [11.1%]; P = 0.576).
488 CANCER January 15, 2003 / Volume 97 / Number 2
TABLE 2
Summary of Results by Location Within Each Extremity
Positive Adjuvant No. of
No. of Mean greatest tumor Unplanned excision surgical radiotherapy Local developing
Location patients dimension (cm) before referral margins given recurrences metastases
Shoulder 74 6.5 47 7 45 13 19
Elbow 41 6.3 26 16 34 5 6
Wrist/hand 24 3.9 16 5 19 5 1
Hip 154 10.6 65 28 125 11 45
Knee 148 9.0 73 35 128 10 49
Ankle/foot 39 5.3 22 8 36 4 11
Whole group 480 8.3 249 99 387 48 131
TABLE 3
Distribution of Histologic Types by Extremity
Upper extremity Lower extremity
Percentage Local Percentage Local



































Upper extremity tumors were significantly smaller
compared with lower extremity tumors (6.0 cm vs. 9.3
cm; P < 0.001) and less often were deep to or involved
the investing fascia (97 patients [69.8%] vs. 280 pa¬
tients [82.1%]; P = 0.003) (Table 1). The mean tumor
dimension decreased from proximal to distal in both
extremities (Table 2). There was a relative excess of
synovial sarcomas, epithelioid sarcomas, and fibrosar¬
comas in upper extremity sites and of liposarcomas
and myxoid liposarcomas in lower extremity sites (Ta¬
ble 3). Histologic grade did not differ significantly
between upper extremities and lower extremities (P
= 0.219) (Table 1).
Treatment factors
The proportion of patients with positive surgical mar¬
gins did not differ significantly between the upper
extremities and the lower extremities (28 patients
[20.1%] vs. 71 patients [20.8%]; P = 0.868). However,
within the group of patients with upper extremity
tumors, positive surgical margins were more frequent
around the elbow (16 of 41 patients; 39.0%) compared
with the wrist and hand (5 of 24 patients; 20.8%) or the
shoulder (7 of 74 patients; 9.5%; P = 0.001).
Overall, radiotherapy was given less often to pa¬
tients with tumors of the upper extremity compared
with its frequency among patients with tumors of the
lower extremity (98 patients [70.5%] vs. 289 patients
[84.8%]; P < 0.001). This was because patients with
tumors around the shoulder were not treated with
adjuvant radiotherapy (45 of 74 patients; 60.8%) as
often as patients with tumors around the elbow (34 of
41 patients; 82.9%) or the wrist (19 of 24 patients;
79.2%; P = 0.048) (Table 2). The proportion of patients
who received adjuvant chemotherapy did not differ
significantly between those with tumors of the upper
extremity or the lower extremity (2 of 139 patients
[1.4%] vs. 8 of 341 patients [2.3%); P = 0.528).
Follow-Up
The median follow-up for survivors was 4.9 years
(range, 0.1-11.1 years) among patients with tumors of
the upper extremity and 4.7 years (range, 0.2-12.9
























FIGURE 1. Kaplan-Meier curve for the local recurrence free rate. Tick marks
represent censored patients.
years) among patients with tumors of the lower ex¬
tremity.
Local recurrence
There were 23 patients (n = 139 tumors) who devel¬
oped local recurrences in the upper extremity and 25
patients [n = 341 tumors) who developed local recur¬
rences in the lower extremity. The median time to
local recurrence was 1.3 years (range, 0.2-9.2 years) for
patients with tumors of the upper extremity and 1.6
years (range, 0.1-6.6 years) for patients with tumors of
the lower extremity. The local recurrence free rate at 5
years was 82% for patients with tumors of the upper
extremity and 93% for patients with tumors of the
lower extremity (log-rank test; P = 0.002) (Fig. 1).
The difference in the local recurrence free rate
between the extremities was investigated with a Cox
proportional hazards regression model. First, recog¬
nizing the difference in tumor size between the ex¬
tremities, regression was performed using the greatest
tumor dimension as a single, continuous variable.
This did not reach significance (P = 0.074), confirming
our belief that tumor size is not a determinant of local
recurrence. A second model was constructed using (in
the following order) categorical variables for surgical
margin status (negative or positive), extremity (lower
or upper), unplanned excision before referral (no or
yes), and an interaction variable of extremity and un¬
planned excision before referral. Plots for each vari¬
able confirmed proportionality of the hazard ratio
over time. Surgical margin status reached significance
in the model (P < 0.001) with a hazard ratio of 3.16
(95% confidence interval, 1.76-5.69) associated with a
positive margin. Extremity, unplanned excision before
referral, and the interaction variable of extremity and
unplanned excision before referral did not reach sig¬
nificance (P = 0.127, P = 0.056, and P = 0.868, respec¬
tively).
An exploratory analysis of the correlation between
an unplanned excision before referral, surgical margin
status, and local recurrence compared crude local re¬
currence rates in four groups (Table 4). Among pa¬
tients who underwent primary excision of a tumor
with positive surgical margins, patients who had tu¬
mors of the upper extremity were more likely to de¬
velop a local recurrence compared with patients who
had tumors of the lower extremity (3 of 13 patients
[23.1%] vs. 2 of 46 patients [4.3%]; P = 0.032).
A further exploratory analysis examined the effect
of radiotherapy on local recurrence by calculating how
many patients who developed local recurrences
among these four groups had received radiotherapy
(Table 4). Six of 11 patients with upper extremity tu¬
mors who underwent unplanned excision before re¬
ferral and reexcision with negative margins and who
developed a local recurrence had not received radio¬
therapy. In three patients, all with tumors located
around the shoulder, this was because radiotherapy
had been given on a previous occasion, precluding
further radiotherapy. In two of the remaining patients,
radiotherapy was not given, because no tumor was
identified in the reexcision specimen. The sixth pa¬
tient had a low-grade fibrosarcoma around the shoul¬
der that was believed to have been completely excised.
Metastasis free survival
Twenty-six patients with upper extremity tumors (n
= 139 tumors) developed a metastasis compared with
105 patients with lower extremity tumors (n = 341
tumors). The median time to metastasis was 1.0 years
(range, 0.1-6.7 years) after surgery for patients with
tumors of the upper extremity and 1.0 years (range,
0.1-12.8 years) after surgery for patients with tumors
of the lower extremity. The metastasis free rate at 5
years was 82% for patients with tumors of the upper
extremity and 69% for patients with tumors of the
lower extremity (log-rank test; P = 0.013) (Fig. 2).
There was a trend toward fewer metastases in patients
with distal tumors (Table 2).
To investigate the difference in metastasis free
rates between the extremities, a Cox proportional haz¬
ards model was constructed using, in the following
order, histologic grade (low [Grade 1] or high [Grade 2
or 3]), greatest tumor dimension (in cm), depth (su¬
perficial or deep), and extremity (upper or lower).
Proportionality over time was confirmed for each vari¬
able. There was an increased risk of metastasis with
high histologic grade (hazard ratio, 17.28; 95% confi¬
dence interval, 4.26-70.10; P < 0.001), greatest tumor
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TABLE 4
Exploratory Analysis of the Relation between Unplanned Excision Before Referral, Surgical Margin Status, and Local Recurrence
Upper extremity Lower extremity
No. oflocal Local recurrences No. of local Local recurrences P value for difference
No. of recurrences not given No. of recurrences not given in local recurrence rates
Group patients (%) radiotherapy patients (%) radiotherapy between extremities
Primary excision with negative
surgical margins 37 2 (5.4) 1 135 7(5.2) 0 0.957
Primary excision with positive
surgical margins 13 3 (23.1) 1 46 2(4.3) 0 0.032
Unplanned excision before
referral, reexcision with
negative margins 74 11 (14.9) 6 135 9(6.7) 2 0.054
Unplanned excision before
referral, reexcision with
positive margins 15 7 (46.7) 0 25 7(28.0) 1 0.231
rates vary with anatomic location. In particular, local
recurrence is more frequent after treatment of an up¬
per extremity sarcoma. Conversely, lower extremity
sarcomas are associated with an increased metastatic
rate.
A number of factors may contribute to the higher
local recurrence rate among patients with tumors of
the upper extremity. These include differences in tu¬
mor characteristics, such as histologic type, and dif¬
ferences in treatment, such as the effect of unplanned
excision before referral and the use of radiotherapy.
The strongest predictor of local recurrence in many
studies is a positive surgical margin, which implies the
presence of residual disease.7,14,20,21 The Cox model
confirmed this correlation in our series and showed
that, after incorporating the effects of a positive sur¬
gical margin, an unplanned excision before referral, or
the location of a soft tissue sarcoma in the upper
extremity rather than the lower extremity, they did not
reach significance. Sadoski et al. suggested that the
relation between a positive surgical margin and local
recurrence is stronger in the upper extremity com¬
pared with the lower extremity.21 However, in our
series, there was a higher local recurrence rate in the
upper extremity in both patients with positive margins
and patients with negative margins (Table 4).
The proportion of patients who had positive sur¬
gical margins was particularly high (16 of 41 patients)
among those who had tumors around the elbow,
which may reflect local anatomy. Despite this finding,
the local recurrence rate in this group was not as high
as it was among patients with tumors in other upper
extremity sites (Table 2). The reason for this may be
that four patients in this group had low-grade liposar-
comas and, thus, were at low risk of local recurrence.
Although it was a subgroup analysis and, thus,
Time in years
FIGURE 2. Kaplan-Meier curve for the metastasis free rate. Tick marks
represent censored patients.
dimension (hazard ratio, 1.05; 95% confidence inter¬
val, 1.02-1.08; per cm increase, P < 0.001), and deep
location (hazard ratio, 1.93; 95% confidence interval,
1.07-3.48; P = 0.028). The variable for extremity did
not reach significance (P = 0.211).
DISCUSSION
This study compared the presentation, treatment, lo¬
cal recurrence free rate, and metastasis free rate of
upper and lower extremity soft tissue sarcomas in our
patient population. We showed that patients with up¬
per extremity tumors have smaller lesions, more often
undergo unplanned excision before referral, have tu¬
mors of different histologic types, and less often meet
our criteria for adjuvant radiotherapy. We also showed
that, after treatment for extremity soft tissue sarcoma,
the local recurrence free rates and metastasis free
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should be treated with caution, it is interesting to note
that there was a significant difference in local recur¬
rence rates between the extremities among patients
who underwent primary excision with positive mar¬
gins. There are a number of possible explanations for
this. We showed previously that an unexpected posi¬
tive margin after a surgical error is associated with a
higher risk of local recurrence compared with a
planned positive margin against a critical structure
(such as nerve, vessel, or bone) or a planned marginal
resection of a low-grade liposarcoma.22 In 5 of 16
patients (31.3%) who underwent primary resection of
an upper extremity sarcoma with a positive surgical
margin, the positive margin was unexpected com¬
pared with 8 of 48 patients (16.7%) with lower extrem¬
ity sarcomas, which may explain the higher local re¬
currence rates. This suggests that primary resection of
a soft tissue sarcoma in the upper extremity is tech¬
nically more demanding or that, to preserve function,
the surgeon is prepared to operate closer to the tumor
in the upper extremity. Another explanation for the
difference in local recurrence rates is that there were
more low grade liposarcomas in the lower extremity.
These tumors are at low risk for local recurrence.23
The distribution of histologic types may have con¬
tributed to the difference in local recurrence rates
between the extremities in another way. The histologic
types angiosarcoma and malignant peripheral nerve
sheath tumor have been associated with an increased
risk of local recurrence.12,24 Both of these types were
relatively more frequent among tumors of the upper
extremity compared with tumors of the lower extrem¬
ity. Within the upper extremity, these histologic types
were associated with 4 of 23 patients (17.4%) who
developed local recurrences, compared with 2 of 25
patients (8.0%) who had tumors of the lower extremity
(Table 3).
Variations in the use of radiotherapy also may
have influenced the local recurrence rate. In particu¬
lar, patients with tumors around the shoulder did not
meet our criteria for radiotherapy as often as patients
who had tumors in other upper extremity sites. This
probably is because a proportion of soft tissue sarco¬
mas around the shoulder occur in muscle (such as
deltoid), where they can be excised with an adequate
margin more readily compared with tumors located in
other upper extremity sites. Therefore, it is more likely
that an unplanned excision will be successful in re¬
moving all identifiable tumor, and adjuvant radiother¬
apy is not indicated after reexcision. It also was more
common for the shoulder to have been treated with
radiotherapy previously, both for the presenting tu¬
mor and for unrelated conditions, such as Hodgkin
disease.
An unplanned excision complicates the further
management of patients with soft tissue sarcoma by
obscuring tissue planes and potentially contaminating
a large volume of tissue. Patients with tumors of the
upper extremity more frequently undergo unplanned
excision before referral, possibly because the tumors
are smaller and more often are superficial. However,
whether unplanned excision increases the risk of re¬
currence remains controversial,25 and we could not
conclusively prove an adverse influence of unplanned
excision on local recurrence in the Cox model.
The finding that lower extremity tumors are asso¬
ciated with a higher rate of metastasis confirms the
reports of other authors.4,9,16 The Cox model sug¬
gested that that most of this difference is accounted
for by recognized risk factors for metastasis (i.e.,
grade, size, and depth4,5,7,8,16) rather than another
hitherto unrecognized feature of lower extremity sar¬
comas. The analysis makes the assumption that, after
the treatment of an extremity soft tissue sarcoma,
local recurrence and metastases are independent
events and are not competing events. The length of
follow-up of survivors was similar among patients
with tumors of the upper extremities and patientswith
tumors of the lower extremities; therefore, we do not
believe that the higher local recurrence rate among
patients with tumors of the upper extremity was
caused by an increased death rate and shorter follow-
up of patients with tumors of the lower extremity.
There were more tumors of the lower extremities
than tumors of the upper extremities in our series, an
experience shared by other authors.11-15 This probably
reflects the greater volume of mesenchymal tissue
available to undergo malignant change in the lower
extremity. Tumors in the upper extremity are smaller,
probably because the smaller volume of the extremity
allows the earlier detection of tumors or because the
upper extremities are exposed, and abnormal swell¬
ings are identified readily. However, in common with
others, we have shown that tumor size is not a strong
predictor of local recurrence.4,5,7 We agree with the
suggestion that the threshold above which a mass
should be treated as potentially malignant should be
lower for patients with tumors of the upper extremity.9
The larger size of lower extremity tumors probably
explains why they more often involve the investing
fascia of the limb and, thus, are classified as deep.
In conclusion, we have shown that, among our
patient population, sarcomas of the upper extremity
were associated with a higher local recurrence rate
compared with sarcomas of the lower extremity be¬
cause of differences in histologic type, the use of ra¬
diotherapy, and local anatomy. Although patients with
upper extremity sarcomas more often underwent un-
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planned excision before referral, we could not conclu¬
sively prove that this had an adverse effect on local
tumor control. In contrast, lower extremity sarcomas
tend to be larger and more often are deep to fascias
compared with upper extremity sarcomas; therefore,
patients with lower extremity sarcomas have an in¬
creased risk of metastasis. This study also shows that,
in our patient population, the higher rate of local
recurrence in the upper extremity was not matched by
a higher rate of metastatic disease. This supports our
philosophy of preserving function in the upper ex¬
tremity when possible. We do not believe that there is
an underlying difference in the biological behavior of
upper extremity soft tissue sarcoma and lower extrem¬
ity soft tissue sarcoma, although the clinical course
differs depending on the anatomic location.
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The Influence of Anatomic Location on Functional Outcome in
Lower-Extremity Soft-Tissue Sarcoma
C. H. Gerrand, FRCSEd (Tr and Orth), J. S. Wunder, FRCS(C), R. A. Kandel, FRCP(C),
B. O'Sullivan, FRCP(C), C. N. Catton, FRCP(C), R. S. Bell, FRCS(C), A. M. Griffin, BSc,
and A. M. Davis, PhD
Background: The purpose of this study was to explore the relationship between the anatomical
location of lower-extremity soft-tissue sarcoma and functional outcome.
Methods: Function was evaluated with the Musculoskeletal Tumor Society (MSTS 1993) score
and Toronto Extremity Salvage Score (TESS); 207 patients (median age, 54 years) were eligible.
The median maximum tumor diameter was 8.0 cm; 58 tumors were superficial and 149 were deep.
Nine locations based on anatomical compartments were defined: 6 tumors were in the groin/femoral
triangle; 8, the buttock; 52, the anterior thigh; 22, the medial thigh; 20, the posterior thigh; 10, the
popliteal fossa; 13, the posterior calf; 11, the anterolateral leg; and 7, the foot or ankle.
Results: Treatment of superficial tumors did not lead to significant changes in MSTS score
(mean, 90.6% preoperatively vs. 93.0% postoperatively; P = .566) or TESS (mean, 86.4%
preoperatively vs. 90.9% postoperatively; P = .059). Treatment of deep tumors lead to significant
reductions in MSTS score and TESS (mean MSTS, 86.9% preoperatively vs. 83.0% postoperatively;
P = .001; and mean TESS, 83.0% preoperatively vs. 79.4% postoperatively; P = .015). Anatomical
location was not a significant predictor of aggregated MSTS and TESS evaluations. Exploratory
analysis showed variation in MSTS pain and gait handicap or limp items and TESS dressing, sitting,
bending, and bathing items by anatomical location.
Conclusions: The treatment of superficial tumors does not lead to significant changes in MSTS
score or TESS. Anatomical location is not a significant predictor of aggregated MSTS and TESS
evaluations. However, there is variation in MSTS and TESS item scores across anatomical locations.
Key Words: Lower extremity—Soft-tissue sarcoma—Anatomical site—Functional outcome.
The function of patients after treatment is an important
consideration in the management of extremity soft-tissue
sarcoma. In this context, function has been conceptual¬
ized in a variety of ways. Some authors have used
clinical measures such as range of motion and muscle
strength1-2 or activities of daily living.1 The Musculo¬
skeletal Tumor Society Rating Scale (MSTS 1987) com¬
bines symptoms and clinical measures,3 and the revised
MSTS (1993) includes scores for symptoms, mobility,
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and the use of assistive devices.4 Other studies have used
generic health measures, such as the Sickness Impact
Profile.5 We have previously used the World Health
Organization definitions of impairment, disability, and
handicap as a guide to the assessment of function.6'7 The
Toronto Extremity Salvage Score (TESS) was based
upon the World Health Organization definition of dis¬
ability as "any restriction or lack of ability to perform an
activity in the manner or within the range considered
normal for a human being."6 The TESS evaluation has
demonstrated reliability, validity, and responsiveness in
the extremity sarcoma population.8'9 The MSTS scores
are closest to the WHO definition of impairments as "any
loss or abnormality of psychological, physiological, or
anatomical structure or function."6
We have previously analyzed factors that predict func¬
tional outcome after treatment of lower-extremity soft-
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tissue sarcoma as measured by the MSTS and TESS
rating systems.7 We showed that large tumor size, resec¬
tion of bone, resection of major motor nerves, and com¬
plications of surgery predicted lower MSTS 1987 and
1993 scores and that patients with large, high-grade
tumors who required motor nerve resection had lower
TESS values.7 Although anatomical location as defined
as proximity to the nearest major joint (hip, knee, ankle)
was not a significant predictor of functional scores in this
study, we hypothesized that the anatomical location of a
tumor is nevertheless important in determining func¬
tional outcome. For example, function after treatment of
a buttock tumor is likely to differ from function after
treatment of a tumor in the foot or ankle by virtue of
anatomical location alone. The purpose of this study
therefore was to further examine the influence of ana¬
tomical location on functional scores in patients with
lower-extremity soft-tissue sarcoma.
PATIENTS AND METHODS
Patients were eligible for this study if they underwent
limb-sparing surgery in our center for lower-extremity
soft-tissue sarcoma and had a minimum follow-up of 1
year for functional evaluation, at which point functional
scores are known to plateau.10 Two measures were used
to assess function. The MSTS (1993) is completed by the
clinician and consists of six items: pain, overall function,
emotional acceptance, walking ability, walking aids, and
gait handicap or limp.4 Each item is rated on a scale of 1
to 5. The total score is calculated from a sum of the
individual items and expressed as a percentage. The
TESS questionnaire is completed by the patient and
comprises 30 items in which the patient indicates the
difficulty experienced in performing a range of everyday
activities, such as dressing, grooming, mobility, work,
sports, and leisure.8 Each item is rated on a scale of 1 to
5 and the total is expressed as a percentage. The TESS
was first used in April 1994, and therefore patients
treated before this date were excluded. Patients were also
excluded if they had metastases at presentation, had a
local or systemic relapse before functional assessment at
1 year, or underwent chemotherapy. The lower extremity
was defined as commencing at the pelvic brim.
We did not use the MSTS (1987) system because it is
site-specific and therefore not suitable for this analysis.
We did not use the generic general health status measure
Short-Form 36 (SF-36) because we have shown that it is
not sensitive to local treatment factors.7
A prospectively collected database was used to iden¬
tify suitable patients and the following data were ex¬
tracted from it: age, gender, type of surgery, metastases
at presentation (yes/no [Y/N]), presentation with a local
recurrence (Y/N), chemotherapy (Y/N), radiotherapy (Y/
N), unplanned excision before referral (Y/N), histologi¬
cal type and grade, maximum tumor diameter in centi¬
meters, resection of bone (Y/N), resection of major
motor nerve (Y/N), and complications of surgery (Y/N).
Complications of surgery were defined as major wound
dehiscence, infection, or fracture.
Anatomical Definitions
The anatomical location of the tumor was determined
by review of the operating note and imaging. One author
(CG) assigned tumors to anatomical regions as described
below. These regions were based upon the concept of
anatomical compartments developed by Enneking be¬
cause these were thought to have both oncological and
functional significance.11 A tumor involving more than
one region was assigned to the region that was most
involved. Tumors superficial to and not involving the
deep investing fascia of the limb were classified as
superficial and others as deep. To minimize errors, data
relating to anatomical location were entered twice into a
spreadsheet (Excel 97, Microsoft, Redmond, WA) and
checked for compatibility with the preexisting anatomi¬
cal classification, in which tumors were grouped by their
proximity to the nearest major joint.
Groin/Femoral Triangle
This triangle comprises proximally the inguinal liga¬
ment, posteriorly the iliopsoas and anterior hip capsule,
and laterally the tendon of rectus femoris, as well as the
proximal extent of the femoral artery, vein, nerve, and
inguinal nodes.
Buttock
The buttock comprises proximally the posterior brim
of pelvis, medially the sacrum, anteriorly the posterior
border of tensor fascia lata, the anterior border of gluteus
medius, and as the deep boundary, the outer table of
pelvis. It also contains the gluteus maximus, minimus,
medius, quadratus femoris, and the proximal extent of
the sciatic nerve.
Anterior Thigh
This comprises proximally the brim ofpelvis, distally the
patella, and laterally the intermuscular septum. It also con¬
tains the quadriceps, including patella and patellar tendon,
sartorius, tensor fascia lata, femoral artery, vein, and nerve.
Medial Thigh
This comprises proximally the pubic rami and ischial
tuberosity, anterolaterally the adductor canal and medial
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intermuscular septum, posteriorly the posterior surface of
adductor magnus, and distally the pes anserinus. It also
contains the gracilis, adductors brevis, longus, magnus,
pectineus, and profunda femoris vessels.
Posterior Thigh
This comprises laterally the intermuscular septum,
medially the adductor magnus fascia, proximally the
ischial tuberosity, distally the musculotendinous junc¬
tions of the hamstring muscles, anteriorly the linea as-
pera, and the posterior face of femur. It also contains the
semimembranosus, semitendinosus, and biceps femoris.
Popliteal Fossa
This comprises superficially the deep fascia, anteriorly
the posterior capsule of knee joint and the heads of
gastrocnemius, distally the confluence of gastrocnemius,
and proximally the musculotendinous junctions of ham¬
strings. It also contains the sciatic nerve, popliteal ves¬
sels, and lymph nodes.
Posterior Calf
This comprises anteriorly the posterior surface of the
tibia, interosseous membrane, posterior aspect of fibula,
and posterior intermuscular septum; posteriorly the deep
fascia of the calf; superiorly the confluence of gastroc¬
nemius; distally the commencement of the tendo Achil¬
les. It also contains the gastrocnemius, plantaris, soleus,
popliteus, flexor digitorum longus, flexor hallucis longus
and tibialis posterior, and the posterior tibial vessels and
nerve.
Anterolateral Leg
This comprises anteriorly the deep fascia of the leg;
posteriorly the lateral surface of the tibia, the interosse¬
ous membrane, the fibula, and the posterior intermuscu¬
lar septum; proximally the proximal extent of the inser¬
tion of tibialis anterior into the tibia; and distally the
superior extensor retinaculum of the ankle. It also con¬
tains the peroneus longus and brevis, peroneus tertius,
extensor digitorum longus, extensor hallucis longus, tib¬
ialis anterior, the anterior tibial vessels, and the deep
peroneal nerve.
Foot and Ankle
Proximally this space in bounded by the superior ex¬
tensor retinaculum anteriorly and the commencement of
the tendo Achilles posteriorly.
Analysis
Initially, descriptive variables were calculated for the
whole group of eligible patients. Recognizing that treat¬
ment of tumors located superficial to the investing fascia
of the limb was likely to have little impact on the
function of the underlying compartment, these superfi¬
cial tumors were analyzed as a separate group. Next,
variables for the anatomical location of deep tumors
were added to factors already recognized to have an
influence on MSTS (1993) score and TESS in multiple
linear regression models. Finally, an exploratory analysis
was performed in which individual MSTS and TESS
items for deep tumors were compared by anatomical
location.
Statistical Notes
Differences in mean values between two groups were
compared with use of independent-samples /-tests and
between multiple groups with one-way analysis of vari¬
ance (ANOVA) and the Tukey post-test. Differences in
proportions were compared with the Pearson x2 test.
MSTS scores and TESS values are not normally distrib¬
uted. Therefore, when comparing scores between two
groups, we used the nonparametric Mann-Whitney test.
When comparing scores before and after treatment, we
used the Wilcoxon test for paired samples, and we used
the Kruskal-Wallis test to compare scores across more
than two groups. Results with a P value of < .05 were
taken to be significant (SPSS software for Windows,
release 10.0.5, 1999; SPSS, Chicago).
RESULTS
Between April 1994 and March 1999, data relating to
397 patients were collected. Ninety-seven patients had
upper-extremity tumors and 17 had an amputation. The
following patients were also excluded: 22 with metasta¬
ses at presentation, 32 who developed metastases, 2 who
died of other causes, 3 with a local recurrence in the first
year, and 10 who received chemotherapy. For seven
patients there were no functional data available. There¬
fore, 207 patients remained in the study.
Completeness of Function Data
Preoperative MSTS results were available for 203, and
1- or 2-year MSTS results were available for 189 pa¬
tients. Preoperative TESS results were available for 172
and 1- or 2-year TESS results were available for 155
patients. Of the patients for whom 1- or 2-year TESS
results were not available, 20 did not speak English, 11
were lost to follow-up, 7 were infirm and unable to
complete the questionnaire, and 14 had no data available
for other reasons.
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TABLE 1. Differences in characteristics and functional scores between deep and superficial tumours
MSTS TESS
Mean Mean Mean
No. of diameter in Complications Mean preop postop Mean preop postop
Site cases cm (SD) of surgery Radiotherapy score score score score
Superficial 58 4.6 (3.2) 10 35 90.6 (32.0- 93.0 (23.0- 86.4 (29.2- 90.9 (41.7-
100.0, 17.2)" 100.0, 14.0) 100.0, 18.6) 100.0, 14.0)
Deep 149 11.2 (6.6) 41 135 86.9 (16.0- 83.0 (23.0- 81.8 (15.0- 79.5 (25.8-
100.0, 20.3) 100.0, 19.9) 100.0, 20.5) 100.0, 18.0)
P < 0.0001'' P = 0.123 P < 0.0001 P = 0.271 P < 0.0001 P = 0.081 P < 0.0001
" Range and standard deviation for functional scores shown in parentheses.
A P values are shown for comparison of values between superficial and deep tumours.
SD, standard deviation; MSTS, Musculoskeletal Tumor Society; TESS, Toronto Extremity Salvage Score.
Characteristics of the Whole Group
There were 106 females (51.2%) and 101 males
(48.8%), of median age 54 (15 to 89) years. Twelve
patients (5.8%) presented with a local recurrence after
treatment elsewhere. Seventy-six patients (36.7%) had
been treated by unplanned excision before referral. The
distribution of histological types was similar to that in
other series, with malignant fibrous histiocytoma in 48
(23.2%), liposarcoma otherwise undesignated in 49
(23.7%), and myxoid liposarcoma in 28 (13.5%). Tu¬
mors were grade 1 in 40 cases (19.3%), grade 2 in 76
(36.7%), and grade 3 in 91 (44.0%). The median maxi¬
mum tumor diameter was 8.0 cm (0.3 to 36.0).
A tissue transfer or split-thickness skin graft was used
for wound closure in 40 cases (19.3%), and 170 patients
(82.1%) received adjuvant radiotherapy. Resection of
bone was required in 12 cases (5.8%), and resection of a
major motor nerve in 12 cases (5.8%). Forty-eight pa¬
tients (23.2%) had a wound complication and 3 (1.4%)
had a fracture.
After anatomical classification there were 58 superfi¬
cial tumors (28.0%) and 149 deep tumors (72.0%). Su¬
perficial tumors were significantly smaller than deep
tumors (4.6 vs. 11.2 cm; P < .0001). Of the deep tumors,
6 were located in the groin/femoral triangle, 8 in the
buttock, 52 in the anterior thigh, 22 in the medial thigh,
20 in the posterior thigh, 10 in the popliteal fossa, 13 in
the posterior calf, 11 in the anterolateral leg, and 7 in the
foot and ankle (Table 2). Of the deep tumors, 119
(79.9%) involved one site only, 28 (18.8%) involved two
sites, and 2 (1.3%) involved three sites.
The Differences Between Deep and Superficial
Tumors
Functional scores grouped according to whether the
tumor was superficial or deep are shown in Table 1.
There was no significant difference in MSTS score or
TESS at presentation when superficial and deep tumors
were compared (mean MSTS score, 90.6% [superficial]
vs. 86.9% [deep]; P = .271; and mean TESS, 86.4%
[superficial] vs. 81.8% [deep]; P = .081). Treatment of
superficial tumors was not associated with a significant
change in MSTS score (mean, 90.6% preoperatively vs.
93.0% postoperatively; P = .566) or TESS (mean,
86.4% preoperatively vs. 90.9% postoperatively; P =
.059). However, treatment of deep tumors was associated
with a significant reduction in MSTS score and TESS
(mean MSTS, 86.9% preoperatively vs. 83.0% postop¬
eratively; P = .001; mean TESS, 83.0% preoperatively
vs. 79.4% postoperatively; P = .015). MSTS and TESS
results differed significantly between superficial and
deep tumors after treatment (mean MSTS, 93.0% [super¬
ficial] vs. 83.0% [deep]; P = .000; mean TESS, 90.9%
[superficial] vs. 79.4% [deep], P = .000).
Variation in Characteristics of Deep Tumors by
Anatomical Location
Variation in tumor size, type, treatment, and functional
scores among deep tumors by anatomical location is
summarized in Table 2. Comparison of MSTS score and
TESS by anatomical location revealed no significant
differences in preoperative MSTS score (P = .120) or
TESS (P — .282). The impact of anatomical location of
deep tumors on postoperative MSTS score was assessed
with a linear regression model in which variables previ¬
ously shown to be significant in predicting postoperative
MSTS score (tumor diameter, grade, motor nerve sacri¬
fice, bone resection, complications of surgery) were
used.7 The only factor to reach significance was resection
of a motor nerve (P < .0001).
A multiple regression model for postoperative TESS
was constructed in the same fashion with use of variables
previously identified as predictive (tumor diameter,
grade, and motor nerve resection). Once more, resection
of a motor nerve was the only variable to reach signifi¬
cance in this model {P = .002).
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motor Compli¬ Mean Mean Mean Mean
No. of in cm nerve Bone cations of Radio¬ preop postop preop postop
Anatomical location cases (SD) resection resection surgery therapy score score score score
Groin/femoral triangle 6 8.8 (1.9) 2 1 4 6 58.6 64.3 54.9 63.8 (25.8-
(16-80, (27-90, (15.0- 82.5, 20.9)
28.1)" 24.1) 89.2, 31.5)
Buttock 8 8.1 (4.1) 2 8 86.8 90.0 79.2 77.8 (54.2-
(33-100, (77-100, (19.4-100, 99.1, 19.7)
22.3) 9.3) 31.9)
Anterior thigh 52 11.8 4 1 12 47 89.8 80.1 80.7 77.5 (25.8-
(6.3) (20-100, (23-100, (21.7-100, 100, 19.6)
18.6) 23.7) 17.6)
Medial thigh 22 13.5 9 17 84.9 88.0 81.2 83.1 (35.8-
(8.5) (27-100, (37-100, (24.1-100, 100, 18.7)
22.7) 18.1) 22.5)
Posterior thigh 20 14.9 2 1 18 90.4 80.5 85.9 75.7 (54.2-
(6.5) (67-100, (43-100, (54.4-100, 96.7, 12.6)
12.1) 17.3) 13.9)
Popliteal fossa 10 9.5 (5.7) 1 3 10 93.8 92.3 90.6 83.3 (43.5-
(80-100, (67-100, (71.7-100, 100, 19.1)
8.3) 11.6) 11.3)
Posterior calf 13 8.8 (4.8) 1 1 5 13 79.8 87.0 76.2 88.3 (68.3-
(24-100, (60-100, (15.0-100, 100, 11.5)
26.1) 14.7) 27.6)
Anterolateral leg 11 8.7 (5.5) 1 6 2 10 91.8 84.4 90.6 80.2 (39.2-
(48-100, (50-100, (66.7-100, 97.5, 18.7)
16.8) 17.3) 10.8)
Foot and ankle 7 4.6 (1.7) 2 3 6 77.7 84.2 90.4 88.1 (73.3-
(24-100, (57-100, (67.5-100, 100, 11.3)
28.0) 17.6) 13.3)
" Range and standard deviation for functional scores shown in parentheses.
SD, standard deviation; MSTS, Musculoskeletal Tumor Society; TESS, Toronto Extremity Salvage Score.
Comparison of MSTS and TESS Items by
Anatomical Location
An exploratory analysis of item variation by ana¬
tomical location was performed with use of the non-
parametric Kruskal-Wallis test. Items in which there
was significant variation by anatomical location were
further examined. There was significant variation by
anatomical location for the pain and gait handicap or
limp items of the preoperative MSTS (Table 3). Tu¬
mors in the groin/femoral triangle were associated
with more preoperative pain than those in other loca¬
tions. Preoperatively all patients with tumors in the
groin/femoral triangle required analgesia, with most
requiring narcotic analgesia. The lowest preoperative
mean score for the gait handicap or limp item was for
tumors in the groin/femoral triangle, followed by the
TABLE 3. MSTS subscales for pain and gait handicap or limp by anatomical location
MSTS preop, mean scores MSTS postop, mean scores
Gait handicap Gait handicap or
Anatomical location Pain or limp Pain limp
Groin/femoral triangle 1.4 4.0 2.7 3.8
Buttock 3.5 5.0 3.8 4.7
Anterior thigh 4.2 4.8 4.0 4.6
Medial thigh 3.8 5.0 4.4 5.0
Posterior thigh 4.0 5.0 3.9 4.8
Popliteal fossa 4.6 4.9 4.4 5.0
Posterior calf 3.9 4.2 4.2 5.0
Anterolateral leg 4.3 4.7 4.2 4.6
Foot and ankle 3.7 4.3 4.0 5.0
MSTS, Musculoskeletal Tumor Society.
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posterior calf, the foot and ankle, and the anterolateral
leg (Table 3).
In the postoperative MSTS, significant variation was
also seen in item scores for gait handicap or limp. Once
more, the lowest postoperative scores were seen in tu¬
mors in the groin/femoral triangle. Patients with tumors
in the medial thigh, popliteal fossa, posterior calf, and
foot and ankle all walked normally (Table 3).
In the preoperative TESS, the exploratory statistical
analysis did not identify any items with significant vari¬
ation by anatomical location, although the item score for
sitting approached significance. Patients with tumors in
the groin7femoral triangle, buttock, and posterior thigh
had the greatest difficulty with sitting (Table 4).
In the postoperative TESS significant variation was
seen in the items for putting on pants, putting on socks or
stockings, getting in and out of the bath, and bending to
pick something up off the floor (Table 4). Once more,
patients with tumors in the groin/femoral triangle had the
greatest difficulty with these activities. Putting on socks
and stockings also appeared to be difficult for those with
posterior thigh or buttock tumors. Getting in and out of
the bath was also difficult for those with posterior thigh
or anterolateral leg tumors. Bending to pick something
up off the floor was most difficult for patients with
tumors in the groin/femoral triangle, buttock, and the
posterior thigh (Table 4).
DISCUSSION
The purpose of this study was to examine the influ¬
ence of anatomical factors on impairment as measured
by MSTS (1993) score and disability as measured by
TESS. We have shown a difference in MSTS and TESS
when superficial and deep tumors are compared and that
although there does not appear to be significant variation
in the MSTS and TESS for deep tumors by anatomical
location, some items do vary with anatomical location.
Our study shows that unlike deep tumors, the treat¬
ment of superficial tumors is not associated with a sig¬
nificant decrease in MSTS and TESS values. In fact,
mean scores for superficial tumors increase slightly after
treatment, whereas those for deep tumors decrease after
treatment. Higher MSTS (1993) and TESS values for
superficial tumors likely reflect their smaller size and the
fact that surgery does not involve major muscle, motor
nerve, or bone resection.
We could not demonstrate that the variables for ana¬
tomical location made a significant contribution to total
postoperative MSTS score and TESS in the regression
model, and it may be that our study was not sufficiently
powered to detect this. However, the exploratory analy¬
sis suggests that most of the variability with anatomical
location lies at the item level, rather than in aggregated
scores. Although the number of patients in the group was
small, it was of interest that tumors in the groin/femoral
triangle were associated with more preoperative pain, as
measured by the MSTS item for pain, than those in other
locations. This may be related to the relatively high rate
of major nerve involvement in this location (two of six
patients required major motor nerve resection). Other
than those in the groin, tumors located below the knee
appeared to be associated with the lowest preoperative
gait handicap or limp item scores. Postoperatively tu¬
mors in the groin/femoral triangle were associated with
the lowest mean MSTS gait handicap or limp item
scores. This may have been because one patient had a
major femoral nerve resection and scored zero for the
gait handicap or limp item postoperatively.
TABLE 4. Selected TESS item scores by anatomical location
Preop TESS,
mean item
scores TESS postop, mean item scores
Putting on Bending to pick
Putting on socks or Getting in and something up off
Anatomical location Sitting pants stockings out of the bath the floor
Groin/femoral triangle 3.8 3.5 3.0 3.2 3.2
Buttock 3.9 4.2 3.8 4.0 3.4
Anterior thigh 4.7 4.6 4.1 4.1 3.9
Medial thigh 4.4 4.4 3.9 4.2 4.0
Posterior thigh 4.2 4.1 3.1 3.5 3.8
Popliteal fossa 4.9 4.6 4.4 4.6 4.0
Posterior calf 4.6 4.9 4.8 4.6 4.7
Anterolateral leg 4.9 4.9 4.3 3.9 4.0
Foot and ankle 5.0 5.0 5.0 4.8 4.8
TESS, Toronto Extremity Salvage Score.
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The TESS evaluation contains a greater number of
items than the MSTS, and some items, such as the ability
to sit, are likely to have a clear relationship with ana¬
tomical location. We found that tumors in the buttock
and posterior thigh were associated with greater diffi¬
culty in sitting than those in other locations, which may
reflect the discomfort experienced when sitting directly
on the tumor. Patients with tumors in the groin/femoral
triangle also have difficulty sitting normally, likely be¬
cause of restriction of normal hip flexion. The postoper¬
ative TESS evaluation confirms that after treatment, pa¬
tients with tumors in the groin/femoral triangle continue
to score lower for the items putting on socks, getting out
of the bath, and bending to pick up, all of which involve
hip flexion.
To conclude, we have shown that when considering
the function of a patient after treatment of lower-extrem¬
ity soft-tissue sarcoma, anatomical location is important.
The treatment of superficial tumors is not associated with
a significant decrease in functional scores, whereas the
treatment of deep tumors is. Although the contribution of
the anatomical location of deep tumors to aggregated
MSTS (1993) and TESS values does not appear to be
significant, there is variation in score items with anatom¬
ical location. This information may be of value in coun¬
seling patients about their likely disability and impair¬
ment after treatment.
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